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ABSTRACT
The overall objective was to develop new synchronization protocols that facilitate fixed-
time artificial insemination (AI). A series of experiments were designed to evaluate the
effects of estradiol and progesterone on gonadotrophin release, follicular wave
emergence and ovulation in beef cattle. In ovariectomized cows, a new CIDR-B device
increased plasma progesterone to near-luteal concentrations, but for only 2 to 3 days.
Injection of 100 mg progesterone increased plasma progesterone approximately 2
ng/mL. Progesterone suppressed plasma LH concentrations but did not affect plasma
FSH concentrations. Estradiol, with or without progesterone, resulted in FSH
suppression with resurgence (and follicular wave emergence) at an interval that varied
according to the estradiol formulation. Estradiol administration following CIDR-B
removal resulted in LH release (and ovulation in intact animals). Both estradiol-17~ and
estradiol benzoate (EB) synchronized ovarian follicular wave emergence in CIDR-B-
treated animals and the interval from CIDR-B removal to ovulation (72 to 120 h) was
shorter and more synchronous in estradiol-treated animals than in controls. In cattle
given a CIDR-B device and estradiol plus progesterone, estradiol treatment following
CIDR-B removal 7 days later resulted in acceptable conception rates to fixed-time AI.
Estradiol or GnRH at the beginning and end of a 7-day MGA-based synchronization
regimen resulted in acceptable pregnancy rates to fixed-time AI. In a single experiment,
EB, GnRH or pLH in CIDR-B- or MGA-treated beef heifers effectively synchronized
ovulation for fixed-time AI. Pregnancy rates were, on average, 58.0% (range 52.5 to
65.0%). A 6- or 7-d interval from GnRH to PGF in a Cosynch regimen resulted in
similar pregnancy rates in cows. The addition of a progestin to a Cosynch or Ovsynch
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regimen improved pregnancy rates in heifers but not in cows. Synchronization of
follicular wave emergence and ovulation in a two-dose PGF-based protocol resulted in
acceptable fertility to fixed-time AI; the administration of EB induced luteal regression
in some animals but E-I 7~ did not. In conclusion, synchronization programs including
GnRH, pLH or estradiol to synchronize follicular wave emergence and ovulation in
CIDR-B-, MGA- or two-dose PGF-protocols resulted in acceptable pregnancy rates to
fixed-time AI.
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1.0 GENERAL INTRODUCTION.
The greatest genetic progress in cattle production has been made through the use
of artificial insemination (AI), especially in dairy herds. The use of AI for genetic
improvement involves the use of semen from genetically superior and highly selected
bulls, while genetically superior bulls and cows are used in the embryo transfer industry.
The utilization of AI has increased the number of cows of high genetically merit. For
instance, the genetic improvement of Holstein cattle for milk production through AI has
increased about 5 times since 1980 (Foote, 1996).
Estrus synchronization in cattle has been linked to AI programs. It is also
recognized that the widespread use of AI depends on effective methods to control the
estrous cycle. Although many methods of synchronization have been developed, only
5% of beef herds in Canada use AI, while in dairy cattle the proportion is 72%
(Vetrepharm Can Inc). The development of new methods of manipulation of the bovine
estrous cycle for fixed-time AI is intended to increase those proportions, particularly in
beef cattle.
Knowledge of the bovine estrous cycle has increased considerably due to the
improvement of techniques such as hormone measurements, real-time ultrasonography
to observe the changes in reproductive organs as they occurred (Pierson and Ginther,
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1984, 1988) and magnetic resonance ImagIng used to detect subtle changes in the
molecular composition of the ovaries (Hilton et aI., 2000).
The scientific literature concerning estrus synchronization, AI and embryo
transfer has multiplied as basic knowledge about the estrous cycle in cattle has
increased. Control of the estrous cycle has gone from the control of the luteal phase to
include the control of follicular growth with ovulation occurring at predictable times,
which may facilitate the use of fixed-time AI. The knowledge of ovarian dynamics and
improvement of synchronization protocols will raise producers' confidence and lead to
an increased use of AI.
2.0 REVIEW OF LITERATURE.
2.1 Physiology of the estrous cycle.
2.1.1 Follicular growth in cattle.
Follicular growth begins in the fetus before parturition. By mid-gestation, the
fetal ovary bears primordial follicles which contain oogonia. A bovine female is born
with a complete collection of oogonia in primordial follicles that have only a single flat
cell layer (Erickson, 1966, Wiltbank, 1997). There are on average 133,000 primordial
follicles in the ovary of a bovine female (Erickson, 1966). Primordial follicles are the
source of future follicles during a female's life. The recruitment process begins with the
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formation of primary) follicles in which the surrounding cells become cuboidal and
proliferate (granulosa cells). When granulosa cells multiply and many cell layers
surround the oocytes, the follicle is called a secondalY follicle. Intercellular cavities
develop which are filled with follicular fluid. The cavities converge and conclude with
the formation of a follicular antrum; the follicle is called an antral or Tertiary follicle.
Fully-grown follicles are called Graafian and become preovulatory after the first
preovulatory gonadotrophin surge and before the first ovulation (onset of puberty). In
the reproductive life of the female, a small number of follicles ovulate, but most become
atretic.
Growth of follicles under 2 mm is thought to be independent of gonadotrophins.
In vitro growth of primordial follicles has been observed in the absence of
gonadotrophins in serum-free media (Braw-Tal and Yossefi, 1997). However, there is
evidence that FSH receptors are functionally active during preantral development;
granulosa cells increased in number and there was more thymidine uptake after being
stimulated with FSH in serum-free cultures of bovine oocytes (McNatty et aI., 1999).
The process of growth and further differentiation of a primordial follicle into an
ovulatory follicle can take as long as 60 days (Lussier et aI., 1987). Antral follicles equal
to or greater than 2 mm in diameter are responsive to gonadotrophins (Webb et aI.,
1999), as demonstrated by the exhibition of waves of follicular growth. Follicular waves
begin at a very early age, in 2-week old calves through puberty (Adams et aI., 1994a;
Evans et aI., 1994b).
The hypothesis that the growth of ovarian follicles in cattle occurs in a wave-like
fashion, and that two waves of follicular activity take place during the bovine estrous
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cycle was postulated by Rajakosky (1960), based on studies of slaughterhouse ovaries.
This hypothesis was continued by daily serial observation of the ovaries using real-time
ultrasonography (Pierson and Ginther, 1984). A wave of follicular growth involves the
sYnchronous development of a group of follicles (8 to 40; Adams, 1999) and is
characterized by a dominant follicle and several subordinates. It has been well
established that a bovine cycle regularly consists of two or three follicular waves
(Ginther et aI., 1989a, 1989b). Follicular waves also occur in pregnant (Ginther et aI.,
1996a), postpartum (Rajamahendran and Taylor, 1990; Savio et aI., 1990a, 1990b) and
even prepubertal (Evans et aI., 1994a, 1994b; Adams et aI., 1994a) cattle.
Many stages of follicular growth have been clearly characterized. Some
definitions are generally accepted to define follicular developmental events. For
instance, recruitment involves gonadotrophin stimulation of a pool of growing follicles.
This is followed by selection, whereby one of these recruited follicles is favored to
continue its further growth becoming a dominant follicle and exerting suppression of its
subordinates. This process is called dominance. With ultrasonography, the emergence of
a follicular wave is typically detected when follicles 4 or 5 mm in diameter appear in
increased numbers in the ovaries compared with what was observed in a previous scan.
It is possible to retrospectively identify the dominant follicle at the time of wave
emergence (by examining diameter and location of the largest follicle during
consecutive days). When the corpus luteum (eL) regresses, the dominant follicle of that
follicular wave becomes the ovulatory follicle. Ovulation can be also detected by
ultrasonography as the disappearance of the dominant follicle observed in the first of
two consecutive observations.
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An interovulatory interval (IOI) is the period between two sequential ovulations.
In this regard, different laboratories have found a predominance of 2-wave 101 (Ginther
et aI., 1989a, 1989b), whereas others observed mostly 3-wave 101 (Savio et aI., 1988;
Sirois and Fortune, 1988). Two-wave 101 (20.4 ± 0.3 days) were shorter (P<O.OI) than
those with three follicular waves (22.8 ± 0.6 days; Ginther et aI., 1989b). Nevertheless,
length of the 101 or number of waves did not affect pregnancy rates (Cooperative
Regional Research Project, 1996). Follicular waves usually emerge on Days 0 and 10 in
2-wave cattle, and on Days 0, 9 and 16 in 3-wave cattle (Ginther et aI., 1989a). Every
follicle has 3 phases of growth. The dominant follicle grows linearly for 5 days
(growing phase), determined retrospectively from the first detection of the dominant
follicle to the day of cessation of progressive increase in diameter. It remains at
approximately the same size for 5 to 7 days (static phase), and then begins to regress by
decreasing size until it is no longer identifiable (regressing phase; Ginther et aI., 1989a).
The dominant follicle exerts suppression on subordinate follicles, which cease to grow
within a few days after the emergence of a follicular wave (Ko et aI., 1991; Adams et
aI., 1993a, 1993b), and a new follicular wave does not appear while the dominant
follicle is in its growing phase or initial period of its static phase (Adams et aI., 1993a).
Elimination of the dominant follicle results in a new follicular wave (Adams et aI.,
1993b). Selection is a dynamic process occurring during the growing phase of the
dominant follicle associated with follicular divergence (beginning of the greatest
difference in growth rate between the two largest follicles; Ginther et aI., 1996b, 2000).
It has been suggested that follicular divergence (or deviation) is an important event in
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the selection of a dominant follicle (Ginther et aI., 2000). It occurs when plasma FSH
concentrations decrease and the dominant follicle grows linearly.
As mentioned previously, follicular waves also occur in prepubertal animals and
their characteristics have been recently studied (Evans et aI., 1994a, 1994b; Adams et
aI., 1994a). The diameter profiles of the dominant and largest subordinate follicles were
found to increase with age; being the greatest between 2 to 8 and 24 to 40 weeks. The
101 after the first ovulation was short (7.7 ± 0.2 days), containing only one follicular
wave and the CL resulting from the first ovulation was smaller and shorter-lived than
the CL of subsequent 101 (Evans et aI., 1994a; Adams, 1998). The second 101 (20.3±0.5
days) was similar in length to the subsequent 101 (Evans et aI., 1994a). It has been
reported that all mechanisms controlling follicular wave dynamics in sexually mature
heifers were present in 36-week-old prepubertal heifers (Adams, 1999).
Follicular dynamics in postpartum animals resembles those in peripubertal
heifers. The first follicle wave emerged 10 to 14 days after calving (Murphy et aI.,
1991). In dairy cows, the post-partum interval to detection of the first dominant follicle
was shorter in autumn (6.8±1.8 days) than in spring (20.0±10.1 days; Savio et aI.;
1990a). In contrast, the respective intervals after parturition to ovulation were very
similar (approximately 27 days). When the first ovulatory follicle was detected within 9
days from parturition, the subsequent 101 was normal in length (18 to 24 days) or long
(>24 days) compared to the length of subsequent estrous cycles; however, when the
ovulatory follicle was identified after 20 days from parturition, the subsequent 101 was
short (9 to 15 days, Savio et aI., 1990b). In beef cattle, the first 101 was almost always
short and all subsequent cycles were ofnormal length (19-23 days; Adams, 1998).
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2.1.2 Endocrinology of the estrous cycle.
The hormonal component of the estrous cycle is ruled by secretions from the
hypothalamo-hypophyso-gonadal axis. Gonadotrophin releasing hormone (GnRH)
dictates the synthesis and secretion of both luteinizing hormone (LH) and follicle-
stimulating hormone (FSH) from the anterior pituitary gland (Herbison, 1997). GnRH is
produced by specialized neurons in the hypothalamus and released in pulses into a portal
blood system that connects the hypothalamus with the pituitary. The pulsatile
characteristic of GnRH secretion is necessary to prevent down-regulation of GnRH
receptors (Roche et aI., 1997) and determines the pulsatile pattern of LH release.
However, FSH secretion is passive and only partially regulated by GnRH. There are
other factors and hormones that coordinate FSH release, i.e., activin, inhibin, follistatin,
estradiol. Increases in inhibin are associated with emergence of each follicular wave,
whereas estradiol increases significantly during the first and last follicular waves.
Inhibin seems to reduce FSH to a level that maintains species-specific numbers of
ovulations (Taya et aI., 1996)
The length of the estrous cycle and the hypothalamic secretion of GnRH are
regulated by progesterone from the CL. There is a strong negative feed-back on GnRH
during mid-cycle, when plasma progesterone concentrations are high, resulting in a
decreased mean concentration and pulse frequency of LH. Late in the estrous cycle,
when prostaglandin F2a (PGF) is secreted from the uterus, progesterone concentrations
are reduced in the systemic circulation, and both mean concentration and pulsatility of
LH increase. At the same time, the future ovulatory follicle is acquiring LH receptors on
granulosa cells, which results in increased estradiol concentrations, and in tum, estrous
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behaviour. The elevated estradiol results in a further increase in GnRH pulses and the
generation of a GnRH surge followed by a peak in LH concentrations (Bryner et aI.,
1990), inducing ovulation of the preovulatory follicle. The increase iIi GnRH pulses and
the LH peak are concurrent with the elevation of FSH that will induce the first follicular
wave. The FSH surge concurrent with the LH peak that will induce ovulation has been
considered the first FSH surge (Bergfelt et aI., 1997). A second FSH surge occurred
around the time of ovulation and this coincided with the emergence of the first follicular
wave (Wiltbank et aI., 2002). Peak concentrations of FSH and LH occurred
simultaneously in 92% of heifers; FSH levels reached their maximum before and
continued high until after the LH peak (Bergfelt et aI., 1997). Each follicular wave was
preceded by an FSH surge and there were 2 or 3 FSH surges during the estrous cycle, in
accordance with the number of follicular waves that a female has between two
consecutive ovulations (Adams et aI., 1992a). Therefore, progesterone regulates LH
release whereas estradiol and inhibins regulate FSH secretion in cattle. A specific
hormonal pattern will determine the number of follicular waves during the cycle and the
time of ovulation.
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2.1.3 Relationship between hormonal and ovarian events.
Interactions between local and systemic hormones and other ovarian factors
during the estrous cycle results in ovulation of the oocyte contained in the dominant
follicle of the last follicular wave. Adams et aI. (l992a) reported that FSH was
temporally related to the growth of small follicles. There are recurrent and transient
increases in FSH concentrations (surges) that will induce the emergence of a follicular
wave approximately one day later (Adams et aI., 1992a). Mean FSH concentrations
increased 8 h before wave emergence and remained elevated for 8 h after wave
emergence (Ginther et aI., 1998). This was followed by a decrease in FSH, which
became significant within an interval of 24 h starting 40 h before follicular growth
divergence, which occurred on average 2.8 days after emergence of the follicular wave
(Ginther et aI., 1998). The initial decline in FSH began when the largest follicles were 6
mm in diameter (Ginther et aI., 1996b). As FSH declined, follicles of the wave
continued to grow, resulting in increasing estradiol secretion. These growing follicles ~4
rom in diameter contain aromatase, an important enzyme of the estradiol production
pathway (McNatty et aI., 1999).
All follicles greater than 5 rom in diameter contribute to the FSH decline and any
5 rom follicle is capable ofbecoming dominant (Gibbons et aI., 1997; 1999). As follicles
continue to grow, FSH is still required by follicles, but its concentration continues to
decline (Ginther et aI., 2001a). Divergence in follicular growth occurs 2.8 days after
follicular wave emergence and is manifested by a continued growth of the dominant
follicle and reduction or cessation of growth of subordinate follicles. Growth divergence
begins when the largest follicle is 8.5 rom in diameter (Ginther et aI., 1996b; Kulick et
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aI., 1999). Treatment with estradiol resulted in a transient decrease of FSH and an
accompanying decline of follicles greater than or equal to 8.5 mm in diameter, which
indicates FSH dependence of the dominant follicle around the time of growth
divergence (Ginther et aI., 2000). However, once the dominant follicle has completed
the process of selection, and granulosa cells have acquired LH receptors (Xu et aI.,
1995), follicular growth divergence has occurred. The dominant follicle acquires LH
receptors and survives in an environment of declining concentrations of FSH. When the
dominant follicle is selected, LH stimulates the production of estradiol and insulin-like
growth factor by follicular cells (Ginther et aI., 2001a, b), increasing capacity to
suppress FSH (Ginther et aI., 2000). Concentrations of FSH are lower than those
required by subordinate follicles (Ginther et aI., 2000) and thus regress. This
suppression of FSH is maintained until the dominant follicle loses ability to produce
estradiol (late static phase) or ovulates.
Elevated concentrations of LH and reduced concentrations of FSH were already
present at the beginning of follicular growth divergence (Ginther et aI., 1998). The
dominant follicle apparently exerts suppression through the production of honnones
(estradiol, inhibin, activin, follistatin), and other secretory products which may act
locally or systemically to suppress the growth of subordinate follicles (Lucy et aI.,
1992). As an evidence of suppressive follicular factors, the injection of steroid-free
bovine follicular fluid suppressed follicular growth while the treatment was
administered (Kastelic et aI., 1990b).
The dominant follicle has also been reported to generate a direct intra- or
interovarian effect that inhibits follicle recruitment (Wolfsdorf et aI., 1997). However,
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all growing and viable follicles are capable of becoming dominant; a subordinate follicle
has been shown to achieve dominant follicle status after ablation of the former dominant
follicle (Adams et aI., 1993a). In addition, follicles recruited at the beginning of the first
and second follicular waves are capable of responding to superstimulatory treatments
(Adams et aI., 1994b). It has also been clearly shown that ovarian responses are greater
when superstimulation is prior to selection of the dominant follicle than when
superstimulation is initiated after dominance is established (Nasser et aI., 1993).
Therefore, those studies explained that, prior to selection, any follicle in a wave is
capable of obtaining ovulatory status and after selection, larger subordinates are capable
of reaching ovulatory status. However, due to declining levels of FSH, only one is
selected.
2.2 Control of the length of the estrous cycle.
The bovine estrous cycle can be shortened or lengthened by the use of honnones
such as estradiol and prostaglandin or progestins that mimic physiological events in the
cycle. Historically, the control of the estrous cycle in cattle has involved two very
different approaches. The first included protocols characterized by the control of luteal
phase (without a accurate knowledge of follicular dynamics). The second (and more
recent) approach involves the manipulation of both luteal and follicular dynamics.
Advances had been slow since the first attempts to control the bovine estrous cycle by
progesterol)e (Christian and Casida, 1948) or estrogens (Wiltbank et aI., 1961) or the
combination of both (Wiltbank et aI., 1965). New approaches to the manipulation of the
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bovine estrous cycle have been applied without impairment of fertility (Adams, 1998;
Roche et aI., 1997, Thatcher et al., 2001).
2.2.1 Prostaglandins.
Secretion of prostaglandin F2a (PGF) by the nonpregnant uterus is responsible
for terminating the luteal phase in the cow by causing regression of the CL. However,
PGF is released by the endometrium as a result of oxytocin pulses from the posterior
lobe of the pituitary. Estradiol produced by the dominant follicle of the last follicular
wave also stimulates the action of oxytocin by inducing synthesis of oxytocin receptors.
The process of uterine-induced luteal regression involves a veno-arterial pathway (the
uterine vein and the adjacent ovarian artery) by which PGF reaches the CL to induce
luteolysis in sheep (Del Campo and Ginther, 1973; Mapletoft and Ginther, 1974), cattle
(Ginther, 1974) or pigs (Del Campo and Ginther, 1973).
After approximately 14 days ofprogesterone secretion, the endometrium secretes
6-h pulses of PGF for approximately 36 h and PGF concentrations increased in uterine
secretions and uterine vein plasma (Hansel et aI., 1975). In one of the first studies
involving PGF, a daily intrauterine infusion of 0.5 mg PGF ipsilateral to the CL between
Days 5 and 16 of the estrous cycle resulted in most of the females treated showing estrus
in the morning of the third day after treatment but on Days 1 to 4 after estrus was not
effective (Rowson et aI., 1972). Similar results were observed in another study in which
heifers treated on Days 6 to 9 or 13 to 16 responded by regression of the CL confirmed
by rectal palpation, while heifers treated 2, 3 or 4 days after estrus had a luteal life span
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of 15 to 19 days (Lauderdale, 1972). These early studies suggested that the response to
PGF treatment depends on the stage of the estrous cycle at which it is applied and that
the CL was not responsive to a single injection of PGF during the first 5 days post-
estrus. Responsiveness to PGF has been shown to increase progressively from 6 to 8
days post-estrus and the CL remains highly responsive for the remainder of diestrus
(Momont and Seguin, 1984). After PGF treatment of beef heifers on Days 7 to 20 after
estrus, the length of the estrous cycle was significantly reduced and pregnancy rates
following estrus detection and AI (72.5%) did not differ from that in controls (73.0%;
Roche, 1974).
The interval from PGF treatment to estrus has also been shown to depend on the
stage of development of the dominant follicle present at the time of treatment. A study
that involved the administration of PGF on different days of the estrous cycle (Days 3 to
10 and 7 to 16) resulted in different intervals from treatment to estrus. It was attributed
that varying intervals depended on growth or atresia of large antral follicles, but no
conclusions were stated (Macmillan and Henderson, 1984). In a more recent study, the
effects of day of PGF treatment were examined based on the selection and development
of the ovulatory follicle (Kastelic et aI., 1990a). The interval from PGF treatment to
ovulation was shorter in heifers treated on Day 5 after ovulation (growing/early static; 3
days) than in those treated on Day 12 (regressing phase of Wave 1 or early growing
phase Wave 2,4.5 days). Treatment on Days 5 or 8 was followed by ovulation of the
dominant follicle of Wave 1 (near its maximum diameter at the time of treatment),
whereas treatment on Day 12 was followed by ovulation of the dominant follicle of
Wave 2; since this follicle was small at the time of treatment, required more time to
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reach ovulatory size. It was concluded that the viable dominant follicle present at the
time of PGF treatment grew to its ovulatory size in all stages of follicle development.
The interval from PGF treatment to estrus will depend on the time of growth up to the
ovulatory size. This study established the rationale for synchronization of follicular
waves prior to inducing luteal regression in estrus synchronization programs.
2.2.2 Progesterone and progestins
Chemically classified as a steroid, progesterone is one of the most important
hormones that have been used to control the estrous cycle in cattle. It was first used in
1948 to alter the length of the cycle (Christian and Casida, 1948). Yearling heifers were
treated with daily injections of 25 or 50 mg of progesterone for 14 days, starting on the
Day 14 of the estrous cycle. Although estrus and ovulation were prevented in heifers
treated with 50 mg of progesterone, heifers came into estrus 5 or 6 days later after
suspension of treatment. The dose of25 mg ofprogesterone was effective in suppressing
estrus in all treated heifers, but ovulation was prevented only in 50% of heifers
(Christian and Casida, 1948).
Later studies demonstrated that progesterone or progestins given for a term
longer than the normal life span of the CL (i.e., >14 days) resulted in synchronous estrus
after treatment was discontinued, but fertility was poor (Trimberger and Hansel, 1955;
Wiltbank et aI., 1965). Recently, it has been shown that "persistent follicles" arise
because of an increased LH pulsatility, which occurs when the CL regresses, but
ovulation was prevented by the low level of progesterone administered (Cooperative
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Regional Research Project, 1996). The administration of progesterone suppresses LH
pulse frequency if given to cattle bearing a CL, which in tum, causes suppression of
dominant follicle growth in a dose-dependent fashion (Adams et aI., 1992b; Sirois and
Fortune, 1990). However, the dose of progestins used to control the estrous cycle in
cattle (melengestrol acetate, MGA, in the feed or progesterone-impregnated devices,
PRID ot CIDR-B) has relatively less suppressive effects on LH secretion than the CL of
the cycle and following luteal regression, the increased LH pulse frequency results in
'persistent' follicles (Custer et aI., 1994; Kojima et aI., 1995; Savio et aI., 1993).
Persistent follicles contain aged, infertile oocytes (Custer et aI., 1994; Mihm et aI., 1994,
Revah and Butler, 1996) and insemination following progestin withdrawal results in
poor fertility (reviewed in Larson and Ball, 1992 and Odde, 1990).
The progesterone-impregnated CIDR-B (controlled internal drug release)
intravaginal device has been recently approved in Canada for synchronization of estrus
in beef cattle. Label directions (for AI) state that the device should be placed in the
vagina for 7 days; PGF is to be given 24 hours before device removal and estrus is
detected for 3 days, starting 48 hours after device removal. The insertion of a CIDR-B
device increased progesterone concentrations 2 h after insertion, remaining high for at
least 48, and decreased very slowly until the day of CIDR-B removal (Macmillan et aI.,
1991). However, the CIDR-B device has been also used with different approaches used
to synchronize follicular development. MGA is the other commercially available orally
administered progestin in the Canadian market. The most common MGA-based estrus
synchronization protocol consisted of 14 days ofMGA feeding followed by an injection
ofPGF 17-19 days later, with insemination at detected estrus (Lamb et aI., 2000). There
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IS a recent trend for the utilization of MGA in short-term protocols for estrus
synchronization. However, the risk of persistent follicles and low fertility still remains
when there is no attempt to control follicular growth. Short-term MGA programs that
included treatment with estradiol or GnRH to synchronize follicular wave emergence
have been designed (Kastelic et aI., 1996, 1997; Thundathil et aI., 1999). Estradiol-17P
treatment at the beginning of an MGA protocol in beef cattle resulted in more consistent
estrus and pregnancy rates (to AI after detected estrus) than GnRH or Controls
(Thundathil et aI., 1999). These synchronization systems are promising if a treatment to
synchronize ovulation for fixed-time AI would be included.
2.3 Manipulation of follicular development.
2.3.1 Steroid hormones: Progesterone and estradiol.
After progesterone was observed to alter the estrous cycle in cattle by
suppressing estrus and preventing ovulation (Christian and Casida, 1948), studies have
been conducted to determine the effects of progesterone on the estrus cycle. In addition,
different forms and doses of estrogens were investigated to determine effects on estrus
and fertility of the treated cattle. Treatments of beef heifers with estrogens resulted in
luteal regression; however, estrus and ovulation did not consistently occur following
luteolysis (Wiltbank et aI., 1961). Later, estradiol was utilized to induce luteolysis in
shortened progestin treatments (Wiltbank et aI., 1965; Wiltbank and Kasson, 1968). A
dose of 5 mg of estradiol valerate was administered on the second day of a 9-day
treatment with 400 mg/head/day of dihydroxy-progesterone acetophenonide (DHPA) in
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feed. The treatment resulted in 95% of the heifers displaying estrus over a 96-h period
and 54% conceived when inseminated at synchronized estrus (Wiltbank and Kasson,
1968). Thereafter, progestin treatments were shortened to 9 days and an injection of
estradiol valerate was administered at the beginning of the treatment period to shorten
the luteal life span.
Recently, it was observed that the administration of 5 mg estradiol valerate (EV)
along with a norgestomet implant (Syncro-Mate-B, 5MB) resulted in regression of
antral follicles (B6 et aI., 1991), and emergence of a new follicular wave at a relatively
predictable time thereafter (B6 et aI., 1993; Mapletoft et aI., 1999). When estradiol was
administered in the late static or regressing phase, emergence of the next follicular wave
was attributed to the extended suppression of plasma FSH concentrations (B6 et aI.,
1993). Therefore, the high estrous response and acceptable pregnancy rates in studies by
Wiltbank and Kasson (1968) were not only due to the luteolytic effects of EV, but also
to the EV-induced follicle turnover.
Estradiol-17~ has been shown to suppress follicular growth when given to
progestin-treated cattle (reviewed in B6 et aI., 1995a). It was also shown to be equally
efficacious, regardless of the stage of follicle development at the time of treatment (B6
et aI., 1995a). However, when given to norgestomet-implanted beef cattle at different
doses (2.5, 5 or 10 mg), the 5 mg E-17~ dose resulted in the least variable interval from
treatment to follicular wave emergence. Overall, emergence of a new follicular wave
occurred 4.3 ± 0.2 days after treatment (range: 3 to 5 days) in 44/47 females (94%; B6 et
aI., 1995a, 1995b). The im injection of 5 mg of resulted in increased plasma estradiol
concentrations reaching peak concentrations 18 h later and decreased circulating FSH
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concentrations (Bo et aI., 1994). Once estradiol concentrations declined, synchronous
FSH release and emergence of a new follicular wave occurred (Bo et aI., 1994). The
mechanism responsible therefore involves suppression and then rebound release of FSH
(Bo et aI., 1994) and possibly LH. Emergence of a new follicular wave depends on the
resurgence of plasma FSH concentrations that in turn depend on circulating estradiol
concentrations.
Different estradiol esters such as estradiol benzoate (EB; Caccia and Bo, 1998,
Macmillan, 1994), estradiol valerate (EV; D'Occhio et aI., 1996; Niasari-Naslaji et aI.,
1996; Mapletoft et aI., 1999) or E-17~ (Kastelic et aI., 1996, 1997; Martinez et aI., 2000)
have been used in combination with different progestin sources in synchronization
programs. Progestins have been incorporated with the initial estradiol treatment (for
follicular wave synchronization) to prevent an estrogen-induced LH surge (Bo et aI.,
1994). Highly acceptable pregnancy rates were obtained in the synchronization of
follicular wave emergence in estrus synchronization protocols for AI (Kastelic et aI.,
1996).
2.3.2 Gonadotrophin releasing hormone or luteinizing hormone.
Although GnRH directs the estrous cycle in cattle, there is endogenous control of
its secretion. The use of exogenous GnRH offers the possibility of controlling follicular
events during the estrous cycle. GnRH has been commercially available since the 1970's
and is used widely (Drost and Thatcher, 1992), predominantly for the treatment of
follicular cysts in cattle (Kittok et aI., 1973). More recently, the effect of GnRH on
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follicular dynamics has been investigated. An experiment was designed to study the
effect of a single injection of a GnRH-analog (buserelin) on follicular dynamics
(Macmillan and Thatcher, 1991). Treatment with GnRH resulted in ovulation of the
largest follicle present at the time of treatment, but not in all cattle. It was concluded that
these changes could have altered the normal wave patterns of follicular development. In
another study, heifers treated with GnRH 32 h before ovulation had a shortened interval
from the LH surge to the emergence of the first follicular wave (Bodensteiner et aI.,
1996). After GnRH treatment, the dominant follicle would ovulate and a new follicular
wave would emerge within 2 days after treatment (Twagiramungu et aI., 1995).
However, administration of GnRH at random stages of the estrous cycle has not always
resulted in ovulation (Kastelic and Mapletoft, 1998). Ovulation depended on the stage of
development of the dominant follicle (Twagiramungu et aI., 1995). The use of GnRH at
different and variable stages of the first follicular wave was investigated in two
preliminary studies (Prescott et aI., 1992; Silcox et aI., 1993), but results were
inconclusive. In a more recent study (Martinez et aI., 1999), the administration of GnRH
or LH to heifers at precise stages of the first follicular wave (Days 3, 6, or 9 after
spontaneous ovulation) resulted in ovulation in 56% and 780/0 of heifers, respectively.
Follicular wave emergence was only induced within 2 days when ovulation of the
dominant follicle occurred (Martinez et aI., 1999). With the remaining non-ovulated
heifers, a new follicular wave emerged spontaneously within 2 days.
GnRH has not resulted in acceptable synchronization estrus and ovulation when
used in synchronization protocols in heifers. This was due to poor synchronization of
wave emergence after the first treatment, and by the time PGF treatment was given 6 or
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7 days later, the interval to estrus was highly great variable. Furthermore, if spontaneous
luteolysis occurred during the period between GnRH and PGF treatment, heifers would
express estrus (Roy and Twagiramungu, 1999), since GnRH did not result in ovulation
of the dominant follicle. When GnRH treatment was followed by PGF 7 days later, a
high number of cattle was observed in estrus over the following 5 days (Thatcher et aI.,
1993).
2.3.3 Follicular ablation.
Physical methods of follicular ablation, such as cautery, have been used to
remove antral follicles (Ko et aI., 1991; Adams et aI., 1992a, 1993a, 1993b). The effect
of follicular puncture and aspiration on the estrous cycle has also been examined.
Pieterse et aI. (1991) observed no changes in estrous cycle length among animals in
which follicles were ablated on Days 3 to 4, 9 to 10 or 15 to 16. However, in another
study, follicle-aspirated females had extended cycles compared with non-aspirated
controls, presumably due to the time required for growth of a new dominant follicle to
an ovulatory size (Stubbings and Walton, 1995). Based on studies of follicular ablation
by electrocautery carried out by Adams et aI. (1992a, 1993a), ultrasound-guided
transvaginal follicle aspiration at random stages of the estrous cycle was used to
synchronize follicular wave emergence and to improve the synchrony of ovulation after
PGF treatment (Bergfelt et aI., 1994). An FSH surge occurred after ablation of all
follicles ~5 mm in the ovaries, resulting in emergence of a new follicular wave within 2
days after aspiration. Treatment with PGF 4 days after ablation resulted in synchronous
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ovulation. A greater synchrony of ovulation was obtained when two doses of PGF were
given 12 h apart (at 4.0 and 4.5 days after follicular ablation) and GnRH or pLH was
administered 24 h later to induce ovulation (Brogliatti et aI., 1998). When ultrasound-
guided follicular aspiration was used to synchronize follicular wave emergence in
CIDR-B-based synchronization programs, synchronous follicular wave emergence
occurred within 1.0 ± 0.1 days after ablation, and ovulation occurred 3.0 to 4.5 days
after CIDR-B removal, with pregnancy rates to AI after estrus detection of 65%
(Martinez et aI., 2000). Although follicular ablation offers a great alternative for
synchronization of follicular wave emergence and ovulation, this technique may be
more appropriate for synchronization of follicular wave emergence in superstimulation
protocols; follicle ablation induces a highly synchronized follicular wave emergence but
it requires appropriate instrumentation and facilities which makes it less feasible under
field conditions. More recently, we have shown that ablation of the two largest follicles
in the ovaries were adequate to induce synchronous follicle wave emergence in a
superstimulatory program (Baracaldo et aI., 2000).
2.4 Control of luteal and follicular dynamics for synchronization of ovulation
using estradiol and progesterone.
The use of estradiol and progesterone in estrus synchronization protocols is
based on the hypothesis that estradiol treatment will synchronize emergence of a new
dominant follicle capable of ovulating after PGF-induced induced luteolysis, with a
highly acceptable pregnancy rates following AI. B6 et aI. (1995a) showed that the
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combination of estradiol-17~ (E-17~) and progesterone synchronized follicular wave
emergence in CIDR-B-treated beef cattle, resulting in 75% of heifers ovulating between
72 and 84 h following CIDR-B removal and PGP administration. 'In another similar
study, the mean interval from treatment to wave emergence was 3.4 ± 0.1 days, and
following CIDR-B removal, all heifers ovulated, with a pregnancy rate of 80.0% to AI
after estrus detection (Martinez et aI., 2000). This treatment protocol was considered to
have great potential in ovulation synchronization programs.
Estradiol and progesterone in combination have been used in other progestin-
based protocols. It has been shown that an injection of progesterone (100 mg) or a
CIDR-B for 24 h on Day 10 of a 17-day norgestomet protocol in Bas indicus heifers
synchronized follicular wave emergence and ovulation (Cavalieri et aI., 1998).
Treatment with 100 mg progesterone provided a shorter interval from implant removal
to estrus (38.4 ± 2.6 h) than 200 mg progesterone (61.5 ± 3.9 h; Cavalieri et aI., 1998).
The combination of estradiol and progesterone was effective in synchronizing follicular
wave emergence but the dose ofhormone used may affect results.
In our laboratory, 5 mg of E-17~ and 100 mg progesterone have been given on
Day 0 of a 7-day MGA program with PGP treatment on the last day of MGA feeding.
The synchronized pregnancy rate in heifers without a CL (apparently not cyclic) was
higher in the group treated with estradiol and progesterone than that in the non-treated
Control group (52% vs 20%, respectively; Kastelic et aI., 1997). The low pregnancy
rates in the Control group receiving MGA without follicular wave synchronization can
be a direct result of the development of persistent follicles that ovulated aged oocytes
after MGA withdrawal.
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High accuracy in the time of ovulation becomes important for fixed-time AI. If a
follicular wave is synchronous, it will be possible to predict the day to induce ovulation
with estradiol (Lammoglia et aI., 1998), LH (Brogliatti et aI., 1998) or GnRH (Pursley et
aI., 1995). Estradiol has been used to synchronize estrus in PGF-based estrus
synchronization protocols (Dailey et aI., 1983; Peters et aI., 1977; Welch et aI., 1975)
and induced estrus, LH release and ovulation in CIDR-B-treated cattle (Lammoglia et
aI., 1998).
2.5 Development of GnRH-based regimens for synchronization of ovulation.
The first attempts of using GnRH in an estrus synchronization program involved
GnRH treatment to synchronize follicular wave emergence, followed by PGF given 6
(Twagiramungu et aI., 1992) or 7 days later (Wolfenson et aI., 1994) to cause luteolysis
of the new-formed and/or old CL.
A lO-day estrus synchronization program with a 6-day interval between GnRH
and PGF treatments, followed by a second GnRH treatment 48 h after PGF, was
proposed for improving the precision ofestrus without reducing fertility (Twagiramungu
et aI., 1995). In another study, a second GnRH treatment after PGF injection improved
the precision of estrus, and permitted fixed-time insemination without adversely
affecting conception rate (Pursley et aI., 1995). This method consisted of an injection of
GnRH followed by PGF 7 days later, a second GnRH injection 48 hours after PGF
treatment, and AI from 0 to 24 hours later. Cows receiving the second GnRH treatment
had a higher rate of ovulation than Control cows receiving only saline (97% vs. 77%,
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respectively). The first injection of GnRH apparently induced LH release and ovulation
of the dominant follicle present at that time in 900/0 of cows and 500/0 of heifers,
resulting in the emergence of a new follicular wave within 2 days after treatment. The
administration of PGF 7 days after treatment apparently induced the regression of the
original and/or the induced CL. The second GnRH injection was given to induce LH
release and synchronous ovulation of the new, GnRH-induced, dominant follicle.
This program called "Ovsynch" (Seguin, 1997) has been widely used on dairy
farms in North America over the last few years (WiItbank, 1997). It seems to be
especially efficacious in dairy fanns in which cows in estrus are not effectively detected
(Wiltbank, 1997). The use of an estrus synchronization program with GnRH followed
by PGF treatment 6 days later in beef cows resulted in pregnancy rate similar to that of
cows bred to a spontaneous estrus (Roy and Twagiramungu, 1996), suggesting that this
program could be utilized in beef herds. The use of a second GnRH treatment given at
the time of AI (48 h after PGF) in cows seemed to facilitate fixed-time AI (Geary et aI.,
2001). However, the Ovsynch program has not been successfully used in dairy heifers
(pursley et aI., 1995).
It has been reported that many heifers were detected in estrus between the first
injection of GnRH and PGF. Many factors can be responsible for this, such as lack of
response to the first GnRH injection. When GnRH treatment was given to beef heifers
on Day 3, 6, or 9 of the first follicular wave, 56% ovulated and therefore, started a new
follicular wave within 2 days (Martinez et aI., 1999). It was proposed that by reducing
the interval from the first GnRH to PGF treatment would reduce the number of heifers
detected in estrus during that period of time (i.e., 6 days a instead of7 days). However,
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it was found that 9% of heifers showed estrus during a 6-day interval while 12% of
heifers were detected in estrus during 7-day interval (Roy and Twagiramungu, 1999).
The use of a progestin-releasing device or MGA feeding may be a alternative to
suppress estrus display during an Ovsynch program for fixed-time AI due to the increase
in plasma progesterone that is released.
A synchronization protocol consisting of a 6-day CIDR-B insertion with GnRH
given at insertion and PGP treatment given and CIDR-B removal resulted in acceptable
pregnancy rates (65%) to AI after estrus detection (75%; Martinez et aI., 2000).
However, the asynchrony of follicular growth at the time of the second GnRH treatment
has not been reduced sufficiently to obtain acceptable pregnancy rates to fixed-time AI
in heifers.
2.6 Problems associated with estrus or ovulation synchronization and artificial
insemination.
The gold standard in determining that a cow is in estrus has been the visual
observation of that cow "standing" while being mounted by a herd mate. Effective
detection of estrus is important for success and profitability of any AI program. Most of
the Canadian dairy herds (70%) that apply AI demonstrate that achievements of good
results are feasible, but heat detection is variable and often inadequate. Detection of
estrus is the most limiting factor in optimizing reproductive efficiency in dairy herds
utilizing AI. Detection efficiency is equal to or less than 50% in most herds (Nebel,
2000).
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Estrus detection affects fertility criteria of any herd and is the number one factor
responsible reproductive perfonnance. The first cause of non-fecundity in a herd is most
often the difficulty to detect estrus and this inefficiency can be partially due to biological
characteristics of the cow (i.e., short estrus, increased milk production in dairy cattle,
lameness, etc.), and to breeding practices (i.e., time spent detecting estrus, criteria used
by the breeder, herd size, etc.). Basically, this can be summarized in two components:
the animal (physiology) and the breeder (observation and experience).
Estrus synchronization in cattle has disadvantages that must be considered.
Twice-daily estrus detection allows for acceptable conception rates when AI is
performed 8 to 12 hours after onset of estrus (Foote, 1975). However, estrus detection
can be tedious, inaccurate and, in some cases, very ineffective. Inaccurate detection of
estrus can be considered as a result of failure by herd personnel to accurately identify
females in estrus (Foote, 1975). Other studies have determined that between 5% and
30% of inseminations were performed when females were not in estrus (Senger et aI.,
1988), and that 19% of inseminations have been carried out when progesterone
concentrations were high (during the estrous cycle or in pregnant cows; Sturman et aI.,
2000). The use of computerized systems has simplified the task of estrus detection
(Walker et aI., 1996). Even though synchronization programs facilitate all animals to
come into estrus in a relatively short period of time, moving and sorting individuals or
groups of heifers or cows with their calves into the working facilities is required. These
tasks are often not practical or feasible for many beefproducers.
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Undetected or falsely detected estrus results in inseminations being performed at
inappropriate times and in an increased calving interval, leading to losses in milk and
calfproduction. It was reported that the insemination ofpregnant animals caused 17% of
embryonic mortality or abortions. Conception rates resulting from insemination of cows
with milk progesterone greater than 10 ng/ml were significantly lower than
inseminations at lesser concentrations of progesterone «2 mglml; Sturman et aI., 2000).
Effective estrus detection in cattle ensures a great part of the success of AI. It has
been emphasized that primary considerations for an "ideal" system for estrus detection
are continuous surveillance, accurate and automatic identification of the female in
estrus, operation for the productive lifetime of the animal, minimal or no labor
requirements and high accuracy to identify behavioural events that correlate with
ovulation (Senger, 1994). Among the present aids for estrus detection, the pressure-
sensitive electronic mount detection systems seem to be the only alternative that include
most features for the "ideal" method of estrus detection, except cost and maintenance.
These are two reasons that avoided the widespread use of this electronic method.
Finally, if estrus detection may be eliminated, and high pregnancy rates are
obtained after a fixed-time AI program, the use of AI in beef herds will be increased.
Hence, it is critical that the process of taking animals to the facilities and the time spent,
and all the associated labor must be reduced in order to apply the AI technology in a
beef operation. Insemination by appointment without the need for estrus detection,
becomes an important tool for the expansion of the use ofAI in beefherds.
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2.7 Fixed-time artificial insemination.
Because inaccurate detection of estrus can be translated into economic losses,
aids for estrus detection and estrus synchronization can be considered at least partial
solutions (Larson and Ball, 1992). The control of the estrous cycle will increase the
number of females inseminated at the beginning of the breeding season and focus the
efforts to observe cows at an expected time. However, the critical part of this puzzle has
not yet been resolved, i.e., the need for accurate detection and the inaccuracy of estrus
detection. The successful use of protocols that would allow for insemination by
appointment (referred to as fixed-time AI) could completely eliminate the need for
estrus detection.
Fixed-time AI has not been completely successful over the past three decades.
Although conception rate following AI at 72 and 96 h after the second dose of PGF was
similar to that following AI after estrus detection (Lauderdale, 1972), fertility after a
single fixed-time AI in PGF-based protocols is low. More recently, pregnancy rates of
35 % have been reported in programs of a single AI after two doses of PGF 14 days
apart, (Seguin et aI., 1999). Therefore, programs that consisted of two doses of PGF
followed by two inseminations have not been implemented in beef or dairy herds
(Peters, 1986). In addition, the double amount of semen would increase the cost of the
AI considerably. The combinations of progestins with PGF or progestins with EB as a
luteolytic agent for timed AI have also been used, but again pregnancy rates have been
poor (Larson and Ball, 1992). Results obtained from pioneer studies demonstrate that
fertility has been disappointingly low when the estrous cycle is controlled only through
the induction of luteal regression (without manipulation of follicles).
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The development of modem synchronization programs that include the control
of both luteal function and follicular dynamics with predictable intervals to ovulation
will facilitate fixed-time artificial insemination.
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3.0 GENERAL HYPOTHESIS
Synchronization of ovarian follicular waves and ovulation will facilitate fixed-
time artificial insemination and result in pregnancy rates comparable to insemination
after detected estrus.
3.1 GENERAL OBJECTIVE
The overall objective of this research was to develop new synchronization
protocols that facilitate fixed-time artificial insemination. Secondary objectives were to
improve fertility in some of the current ovulation synchronization programs and to
compare different programs involving manipulation of CL and follicular growth for
synchronization of follicular wave emergence and ovulation.
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4.0 GENERAL MATERIALS AND METHODS
4.1 Animals: The cows and heifers used in the experiments described in Chapters
5.0 and 6.0 of this thesis were housed outdoors in feedlot pens at the Goodale Research
Farm, University of Saskatchewan, and fed barley silage, with free access to water. The
cows used in Experiment 1 of Chapter 6.0 were kept on pasture consisting of oats and
native grass with free access to water during the winter in Cordoba, Argentina (31 0 24'
S, 640 11' W, 400 meters above sea level). The cattle used in field experiments
(Chapters 7.0 to 11.0) were housed in feedlot pens (heifers in Chapter 7.0, 8.0.).
However, the cows used in Experiment 2 of Chapter 7.0 were kept on pasture of native
grass in southern Alberta, and heifers in Experiment 3 of Chapter 10.0 were kept on
pasture during the spring in Cordoba.
4.2 Body condition score was evaluated based on a scale from 1 (lean) to 5 (obese;
Mackeyet aI., 2000).
4.3 Breeding season: All field experiments involving fixed-time AI were carried out
during the spring and beginning of the summer (April 15 to July 1).
4.4 CIDR-B device preparation: Devices were kept in a mild iodine solution (0.1-
0.5%; Betadine solution 10%; Purdue Frederick Inc, Pickering, ON, Canada)
immediately prior to use. The applicator was always washed and then, kept in a strong
iodine solution (5%) before use in each female. The CIDR-B was introduced into the
applicator by folding its arms (changing from T- to I-shape) and then, inserted into the
anterior vagina by pushing forward the plunger of the applicator, allowing the device to
expand its arms and recovering the original T-shape.
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4.5 MGA preparation: In the MGA-based protocols, MGA was obtained from a
commercial source as a premix at a concentration of 220 mg/kg and then, it was mixed
with the remaining ration to be fed. The size of the feeding bunk was sufficient to allow
animals to consume equal amount of ration at the same time, so that the MGA intake
could be evenly distributed.
4.6 Hormone preparation and injections: Steroid hormones were diluted in benzyl
alcohol (10% of the final volume), stirred for 15 minutes and then canola oil was added
to the final volume. The total dose of steroid hormones administered was contained in 2
mL of canola oil in all experiments throughout the thesis. The commercial preparations
of GnRH and prostaglandin were injected at the dose recommended by the
manufacturer, 100 f.1g gonadorelin and 500 f.1g cloprostenol, respectively. Porcine LH
was administered at one half(12.5 mg) of the recommended dose (25 mg; Experiment 3,
Chapter 10.0). All injections were given intramuscularly in the gluteal region.
4.7 Estrus detection: In all experiments, estrus detection was performed by one
person at 12 h intervals (e.g.; 7:00 am and 7:00 pm) for at least 30 minutes, except in
Experiment 4 in Chapter 10.0 and the two experiments of Chapter 11.0 in which females
were observed by two or more persons. Only those animals, which were standing to be
mounted for more than 4 seconds were considered to be in standing estrus.
4.8 Animal care: The University of Saskatchewan Animal Care Committee has
approved the protocols (No. 19970080) for these experiments.
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4.9 Statistical packages: Almost all statistical analyses were conducted using SAS
(SAS User's Guide, 1990; SAS Institute Inc., Cary, NC, USA). One-way analysis of
variance followed by LSD test or non-parametric tests (Mann-Whitney two-sample rank
sum test; Kruskal-Wallis test, Bartlett's test for homogeneity of variances; Norman and
Streiner, 2000) were performed by using Statistix (Statistix Student Version, version
2.0, Analytical Software, Tallahassee, Florida, USA). Logistic regression in Chapter 9.0
was performed by using SPSS (SPSS version 10.05, 1999, SPSS Inc., Chicago, IL,
USA).
4.10 Probabilities: A probability of 5% (P < 0.05) was used to determine that a
difference was significant, and probabilities between 5 and 10% (P > 0.05 to P < 0.10)
were used as an indication that a difference approached significance (e.g.; tendency to
be significantly different). However, actual probability levels obtained from the
statistical analysis (i.e., P < 0.0001, P = 0.4, etc.) have been reported in all chapters of
this thesis.
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5.0 EFFECTS OF STEROID HORMONES ON GONADOTROPHIN
RELEASE IN OVARIECTOMIZED COWS TREATED WITH A
CONTROLLED INTERNAL DRUG RELEASE (CIDR-B) DEVICE.
5.1 Abstract
A series of experiments were conducted to evaluate the effects of estradiol and
progesterone on gonadotrophin release in ovariectomized cows. In Experiment 1,
ovariectomized cows (n = 16) received a used CIDR-B device and 5 mg estradiol-17P
(E-17P) on Day 0 and were randomly allocated to four treatment groups to receive 0, 25,
50, or 100 mg of progesterone. The CIDR-B devices were removed 7 d later. In all
groups, plasma progesterone concentrations were elevated by 24 h after insertion of the
CIDR-B devices (P < 0.0001). Mean plasma LH concentrations were similar among
groups (P = 0.7); mean plasma LH decreased (P < 0.0007) by 36 h after treatments
began, remained low (P = 0.013) until 72 h, and returned to pretreatment concentrations
12 h later (i.e., 84 h after treatment). There was no effect of progesterone treatment on
plasma FSH concentrations (P = 0.5). In Experiment 2, ovariectomized cows (n = 17)
were randomly assigned to receive a new CIDR-B device or nothing on Day 0
(beginning of the experiment). On Day 5, half of each group received an injection of
either 5 mg ofE-17P or 5 mg ofE-17P + 100 mg of progesterone. The CIDR-B devices
were removed on Day 10. Plasma progesterone concentrations increased (P < 0.0001)
by 24 h after CIDR-B insertion. There was an effect of time (P < 0.0001) on plasma LH
and FSH concentrations. Plasma LH concentrations declined (P < 0.05) by 6 h after
34
treatment on Day 5 and LH surges occurred between 18 hand 24 h in groups receiving
E-17~ without or with progesterone, respectively. There was a decrease (P < 0.0001) in
plasma FSH concentrations by 6 h and resurgence by 48 h after estradiol treatment. In
Experiment 3, ovariectomized cows (n = 16) received a used CIDR-B device on Day 0
(beginning of the experiment) and were allocated randomly into three treatment groups
to receive: 5 mg of E-17~ on Day 0 (Group EO), 5 mg of E-17~ on Day 1 (Group E1), or
5 mg of E-1713 + 100 mg of progesterone on Day a (Group EP). The CIDR-B devices
were removed on Day 7 and an injection of 1 mg estradiol benzoate (EB) was given to
all cows on Day 8 (24 h later). There was an effect of time and treatment-by-time
interaction (P < 0.0001) on plasma progesterone, estradiol, LH and FSH concentrations.
Administration of 100 mg of progesterone at CIDR-B insertion resulted in an increase
(P < 0.0001) of 2.0 ng/mL progesterone over CIDR-B alone. The use of a CIDR-B
device alone suppressed LH for 6 h. Estradiol-17~, administered with or without
progesterone, induced an LH surge within 24 h and suppressed plasma FSH for
approximately 48 h. Plasma progesterone concentrations declined to baseline by 12 h
after CIDR-B removal. For the second part of this experiment, the injection of 1 mg EB
resulted in transient LH and FSH suppression (P < 0.02) by 6 h comparable to that of 5
mg of E-17~ at the time of CIDR-B insertion, followed by an LH surge at 24 h. In
Experiment 4, ovariectomized cows (n = 16) received a used CIDR-B device on Day a
(beginning of the experiment) and were allocated randomly to 3 treatment groups to
receive 3 different forms of estradiol: 5 mg of E-17~, EB or estradiol valerate (EV) plus
100 mg of progesterone in 2 mL canola oil. The CIDR-B devices were removed on Day
7. There was an effect of time and treatment-by-time interaction (P < 0.0001) on plasma
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estradiol and FSH concentrations. Plasma estradiol concentrations increased and reached
a higher peak (P < 0.01) more rapidly after E-17~ treatment than following treatment
with EB or EY. Plasma estradiol concentrations were at baseline 'by 36 h in E-17~­
treated cows and by 96 h in EB- and EY-treated cows. Plasma FSH concentrations
decreased (P < 0.0001) after estradiol treatment in all groups, reached a nadir at 24 h
and increased by 60 h in all groups, but concentrations remained higher (P < 0.02) in E-
17~-treated than in EB- or EY-treated cows. In summary, the use of a new CIDR-B
device increased plasma progesterone to near luteal concentrations, but for only 2 days.
Administration of 100 mg progesterone to ovariectomized cows at CIDR-B insertion
increased plasma progesterone approximately 2.0 ng/mL compared to those that
received only a CIDR-B device. Progesterone did not affect plasma FSH concentrations.
Administration of E-17P, with or without progesterone, caused a decrease in LH
concentration followed by an LH surge within 24 h after treatment. Estradiol treatment
resulted in FSH suppression with concentrations and length of suppression dependent on
the estradiol fonnulation. Gonadotrophin response to the administration of 1 mg of EB
after CIDR-B removal was equivalent to that induced by 5 mg of E-17~ at CIDR-B
insertion.
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5.2 Introduction
Estradiol and progesterone have been used in estrus synchronization programs.
Both hormones are usually administered at the time of insertion of a progestin-releasing
device to synchronize follicular wave emergence. Synchronous ovulation is usually
induced by giving a small dose of estradiol (e.g., 1.0 mg) after progestin removal
(Lammoglia et aI., 1998).
Estradiol affects follicular wave dynamics (B6 et aI., 1991, 1993, 1994, 1995a).
When estradiol-17~ (E-17~) was given to heifers at different stages of the first follicular
wave, emergence of a new follicular wave occurred, on average, 4.3 days later (B6 et
aI., 1995b). However, E-17~ caused regression of early stage dominant follicles only in
heifers that had previously received a progestin implant (B6 et aI., 1994). Plasma FSH
concentrations decreased by 6 h and increased between 30 and 72 h after estradiol
treatment in norgestomet-implanted heifers (B6 et aI., 1994).
Different estradiol esters may be expected to have different effects on FSH
secretion. Estradiol valerate (EV) has a long life in the circulation and a prolonged
suppressive effect on FSH and ovarian follicular growth (B6 et aI., 1991, 1993). When 5
mg EV was given to heifers on Day 1 after ovulation, early emergence of the second
follicular wave occurred, while treatment on Days 3 or 6 delayed follicular wave
emergence as compared to Control heifers (B6 et aI, 1993). Estradiol benzoate (EB) also
has a long circulating life; treatment with 5 mg EB resulted in the emergence of a
follicular wave, on average, 1 day later than in cows given 5 mg E-17~ (B6 et aI., 1996).
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However, a contemporaneous comparison of the effects of E-17~, EB and EVon
gonadotrophin concentrations has not been made.
The administration of E-1 7~ to ovariectomized cattle caused an initial decrease
in plasma LH concentrations followed by an LH surge, approximately 12 to 24 h later
(Short et aI., 1973; Hausler and Malven, 1976; Schoenemann et aI., 1985). A
norgestomet implant or a series of progesterone injections also decreased LH pulsatility
and blocked the estradiol-induced LH surge (Schoenemann et aI., 1985; Bolt et aI.,
1990). When 10 mg E-17~ was given (alone or in combination with norgestomet) to
ovariectomized cattle, plasma FSH concentrations were depressed for 64 h (Bolt et aI.,
1990). Therefore, estradiol would appear to have a differential effect on LH and FSH
and the effect on LH was dependent on the presence or absence ofprogesterone.
Progesterone-releasing devices (i.e., CIDR-B, PRill) have been used widely to
synchronize estrus and ovulation. However, these devices have also been used to create
models of follicular persistence (Savio et aI., 1993). In intact cows, a PRID altered LH
secretion, leading to an increase in LH pulsatility and development ofpersistent follicles
(Roberson et aI., 1989; Kojima et aI., 1992). However, when two devices were used, the
resulting elevated plasma progesterone concentrations caused a decrease in mean LH
concentrations and pulsatility (Roberson et aI., 1989; Kojima et aI., 1992) and prevented
formation of persistent follicles. We hypothesized that the development of persistent
follicles could be prevented in CIDR-B-treated cattle by administering estradiol at the
time of CIDR-B insertion, which would result in suppression of the present dominant
follicle followed by the emergence of a new follicular wave (B6 et aI., 1995a; Martinez
et aI., 2000). This combination induced a suppression of the dominant follicle followed
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by a resurgence of FSH and the subsequent emergence of a new follicular wave. The
effect of various doses ofEB (along with CIDR-B devices) has been studied (O'Rourke
et aI., 2000). However, as different estradiol esters have been used in· the manipulation
of follicular wave dYnamics for estrus synchronization, we considered that a comparison
of their effects on gonadotrophins in ovariectomized cattle would be important.
A series of experiments were designed to detennine the effects of estrogen and
progesterone treatments on circulating concentrations of gonadotrophins in
ovariectomized cows. The objective of the first experiment was to determine the dose of
progesterone, given concurrently with a standard dose ofE-17~, capable of affecting LH
release in CIDR-B-treated, ovariectomized cows. The second experiment was designed
to determine the effect of a CIDR-B device on basal circulating gonadotrophin
concentrations in ovariectomized cows, and the effect of E-17P (alone or with
progesterone) on gonadotrophin release. The third experiment was designed to
determine the effect of E-17P on gonadotrophin concentrations when administered with
low or high plasma progesterone concentrations and to determine timing of LH release
after CIDR-B removal and treatment with EB. The fourth experiment was designed to
determine: 1) the circulating life-span of three different estradiol forms; 2)
gonadotrophin profiles after treatment with three different estradiol forms administered
with progesterone; and 3) the period of inhibition ofFSH-release after administration of
the three different estradiol forms in progesterone-treated, ovariectomized cows.
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5.3 Materials and Methods
5.3.1 Animals
Beef cows (n = 1J), which had been ovariectomized 11 to 12 months earlier,
were used in these experiments. Cows were housed outdoors in feedlot pens at the
Goodale Research Farm, University of Saskatchewan and fed barley silage, with free
access to water.
5.3.2 Experiment 1
On Day 0 (beginning of the experiment), cows (n=16) received a once-used
CIDR-B (Vetrepharm Canada Inc, Belleville, ON, Canada) device and 5 mg of E-17~
(Sigma-Aldrich Canada Ltd, Oakville, ON, Canada) in 2 mL canola oil and were
randomly allocated to four groups treated 0, 25, 50 or 100 mg of progesterone (Sigma-
Aldrich Canada Ltd) in 2 mL canola oil. The CIDR-B devices were removed 7 d later.
Blood samples were taken every 12 h from CIDR-B insertion to the end of the
experiment to measure progesterone, estradiol, FSH and LH (Figure 5.1).
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Days
o 1
5 mg E-I7~ plus: 0 mg P
25mgP
50mgP
IOOmg P
CIDR-B
removal
in all groups
8 9 10
Figure 5.1 Treatment schedule of ovariectomized beef cows (n = 16) receiving a once-
used CIDR-B device on Day 0 (beginning of the experiment) and
concurrently injected i.m. with 5 mg E-17~ plus 0, 25, 50 or 100 mg
progesterone (P) im. The CIDR-B devices were removed on Day 7. Blood
samples were taken every 12 h from CIDR-B insertion to the end of the
experiment to measure progesterone, estradiol, FSH and LH.
5.3.3 Experiment 2
Seventeen cows were assigned randomly to receive a new CIDR-B device or
nothing on Day 0 (beginning of the experiment). On Day 5, half of each group received
an i.m. injection of 5 mg E-17~ or 5 mg E-I7~ plus 100 mg progesterone in 2 mL canola
oil. The CIDR-B devices were removed on Day 10. Blood samples were collected every
24 h from CIDR-B insertion to Day 10 for progesterone measurement, every 6 h for 48
h after E-I7~; and every 12 h to the end of the experiment on Day 10 for progesterone,
LH, and FSH analysis (Figure 5.6).
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1) CIDR-B
2) CIDR-B
3) No CIDR-B
4) No CIDR-B
E-17~
E-17~/P
E-17~
E-17~/P
CIDR-B removal
CIDR-B removal
Figure 5.2 Treatment schedule of ovariectomized beef cows (n = 17) after insertion of a
progesterone-releasing CIDR-B device or not (Day 0) followed by an i.m.
injection of E-17~ (E-17~) or E-17~ plus progesterone (E-17~1P) on Day 5.
The CIDR-B devices were removed on Day 10 (as indicated by arrows).
Blood samples were collected every 24 h from CIDR-B insertion to Day 10
for progesterone measurement; every 6 h for 48 h after E-l 7~ and
progesterone treatment and, every 12 h to the end of the experiment on Day
10 for estradiol, LH and FSH analysis.
5.3.3 Experiment 3
Ovariectomized ,beef cows (n = 16) received a once-used CIDR-B device on Day
o (beginning of the experiment; 2 d after completion of Experiment 1). Cows were
allocated randomly to three groups treated i.m. with 5 mg E-17~ on Day 0 (Group EO), 5
mg E-17~ on Day 1 (Group El), or 5 mg E-17~ plus 100 mg P on Day 0 (Group EP).
The CIDR-B devices were removed on Day 7 and all cows were given 1 mg i.m. ofEB
(Sigma-Aldrich) in 2 mL canola oil on Day 8. Blood samples were taken every 6 h for a
period of 72 h after CIDR-B insertion, then every 12 h until 24 h after CIDR-B removal
(Day 8), and every 6 h for 48 h thereafter for progesterone, estradiol, LH, and FSH
analysis (Figure 5.3).
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Figure 5.3 Treatment schedule of ovariectomized beef cows (n = 16) treated with a
once-used CIDR-B device on Day 0 along with the administration of 5 mg E-
17P (E-17P) on Day 1 (E1) or on Day 0 (EO), or 5 mg E-17P and 100 mg
progesterone (P) on Day 0 (EP). The CIDR-B devices were removed on Day
7 (as indicated by arrows), followed 24 h later by an injection of 1 mg ofEB
(Day 8). Blood samples were taken every 6 h for a period of 72 h after
CIDR-B insertion, then every 12 h until 24 h after CIDR-B removal, and
then, every 6 h for 48 h.
5.3.4 Experiment 4
Sixteen ovariectomized beef cows received a once-used CIDR-B device on Day
o (beginning of the experiment) and were allocated randomly to three groups treated
with 100 mg of progesterone plus 5 mg of one of 3 different estradiol esters: E-17~, EB
or EV in 2 mL canola oil. The CIDR-B devices were removed on Day 7. Blood samples
were collected every 6 h from Cay 0 to Day 3 and every 12 h thereafter to measure
progesterone, estradiol, FSH and LH (Figure 5.4).
43
Days
o 1 2 3 4 5 6 7 8
CIDR-B + E-17~/P
CIDR-B + EB/P
CIDR-B + EV/P
CIDR-B
removal
(all groups)
Figure 5.4 Treatment schedule of ovariectomized beef cows treated with a once-used
CIDR-B device on Day 0 (beginning of the experiment) and randomly
assigned to three groups to receive 100 mg progesterone plus 5 mg E-17~,
EB or EV i.m. in 2 mL canola oil. The CIDR-B devices were removed on
Day 7. Blood samples were collected every 6 h from Days 0 to 3 and every
12 h thereafter to measure progesterone, estradiol, FSH and LH.
Blood samples for estradiol, progesterone, LH and FSH radioimmunoassay were
collected in heparinized tubes, kept at approximately 4°C and centrifuged within 4 h
after collection; plasma was stored frozen at -20°C until assayed.
The progesterone assay for Experiments 1, 3 and 4 were carried out using a
solid-phase enzyme-linked immunoassay as described by Del Vecchio et al (1995).
Progesterone was extracted with 2.5 mL ether added to 250 J.lL aliquots of plasma. The
intra- and inter-assay coefficients of variation were 5.4 and 10.6 and the sensitivity was
4.0 pg/tube. The progesterone and estradiol assays for Experiment 2 were conducted as
described by Rawlings et al. (1984). Progesterone was extracted with 3 mL of hexane
added to 200 J.lL aliquots of plasma. The sensitivity of the progesterone
radioimmunoassay was 0.1 ngjrnL. Intra-assay coefficient of variation was 9.2% and
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4.0% for reference sera with mean levels of 1.8 and 13.4 ng/mL, respectively. Estradiol
was extracted with ethyl ether. The sensitivity of the assay was 0.5 pgjmL and the intra-
assay coefficient of variation was 5.3% and 9.1 % for reference sera with mean levels of
31.7 and 208.6 pgjmL, respectively.
Plasma LH concentrations were detennined by double antibody
radioimmunoassay (Honaramooz et aI., 2000) and are expressed in tenns of NIDDK-
bLH4. The sensitivity of the assay was 0.06 ng/mL, assessed as the lowest concentration
of LH capable of displacing labeled LH from the antibody. Intra-assay coefficient of
variation was 7.9% and 5.5% for reference sera with mean LH concentrations of 0.4 and
1.0 ngjmL, respectively. Plasma concentrations of FSH were detennined using a liquid-
phase antibody radioimmunoassay (Rawlings et aI., 1984; Honaramooz et aI., 1999).
The first antibody used was NIDDK anti-oFSH-1 and FSH concentrations are expressed
in terms of USDA-bFSH-l. The sensitivity of the assay was 0.13 ngjmL. Intra-assay
coefficient of variation was 6.8% and 6.8% for reference sera with mean FSH
concentrations of 1.7 and 3.6 ngjmL, respectively.
Time-series honnone data were analyzed USIng the GLM procedure with
repeated measures of (main effects of treatment, time and the treatment-by-time
interaction; SAS User's Guide, 1990). Main effects of treatment and time were
compared by a protected LSD test. Mean and standard error of the mean (SEM) were
used to describe honnone concentrations at different times. One-way analysis of
variance was used to compare the interval from treatment to LH or FSH surges
(statistically significant increases of circulating honnone concentrations over 1 ng/mL).
In Experiment 2, plasma progesterone concentrations were separately analyzed from
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Days 0 to 5 and from Days 5 to 10. In Experiment 2, the Mann-Whitney two-sample
rank sum test was used to compare the interval from estradiol treatment to LH peak
concentrations in those groups receiving an injection of estradiol (alone or in
combination with progesterone). In Experiment 3, data for the first 48 h after estradiol
treatment were normalized to E-17B treatment and later analyzed for the effects of
treatment, time, and treatment-by-time interaction on plasma FSH and LH
concentrations. Although probability of 5% (P<0.05) was taken as the level of
significance in all analyses, probability levels obtained in the statistical tests (i.e.,
P<O.OOOl, P=OA, etc.) are reported.
The protocols for these experiments were approved by University of
Saskatchewan Animal Care Committee.
5.4 Results
5.4.1 Experiment 1
Progesterone. There was a tendency for an effect of treatment (P = 0.10), and there was
an effect of time (P < 0.0001) and treatment-by-time interaction (P < 0.0002) on plasma
progesterone concentrations. Mean plasma progesterone concentrations were higher in
the groups treated with 50 mg (P = 0.05) or 100 mg (P = 0.02) of progesterone than in
the group treated with 0 mg of progesterone. Maximum concentrations were reached 24
h after treatment (P = 0.0025) and were highest (P < 0.001) in the group treated with 100
mg (6.2 ± 0.4 ng/mL), intermediate in the groups treated with 25 mg (3.2 ± 0.36 ng/mL)
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and 50 mg (3.9 ± 0.4 ng/mL) of progesterone, and the lowest (P < 0.001) in the group
treated with 0 mg progesterone (2.4 ± 0.4 ng/mL). By 48 h after treatment, plasma
progesterone concentrations were attributed only to the CIDR-B devices in all groups
(P>O.4; Figure 5.5).
Luteinizing hormone. There was no effect of treatment (P = 0.7) or treatment-by-time
interaction (P = 0.7) on plasma LH concentrations; however, there was an effect of time
(P = 0.0001). In all treatment groups, mean (± SEM) LH concentrations tended to
increase (P = 0.08) from pretreatment levels (1.4 ± 0.2 ng/mL) by 12 h after estradiol
and progesterone treatment (1.9 ± 0.2 ng/mL). Then, LH concentrations decreased (P <
0.007) to 0.4 ± 0.2 ng/mL by 36 h after treatment, and remained low until 72 h, and
finally increased (P = 0.01) to pretreatment concentrations by 84 h, where it remained
for the remainder of the sampling period (1 dafter CIDR-B removal; Figure 5.5).
Follicle stimulating hormone. There was no effect of treatment (P = 0.5) or treatment-
by-time interaction (P = 0.9), however, there was an effect of time (P = 0.0001) on
plasma FSH concentrations. FSH concentrations decreased (P < 0.0001) from 3.3 ± 0.2
ng/mL at the time of treatment to 2.2 ± 0.2 ng/mL and 1.5 ± 0.2 ng/mL at 12 h and 24 h
after estradiol treatment, respectively. Plasma FSH concentrations remained low until 48
h after treatment. Mean (± SEM) plasma FSH concentrations increased (P < 0.01) to 3.5
± 0.2 ng/mL by 60 h after treatment (Figure 5.5).
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Figure 5.5 Mean (±SEM) plasma progesterone, LH and FSH concentrations in
ovariectomized beef cows receiving a once-used CIDR-B device on Day 0
(beginning of the experiment) and concurrently given an i.m. injection of 5
mg E-17~ plus 0, 25, 50, or 100 mg progesterone. The CIDR-B devices were
removed on Day 7.
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5.4.2 Experiment 2
Progesterone. There was an effect of treatment (P < 0.0001), time (P < 0.0001), and
treatment-by-time interaction (P < 0.0001) on plasma progesterone concentrations.
Mean plasma progesterone concentrations from Day 0 to 5 were higher (P < 0.0001) in
groups receiving CIDR-B devices than those that did not. On Day 6, progesterone
concentrations in the two CIDR-B-treated groups and E-17~/P-treated groups were
similar and higher (P < 0.0001) than those in the E-17~-treated group. Administration of
100 mg of progesterone increased (P < 0.0001) plasma concentration for approximately
2.0 ng/mL progesterone 24 h after treatment compared to the CIDR-B-treated group that
did not receive on injection ofprogesterone. Progesterone concentrations in the E-17~/P
group decreased (P < 0.01) to pretreatment concentrations by 72 h after treatment
(Figure 5.6).
Luteinizing hormone. There was an effect of time (P < 0.0001), but no effect of
treatment (P = 0.3), or treatment-by-time interaction (P = 0.2) on plasma LH
concentrations. There was a decrease (P < 0.05) in plasma LH concentrations 6 h after
treatment, followed by an increase (P < 0.001) at 18 and 24 h, and a decrease to baseline
36 h after treatment (Figure 5.6). There was a tendency (P < 0.08) for an effect of
progesterone administration on the time to the median LH peak, which was 18 h in the
groups treated with E-l 7~ alone and 24 h for groups that also received progesterone
along with E-17~ (Figure 5.6).
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Follicle stimulating hormone. There was an effect of time (P < 0.0001), but no effect of
treatment (P = 0.4), or treatment-by-time interaction (P = 0.8) on plasma FSH
concentrations. Mean (± SEM) plasma FSH concentrations in all groups decreased (P <
0.0001) 6 h after treatment with E-l7~, remained low until 36 h, and then increased (P <
0.005) by 48 h after treatment (Figure 5.6).
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5.4.3 Experiment 3
Progesterone. There was no effect of treatment (P = 0.6), but there was an effect of time
(P < 0.0001) and treatment-by-time interaction (P < 0.0001) on mean plasma
progesterone concentrations. Plasma progesterone concentrations increased (P < 0.0001)
by 6 h and were higher (P < 0.0001) in the E-17PIP group at 6 h after CIDR-B insertion
than in the other groups. In all groups, plasma progesterone concentrations dropped by
84 h after treatment (P < 0.0001). After CIDR-B removal on Day 7, progesterone
concentrations declined (P < 0.0001) to undetectable values by 12 h (Figure 5.7).
Luteinizing hormone. There was no effect of treatment (P = 0.7), but there was an effect
of time (P < 0.0001) and a treatment-by-time interaction (P = 0.05) on mean plasma LH
concentrations. When data for the first 48 h after treatment were normalized to E-17P
treatment and analyzed, outcomes were very similar to those of the previous analysis
(effects of treatment, P = 0.80; time, P < 0.0001; and treatment-by-time interaction, P <
0.007). Mean (± SEM) LH concentrations decreased (P < 0.05) 6 h after CIDR-B
insertion in all treatment groups. Plasma LH concentrations then increased (P < 0.05) in
all groups, peaking 18 h after estradiol injection in the E1 group (3.1 ± 0.4 ng/mL) and
at 24 h in the EP (2.6 ± 0.4 ng/mL) and EO (1.6 ± 0.4 ng/mL) groups (Figure 5.7). Then,
plasma LH concentrations declined to levels lower than 1 ng/mL and remained around
that concentration thereafter.
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Estradiol. There was a tendency for an effect of treatment (P = 0.09), and there was an
effect of time (P < 0.0001) and a treatment-by-time interaction (P < 0.0001) on mean
plasma estradiol concentrations. In all groups, estradiol concentrations peaked (P <
0.0001) at 6 h after treatment with 5 mg E-17~, decreasing to baseline by 30 h (P = 0.2),
24 h (P = 0.2) and 30 h (P = 0.2) in E1, EP and EO groups, respectively (Figure 5.7).
Follicle stimulating hormone. There was an effect of treatment (P < 0.008), time (P <
0.0001) and a treatment-by-time interaction (P < 0.0001) on mean plasma FSH
concentrations (Figure 5.7, Table 5.1). When data for the first 48 h after estradiol
treatment were normalized to time of E-17~ treatment and analyzed, outcomes were
very similar to those of the previous analysis (effects of treatment, P = 0.007; time, P <
0.0001; and treatment-by-time interaction, P < 0.0001, on plasma FSH concentrations).
Mean (± SEM) plasma FSH concentrations were reduced (P < 0.0001) from those at the
time of treatment (2.0 ± 0.1 ng/mL) by 6 h in all groups (1.3 ± 0.1 ng/mL; Table 5.1).
By 30 h after treatment, plasma FSH values reached a nadir (average 0.9 ± 0.1 ng/mL;
Figure 5.7). Plasma FSH concentrations began to increase after 30 h (Figure 5.7; Table
5.1).
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Hormone changes after EB treatment 24 h after CIDR-B removal. Mean plasma
progesterone concentrations were less than 1.0 ng/mL 12 h after CIDR-B removal
(Figure 5.8). Plasma estradiol concentrations increased (P < 0.0001) from 1.0 ± 0.4
pg/mL at the time ofEB treatment (24 h after CIDR-B removal) to 15.0 ± 2.1 pg/mL by
6 h, continued to increase until 24 h (32.6 ± 2.4 pg/mL), and then decreased (P < 0.01).
By 48 h after EB treatment, estradiol concentrations (9.9 ± 1.6 pg/mL) were still higher
(P < 0.05) than those at the time of treatment. Plasma LH concentrations decreased (P <
0.02) for 6 h, and then increased at 18 h after EB treatment, declining to basal
concentrations by 30 h after treatment. Plasma FSH concentrations decreased by 6 h (P
< 0.01), reached a nadir by 30 h and then increased (P < 0.04) at 48 h after treatment.
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Figure 5.8 Mean (±SEM) plasma progesterone, estradiol, FSH and LH concentrations
after treatment with 1 mg EB (EB) 24 h after CIDR-B removal in
ovariectomized beef cows (n = 16).
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Table 5.1 Mean (± SEM) FSH concentrations in ovariectomized beef cows (n = 16)
treated with a CIDR-B device on Day 0 plus administration of E-17~ on Day
oor on Day 1 or E-17P and progesterone on Day O. The CIDR-B devices
were removed 7 d later.
End points E1 EO EP
FSH concentration at CIDR-B insertion 2.3 ± 0.1 1.5 ± 0.1 1.8 ± 0.1
Concentration at 6 h 1.8 ± 0.1 0.9 ± 0.1 1.2 ± 0.1
Nadir concentration (ng/mL) 1.1 ± O.l a b b0.7 ± 0.1 0.8 ± 0.1
Concentration at 36 h (ng/mL) 1.4 ± 0.1 0.9 ± 0.1 1.2 ± 0.1
Maximal concentration (ng/mL) 2.2 ± 0.1 2.0 ± 0.1 2.2 ± 0.1
Intervals (h) from E-17P
to nadir concentration 30 30 18
to initial increase 48a 42ab 36b
to maximal concentration 72 84 72
ab Means with different superscripts differ significantly (P < 0.05).
5.4.4 Experiment 4
Progesterone. There was no effect of treatment (P = 0.4) or treatment-by-time
interaction (P = 0.9), but there was an effect of time (P < 0.0001) on plasma
progesterone concentrations (Figure 5.9). Progesterone concentrations increased from
0.4 ± 0.2 to 6.1 ± 0.2 ng/mL by 24 h after insertion of a CIDR-B device, decreasing to
4.9 ± 0.2 ng/mL at 72 h.
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Luteinizing hormone. There was no effect of treatment (P > 0.1), but there was an effect
of time (P < 0.0001) and treatment-by-time interaction (P < 0.02) on plasma LH
concentrations (Figure 5.9). In the E-17~ group, there was an increase (P = 0.02) in
plasma LH concentrations by 24 h (from 0.8 ± 0.4 ng/mL to 2.1 ± 0.4 ngjmL), which
was followed by a decrease (P = 0.003), reaching a nadir at 72 h after treatment. Mean
plasma LH concentrations increased (P = 0.05) by 96 h after treatment. An increase (P <
0.001) in plasma LH concentrations was observed 12 h after CIDR-B removal in EB-
and EV-treated groups.
Estradiol. There was no effect of treatment (P = 0.6), but there was an effect of time (P
< 0.0001) and treatment-by-time interaction (P < 0.0001) on mean plasma estradiol
concentrations (Figure 5.9). Plasma estradiol concentrations increased (P < 0.0001) from
0.4 ± 9.7 pgjmL at the time ofCIDR-B insertion to 214.0 ± 9.7 pgjmL by 12 h in the E-
17~ group; 1.81 ± 9.7 pgjmL at treatment to 97.1 ± 9.7 pg/mL at 12 h in the EB group;
and from 2.8 ± 8.9 pg/mL to 58.6 ± 8.9 pgjmL at 12 h in the EV group. Peak
concentration of estradiol in cows treated with E-17~ was the highest (P < 0.0001),
while peak concentrations were higher in the EB group than in the EV group (P <
0.005). However, plasma estradiol concentrations decreased (P < 0.0001) at 24 h in the
E17~ group and by 72 h after treatment (5.2 ± 9.7 pg/mL) were lower (P = 0.05) than
those in the EB (32.3 ± 9.7 pg/mL) or EV (28.9 ± 8.9 pgjmL) groups. Plasma estradiol
concentrations were at baseline at 36 h in E-17~-treated animals and at 96 h in EB- and
EV-treated cows (P < 0.0001) (Figure 5.9).
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Follicle stimulating hormone. There was no effect of treatment (P > 0.1), but there was
an effect of time (P < 0.0001) and treatment-by-time interaction (P < 0.0001) on plasma
FSH concentrations. Plasma FSH concentrations decreased (P < 0.0004) by 12 h after
estradiol treatment. Plasma FSH concentrations in the E-17~-treated group increased (P
< 0.0001) by 60 h to pretreatment concentrations, and remained higher (P < 0.05) than
in the EB and EV groups until the time of CIDR-B removal (Figure 5.9).
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Figure 5.9 Mean (±SEM) plasma estradiol, LH and FSH concentrations in
ovariectomized beef cows receiving a once-used CIDR-B device on Day 0
and 5 mg ofE-17~,EB or EV plus 100 mg progesterone at that time. CIDR-
B devices were removed on Day 7.
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5.5 Discussion
The use of new CIDR-B devices resulted in plasma progesterone concentrations
(,....,7 ng/mL) in ovariectomized cows, similar to those occurring between Days 11 and 15
of the estrous cycle in intact heifers (Kesner et aI., 1982). In previous studies, plasma
progesterone reached approximately 7 ng/mL 24 h after CIDR-B insertion in
ovariectomized cattle (Macmillan et aI., 1991; Macmillan and Peterson, 1993). High
progesterone concentrations were detected as early as 6 h and remained elevated for at
least 48 h after CIDR-B insertion, similar to previous reports in ovariectomized (Burke
et aI., 1996) and intact (Nation et aI., 2000; Burke et aI., 1999) cattle.
In our studies, 100 mg i.m. progesterone also increased progesterone
concentrations in ovariectomized cows. Progesterone given i.m. to ovariectomized cows
concurrently with a used CIDR-B device resulted in plasma progesterone concentrations
equivalent to those in ovariectomized cows treated only with a new CIDR-B device;
however, plasma progesterone remained elevated for a shorter interval (24 h after
treatment). Daily progesterone injections given at the end of the estrous cycle increased
the length of the estrous cycle in intact heifers (Christian and Casida, 1948) by
suppressing estrus and ovulation. Furthermore, daily administration of high (300 mg/d)
or 'physiological' (150 mg/d) doses of progesterone starting 6 days after ovulation
resulted in regression of the dominant follicle of the first follicular wave (Adams et aI.,
1992b). More recently, it was reported that a single injection of progesterone induced
regression of a persistent dominant follicle in melengestrol acetate-treated (200 mg
progesterone; Anderson and Day, 1998; McDowell et aI., 1998) or norgestomet-treated
(100 mg progesterone; Cavalieri et aI., 1998) heifers. Treatment with a CIDR-B device
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for 24 h, or injections ofprogesterone in canola oil or alcohol/saline vehicle given on the
Day 10 of a 17-day treatment with norgestomet implants in Bos indicus heifers resulted
in the emergence of a new follicular wave, on average, 2.6 days after treatment
(Cavalieri et aI., 1998). Based on our studies in ovariectomized cows, the effect of
progesterone on plasma LH concentrations became apparent after the effects of estradiol
disappeared at 36 h, and then circulating LH remained low until 72 h after CIDR-B
insertion. Therefore, the use of CIDR-B devices in intact animals would reduce the LH
concentrations for 72 h and induce the regression of the LH-dependent dominant
follicle.
The suppressive effect of progesterone on dominant or persistent follicles has
been attributed to a decrease in concentrations and pulsatility of circulating LH resulting
from treatment with exogenous progestins in the absence of a CL (Sirois and Fortune,
1990; Yelich et aI., 1997). After selection, a dominant follicle has acquired LH
receptors, becoming LH-dependent (Xu et aI., 1995). A sudden rise in plasma
progesterone concentrations may result In decreased plasma LH concentrations,
changing the pattern of LH secretion and affecting the growth of the LH-dependent
dominant follicle. In Experiments 2 and 3, the injection ofprogesterone and E-17~ given
concurrently with the insertion of a new or used CIDR-B device induced a decrease in
mean LH concentrations at 6 h, followed by a surge-like increase at 18 to 24 h. In
Experiment 3, although progesterone was injected at CIDR-B insertion in the EP group
and a CIDR-B device was inserted one day before E-17~ in the El group, plasma
progesterone concentrations were not sufficient to prevent an E-17~-induced LH surge.
However, it has been reported that a norgestomet implant placed one day before E-17~
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treatment blocked the E-I7p-induced LH surge In intact (B6 et aI., 1994) or
ovariectomized (Bolt et aI., 1990) heifers. Those studies suggest that norgestomet
released from the implant more effectively suppressed LH release than CIDR-B devices
used in our studies in ovariectomized cows. However, the effect ofbody size or category
of cattle used cannot be excluded as influencing the suppressive effect of progesterone.
The dose of 100 mg progesterone used in our studies may be also marginal in
suppressing LH release. The administration of 200 mg progesterone has been reported to
delay the onset of estrus and ovulation of a newly recruited dominant follicle (Murray et
aI., 1998}. Nevertheless, treatment with progesterone by injection should be considered
when using estradiol to synchronize follicular wave emergence in stages of the estrous
cycle in which endogenous progesterone is declining or may be low, e.g., end of the
estrous cycle.
In studies in ovariectomized cattle, mean plasma LH concentrations decreased 2
to 8 h after CIDR-B insertion (Burke et aI., 1996). In another study, serum LH
concentrations declined slightly 3 h after E-17P administration and then increased in a
surge-like fashion (Shoenemann et aI, 1985). This phenomenon was also found in post-
partum anestrous cows in which a transient initial decrease in mean LH concentrations
and reduced LH pulsatility were observed after progesterone treatment (Nation et aI.,
2000). Both endpoints have been reported to return to pretreatm<:?nt concentrations by
Day 3 after CIDR-B insertion in ovariectomized cattle (Burke et aI., 1996) and by Day 4
in intact cattle (Nation et aI., 2000). Based on the results of our studies, it may be
speculated that 5 mg E-17P at CIDR-B insertion masked the suppressive effect of
progesterone on LH until at least 36 h after treatment. The combined effects of both
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steroid hormones in suppressing both FSH and LH would cause regression of FSH- and
LH-dependent follicles. This would be followed by a surge in FSH and emergence of a
new follicular wave.
Plasma estradiol concentrations consistently peaked 6 h after E-17~ treatment in
ovariectomized cows and decreased gradually to baseline by 36 h. In previous studies,
plasma estradiol concentrations increased dramatically by 2 (B6 et aI., 2000a) and 6 h
(B6 et aI., 1994) after treatment with E-17~. In the present study, plasma estradiol
concentrations increased more rapidly and reached a higher peak after E-l 7~ treatment
than after treatment with EB, or EV. In addition, plasma estradiol concentrations
returned to baseline 96 h after treatment with EB or EV, consistent with previous studies
in ovariectomized (O'Rourke et aI., 2000) and intact heifers (B6 et al., 1993). In
addition, when 10 mg EB was given to ovariectomized heifers, plasma estradiol
concentrations peaked at inconsistent times, returning to basal concentrations by 120 h
in ovariectomized heifers (O'Rourke et aI., 2000) or 160 h in intact cattle (Vynckier et
aI., 1990).
Peak concentrations of estradiol depended on the formulation used. Therefore,
each estradiol form is expected to have different effects on gonadotrophin
concentrations and ovarian follicles. As mentioned above, treatment with E-17~ resulted
in a sharp LH peak, while treatment with EB or EV did not. It is also noteworthy that in
E-17~-treated cows, plasma LH concentrations increased to pretreatment concentrations
84 h after treatment, remaining higher than after treatment with the other estradiol
esters, whereas circulating LH increased only after CIDR-B removal in the EB and EV
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groups. This also occurred after treatment with the crystalline form of EB gIven
intravaginally (Burke et aI., 1996).
Increased concentrations of circulating estradiol suppressed plasma FSH
concentrations. In ovariectomized cows with or without CIDR-B devices, 5 mg E-17~
reduced plasma FSH concentrations from 6 to 48 h after treatment. Similar results have
been observed after treatment 10 mg E-l 7~ (with or without a norgestomet implant) in
ovariectomized heifers in which plasma FSH concentrations did not reach pre-treatment
concentrations by 60 h (Bolt et aI., 1990). If extrapolated to intact animals, suppression
of plasma FSH concentrations for this interval may result in the emergence of a
follicular wave one day later (i.e., 3- to 4-day interval from treatment to wave
emergence; B6 et al., 1995a). In Experiment 4, plasma FSH concentrations increased
earlier and reached higher peak concentrations in the E-17~ group than in the EB or EV
groups; FSH returned to pre-treatment concentrations by 2.5 d (60 h) after treatment in
the E-17~ group while in the EB and EV groups, plasma FSH began to increase by 96 h
after treatment. A similar result was shown after 5 mg EV was given to cyclic Holstein
cows (Barnes et aI., 1981). The delayed surge in plasma FSH concentrations may
explain delayed wave emergence observed in intact cattle after treatment with 5 mg of
EB (B6 et aI., 1996) or EV (B6 et aI., 1993; Mapletoft et aI., 1999). In addition, there
may be increasing variability in individual responses due to different estradiol
concentrations. However, after administration of 1 mg EB, plasma FSH concentrations
had a similar pattern of decline to that after 5 mg E17~ (Experiment 3). Similar FSH
suppression and plasma FSH profiles following an injection of 1 mg EB were observed
in ovariectomized heifers (O'Rourke et aI., 2000). Results indicate that FSH secretion
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and release are estradiol dose-dependent and that different estradiol esters suppress FSH
release differently, depending on the length of time that estradiol remains elevated in the
circulation. Therefore, a small dose of EV may have a similar effect on gonadotrophin
release as a small dose ofEB.
In summaI)', CIDR-B devices were effective in inducing increased circulating
concentrations of progesterone similar to those found during the luteal phase. of the
estrous cycle. However, plasma progesterone concentrations remained elevated for 48 h,
and were not capable of blocking estradiol-induced LH release, even though
supplementary progesterone was injected concurrently with estradiol. Estradiol-17~ and
progesterone resulted in LH and FSH suppression by 6 h after treatment. However,
suppressive effects were followed by LH release in a surge-like manner while FSH
concentrations remained depressed until 36 h after treatment. Therefore, treatment with
estradiol and CIDR-B devices in intact cattle may result in suppression of small follicles
(by estradiol) and large dominant follicles (by progesterone), which would be followed
by the emergence of a new follicular wave following the resurgence of FSH.
Additionally, EB and EV had a longer suppressive effect than E-17~ on circulating FSH
concentrations. However, at a lower dose, EB suppressed plasma FSH concentrations
for a shorter interval than a high dose and after CIDR-B removal, resulted in an LH
surge that could induce ovulation in intact cattle.
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6.0 EFFECTS OF ESTRADIOL-17P AND ESTRADIOL BENZOATE ON
OVARIAN FOLLICULAR DYNAMICS IN CIDR-B-TREATED BEEF
CATTLE.
6.1 Abstract
The objectives were to: 1) compare the effects of either estradiol-17P (E-17P) or
estradiol benzoate (EB) in the synchronization of ovarian follicular wave emergence and
ovulation in CIDR-B-treated beef cattle; and 2) determine the timing of LH release and
ovulation of the dominant follicle of a synchronized follicular wave after administration
of EB at various intervals after progesterone withdrawal. In Experiment 1, non-lactating
Hereford cows (n = 29) received a new CIDR-B intravaginal insert on Day 0 (beginning
of the experiment), and were randomly assigned to receive i.m. injections of 1 or 5 mg
of E-17P or EB on Day 1. On Day 8, CIDR-B devices were removed and PGF was
given i.m. Transrectal ultrasound examinations were done once daily from 2 days before
CIDR-B insertion to 2 days after CIDR-B removal and then twice daily to ovulation.
There was no difference among groups in the interval from estradiol treatment to
follicular wave emergence (P = 0.5). Treatment with 5 mg of E-17P resulted in the least
variable interval to wave emergence (P < 0.005), compared with the other treatment
groups which were not different (P = 0.1). For the interval from CIDR-B removal to
ovulation, there were no differences among groups for either means or variances (P =
0.5 and P = 0.1, respectively). In Experiment 2, beef heifers (n = 32) received a once-
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used CIDR-B device on Day 0 (beginning of the experiment) and were randomly
assigned to receive i.m. injections of either 5 mg E-17P plus 100 mg progesterone or I
mg EB plus 100 mg progesterone i.m. On Day 7, CIDR-B devices were removed and all
heifers received PGF. On Day 8 (24 h after CIDR-B removal), each group was randomly
subdivided to receive either 1 mg E-17~ or 1 mg EB i.m. Treatment with either form of
estradiol did not affect the mean (± SEM) interval from treatment to follicular wave
emergence (4.1 ± 0.2 days, P = 0.7) or overall median interval from CIDR-B removal to
ovulation (76.6 h; P = 0.7) or the range (72 to 120 h; P = 0.08). In Experiment 3,
follicular wave emergence was induced in heifers (n = 40) with a once-used CIDR-B
device and 5 mg E-17~ plus 100 mg progesterone i.m. on Day O. On Day 7, CIDR-B
devices were removed, PGF was administered and heifers were assigned to four groups.
The Control group received no treatment and the other three groups were given 1 mg
i.m. EB at 12, 24, or 36 h after CIDR-B removal. Ultrasonographic examinations were
done once daily from Day 0 to the day ofEB treatment (to monitor ovarian changes) and
then twice daily from EB treatment to ovulation. Blood samples were taken every 6 h
from EB treatment to ovulation. Plasma estradiol concentrations increased within 6 h (P
< 0.001) after EB treatment in all three groups. Plasma LH concentrations peaked 78.0 ±
23.0 h after CIDR-B removal in the Control group compared to 37.8 ± 8.5, 44.4 ± 10.3,
and 51.0 ± 5.1 h after CIDR-B removal in groups treated with EB at 12, 24, or 36 h,
respectively (means, P < 0.001; variances, P < 0.001). Mean (± SEM) intervals from
CIDR-B removal to ovulation were 102.0 ± 6.7,63.6 ± 3.6, 81.6 ± 3.5, and 78.0 ± 4.1 h
for Control heifers or those treated with EB at 12, 24, and 36 h, respectively (P < 0.05).
In summary, both E-17P and EB effectively synchronized ovarian follicular wave
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emergence and ovulation in CIDR-B-treated cattle. The interval from CIDR-B removal
to ovulation was significantly shorter and less variable in all EB-treated groups
compared to the Control group and ovulation was hastened in heifers that received EB at
12 h compared to 24 or 36 h after CIDR-B removal.
6.2 Introduction
There is widespread use of CIDR-B devices for controlling estrus and ovulation
in cattle. Estradiol has been used to synchronize follicular wave emergence (B6 et aI.,
1991, 1993). Numerous studies have investigated the use of different estradiol
preparations in progestin-based synchronization programs (Lammoglia et aI., 1998;
Burke et aI., 1999; Martinez et aI. 2000). The administration of 5 mg estradiol-17P (E-
17P) to progestin-treated heifers (B6 et aI., 1994) suppressed small antral follicles,
followed by the emergence of a new follicular wave, on average, 4.3 days later (B6 et
aI., 1995a), whereas the same dose of estradiol benzoate (EB) in Hereford cows induced
emergence of a new follicular wave 5.4 days later (B6 et aI., 1996). More recently,
treatment with 1, 2.5 or 5 mg EB (and 50 mg of progesterone) resulted in a median day
of follicular wave emergence of 4.0 days in CIDR-B-treated beef cows; this interval was
significantly more synchronous in cows given 2.5 mg than in those given 5 mg EB
(Caccia and B6, 1998).
Estradiol benzoate has been used to induce estrus in prostaglandin F2a- (PGF)
treated cattle (Welch et aI., 1975; Peters et aI., 1977; Dailey et aI., 1983). In CIDR-B-
treated cattle, the administration of 0.38 (heifers) or 1.0 (cows) mg EB 24 to 30 h after
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CIDR-B removal resulted In estrus In 86 and 100% of the cattle, respectively
(Lammoglia et aI., 1998). Furthermore, EB treatment induced a synchronous LH surge
(between 16 and 20 h after treatment), resulting in significantly higher pregnancy rates
than in non-treated cattle' (Lammoglia et aI., 1998). However, a critical comparison
between E-17~ and EB has not yet been done and the effect of the interval between
CIDR-B" removal and EB treatment on the timing and synchrony of ovulation has not
been studied.
Three experiments were conducted to compare the effects of E-17~ and EB on
the synchronization of follicular wave emergence and ovulation in CIDR-B-treated beef
heifers and to determine the timing of LH release and ovulation after the administration
of EB at various intervals after progesterone withdrawal.
. 6.3 Materials and Methods
6.3.1 Experiment 1
Non-lactating Hereford cows (n = 29) 3 to 6 years of age, weighing 450 to 550
kg) and kept in pasture consisting of oats and native grass during the winter in Cordoba,
Argentina (31 0 24' S, 640 11' W, 400 meters above sea level) were used in this
experiment. Cows received a new progesterone-releasing vaginal device (CIDR-B;
Vetrepharm Canada Inc, Belleville ON, Canada) intravaginally on Day 0 (beginning of
the experiment), and were assigned to four groups to receive an i.m. injection of 1 or 5
mg of E-17~ or EB (both from Sigma-Aldrich Canada Ltd, Oakville, ON, Canada) in 2
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mL canola oil on Day 1 (2x2 factorial layout). On Day 8, CIDR-B devices were
removed and 500 Ilg of cloprostenol (PGF; Estrumate, Schering Canada Inc, Pointe-
Claire, PQ, Canada) was given i.m. Transrectal ultrasonographic examinations were
done by a single operator using a real-time B-mode scanner with a 5.0 MHz linear-array
transducer (Aloka SSD-500, ISM Inc, Edmonton, AB, Canada). Ultrasonography was
performed once daily from 2 days before CIDR-B insertion to 2 days after CIDR-B
removal, and then every 12 h to ovulation or to 7 days after device removal if ovulation
did not occur. During each examination, a sketch of each ovary was made and the
diameter and location of follicles 3 mm in diameter were recorded. Ovulation was
defined as the abrupt disappearance (from one examination to the next) of a previously
identified follicle greater 8 mm in diameter. The dominant follicle of a wave was
defined as the follicle that reached the largest diameter. The day of wave emergence was
retrospectively defined as the day when the dominant follicle was first detected at a
diameter of 4 to 5 nun. However, if the dominant follicle was not detected until it
reached 6 or 7 nun, the previous day was considered the day of wave emergence
(Ginther et aI., 1989b). Two-way analysis of variance was used to compare the effects of
dose (lor 5 mg), estradiol formulation (E-17P or EB) and the dose-by-formulation
interaction. The LSD multiple comparison test was used to locate differences among
groups. Statistical analyses were conducted with a commercial program for statistical
analysis (Statistix Student Version, version 2.0, Analytical Software, Tallahassee,
Florida, USA).
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6.3.2 Experiment 2
Thirty-two pubertal beef heifers were housed outdoors in feedlot pens at the
Goodale Research Pann, University of Saskatchewan and fed barley silage, with free
access to water. Heifers had a once-used CIDR-B inserted intravaginally on Day 0
(beginning of the experiment) and were assigned to four groups; half of the heifers
received an i.m. injection of 5 mg E-17P plus 100 mg ofprogesterone in 2 mL canola oil
and the other half received 1 mg EB plus 100 mg of progesterone in 2 mL canola oil.
After CIDR-B removal and PGP treatment (Day 7), the heifers received i.m. injections
of either 1 mg E-17P or EB in 2 mL canola oil on Day 8, (24 h after CIDR-B removal).
Transrectal ultrasonography was done once daily from Day 0 to Day 9 to monitor
ovarian follicular development, and every 12 h thereafter to detect ovulation. Data prior
to the second injection of estradiol were dependent only on the initial treatment,
therefore, diameter of the dominant follicle and CL at the time of the first estradiol
treatment and the interval from estradiol treatment to the emergence of the next
follicular wave were compared as two groups (i.e., E-17P or EB). Student's t-tests were
used to compare, between groups, the diameters of the dominant follicle and the CL at
the time of treatment with estradiol or PGP, the interval from estradiol treatment to the
emergence of the next follicular wave, and the interval from CIDR-B removal to
ovulation. Bartlett's test of homogeneity of variance was used to compare the variability
of the day of wave emergence. Statistical analyses were conducted with a commercial
program for statistical analysis (Statistix Student Version).
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6.3.3 Experiment 3
Beef heifers (n = 40), housed outdoors in feedlot pens at the Goodale Research
Farm, University of Saskatchewan and fed barley silage, received a once-used CIDR-B
device and an i.m. injection of 5 mg of E-17~ plus 100 mg of progesterone in 2 mL
canola oil on Day 0 (beginning of the experiment). On Day 7, CIDR-B devices were
removed, 500 Jlg PGF was administered concurrently. Heifers were randomly assigned
to four groups to receive no treatment (Control), or an i.m. injection 1 mg of EB (in 2
mL canola oil) 12, 24, or 36 h after CIDR-B removal (Figure 5.1). Transrectal
ultrasonographic examinations were done once daily from Day 0 to Day 7 to monitor
ovarian follicular development and twice daily from EB treatment to ovulation using a
real-time, B-mode scanner (Aloka SSD-500) with a 7.5 MHz linear-array transducer. In
the Control group, examinations were performed as in the group given EB 24 h after
CIDR-B removal. Blood samples were taken daily (for detennination of estradiol and
progesterone concentrations) and every 6 h for 48 h after EB administration (for LH
concentrations).
Blood processing. Blood samples for estradiol, progesterone, LH and FSH
radioimmunoassay were collected in heparinized tubes, kept at approximately at 4°C,
centrifuged within 4 h after collection, and plasma frozen until assayed. Plasma LH
concentrations were detennined by double antibody radioimmunoassay (Honaramooz et
aI., 2000) and were expressed in terms of NIDDK-bLH4. The sensitivity of the LH
assay, assessed as the lowest concentration ofLH capable of displacing labeled LH from
the antibody, was 0.06 ng/mL. Intra- and inter-assay coefficients of variation were 5.9
and 2.5%, respectively, for reference sera with mean LH concentrations of 0.35 and 0.95
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ngimL. Plasma concentrations of FSH were determined using a liquid-phase antibody
radioimmunoassay (Rawlings et aI., 1984; Honaramooz et aI., 1999). Assays for
progesterone and estradiol were conducted as described by Rawlings et aI. (1984).
Progesterone was extracted with 3 mL of hexane added to 200 JlL aliquots of plasma.
The sensitivity of the progesterone radioimmunoassay was 0.1 ng/mL. Intra- and inter-
assay coefficients of variation were 12.0 and 13.8% (means, 1.36 and 0.44 ng/mL,
respectively). Estradiol was extracted with ethyl ether. The sensitivity of the assay was
0.5 pg/mL and the intra- assay coefficient of variation was 6.3 and 4.0% (means 8.6 and
207.2 pg/mL, respectively).
Maximal mean concentrations of plasma estradiol or LH were calculated with
data from all heifers at the time of the highest hormone concentration in the treatment
group, whereas mean peak concentrations were calculated with the highest
concentration ofan individual heifer within a treatment group.
Hormonal data were analyzed using the GLM procedure (main effects:
treatment, time and treatment-by-time interaction; SAS/STAT User's Guide, 1990).
Main effects and mean LH concentrations during the LH surge were compared by the
protected LSD test. One-way analysis of variance was used to compare the interval from
EB treatment to ovulation and the LSD multiple range test was used to compare means.
Variability in ovulation time (expressed as variance) was compared by Bartlett's test.
Analyses of data points were conducted with a commercial program for statistical
analysis (Statistix Student Version).
The protocols for these experiments were approved by University of
Saskatchewan Animal Care Committee.
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Figure 6.1 Treatment schedules of beef heifers treated with a once-used CIDR-B device
on Day 0 along with the administration of E-17P and progesterone. The
CIDR-B devices were removed on Day 7. An i.m. injection of 1 mg of EB
was given 12, 24, or 36 h after CIDR-B removal. Blood samples were
collected every 6 h from EB treatment to ovulation.
6.4 Results
6.4.1 Experiment 1
One cow treated with 1 mg E-17P and two cows treated with 5 mg EB had
emergence of a follicular wave 2 days before treatment (Day -2); the future dominant
follicle was not suppressed, and continued growing until it ovulated (after CIDR-B
removal). Statistical analyses were done both for the complete data set, and for the data
excluding these 3 cows and the results are shown in Table 6.1. The administration of 5
mg of E-17P resulted in the least variable interval to wave emergence (P < 0.005),
compared with the other treatment groups which were not different (P > 0.1). There was
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an effect of dose (P < 0.05) and estradiol fonnulation (P < 0.01) on the diameter of the
dominant follicle at CIDR-B removal; cows treated with E-17~ had a larger dominant
follicle (l0.4 ± 0.5 mm) than those treated with EB (7.9 ± 0.6 mm). However, there was
no difference on the diameter of the dominant follicle at the time of CIDR-B removal
between cows treated with 1 mg of EB and those treated with 1 or 5 mg E-17~ (P >
0.05). The diameter of the CL at CIDR-B removal was the smallest in cows treated with
1 mg E-17~ compared to the rest of treatment groups (P < 0.03). There was no
difference among groups in the mean (P = 0.5) or variability (P = 0.1) of the interval
from CIDR-B removal to ovulation (Table 6.1).
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Table 6.1 Mean (± SEM) diameter of the dominant follicle (DF) and intervals from
estradiol benzoate (EB) treatment to follicular wave emergence and from
CIDR-B removal and PGF treatment to ovulation in non-lactating
Hereford cows treated with a CIDR-B device one day before EB
treatment (Experiment 1).
5 mg E-17~ 1 mg E-17~ 5mgEB 1 mgEB
No. of cows 8 7 6 8
Diameter (mm) ofDF at
Estradiol treatment 11.4 ± 1.1 10.8 ± 1.0 10.1±1.3 9.8 ± 1.3
CIDR-B removal 9.4 ± 0.5a 10.9 ± 0.9a 7.0 ± 0.9b 8.8 ± 0.7ab
Diameter (mm) ofthe CL at
Estradiol treatment
CIDR-B removal
19.1 ± 1.5
15.1 ± 1.8a
20.4 ± 1.5
10.3±1.1b
18.6±2.6 17.0±2.1
14.1 ± 1.6ab 15.1 ± 2.0ab
Interval (d) from estradiol treatment to wave emergence
Mean(± SEM) 3.6 ± O.2x 4.1 ± O.3y 5.5 ± 0.5Y 3.6 ± 0.5Y
Range 3 t04 3 to 5 4 to 8 2 to 6
Interval (h) from CIDR-B removal to
Ovulation 99.0 ± 7.4xy 80.6 ± 4.3x 98.0 ± 12.9Y 94.5 ± 8.3XY
Range 72 to 132 72 to 96 72 to 144 72 to 144
No. cows ovulating 8 7 6 8
ab Means with superscripts not in common are different (P < 0.01):
xy Variances with superscripts not in common are different (P < 0.05).
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6.4.2 Experiment 2
In one heifer that received EB and one that received E-17~, treatment was not
followed by wave emergence. Therefore, data analyses were done for all heifers and for
heifers excluding these two non-responders, and the results are shown in Table 5.2.
Mean (± SEM) diameter of the dominant follicle and of the CL at CIDR-B insertion
(12.0 ± 0.5 mm; 19.7 ± 0.7 mm, respectively) or removal (9.5 ± 0.3; 14.3 ± 0.9 mm,
respectively) did not differ (P = 0.3, P = 0.4, respectively) between estradiol groups.
The mean (P = 0.7) and variability (P = 0.6) of the interval from treatment to
follicular wave emergence were not different between the E-17~ and EB groups. The
interval from CIDR-B removal to ovulation also did not differ between groups (P = 0.7).
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Table 6.2 Mean (± SEM) intervals (and their range) from estradiol treatment to
follicular wave emergence and from CIDR-B removal to ovulation in CIDR-
B-treated beef heifers after administration of estradiol-17P or estradiol
benzoate to synchronize follicular wave emergence and ovulation
(Experiment 2).
Estradiol-17P Estradiol benzoate
Induction of follicular wave emergence
No. ofheifers 16 16
Interval (d) from estradiol treatment to
Wave emergence 3.4 ± 0.5 3.7 ± 0.6
Range
-3 to 5 -5 to 6
Excluding non-responding heifers
No. ofheifers 15 15
Wave emergence (d) 3.9 ± 0.2 4.3 ± 0.2
Range (d) 3 to 5 3 to 6
Induction ofovulation
Interval (h) from CIDR-B removal to
Ovulation
Range
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75.8 ± 3.0
72 to 120
77.3 ± 1.9
72 to 96
6.4.3 Experiment 3
The overall mean (±SEM) interval from E-17~ treatment to the emergence of the
new follicular wave was 4.1 ± 0.2 d. The diameter of the dominant follicle at the time of
EB treatment at 12, 24 and 36 h was 9.4 ± 0.7, 9.8 ± 0.2, and 10.7 ± 0.4 mID,
respectively (P = 0.3). There was an effect of time of estradiol treatment on the mean
and variance of the interval from CIDR-B removal to estrus (P = 0.001; P = 0.004,
respectively) and to ovulation (P < 0.001; P < 0.07, respectively; Table 5.3).
Table 6.3· Mean (± SEM) interval (h) from CIDR-B removal to estrus and to ovulation
in Control heifers and those treated with estradiol benzoate (EB) at 12,24, or
36 h after CIDR-B removal (Experiment3).
EB administered at
No. ofheifers
Control
10
12 h
10
24h
10
36h
10
Interval (h) from CIDR-B removal to
Estrus
Ovulation
Median
Range
63.6 ± 7.0ax
102.0 ± 6.7cy
96
84 to 144
33.3 ± l.4by 45.0 ± 3.3by 52.0 ± 2.7aby
63.6 ± 3.6ax 81.6 ± 3.5bx 78.0 ± 4.1 bxy
60 72 84
60 to 84 72 to 108 48 to 96
abc Means and xy variances with superscripts not in common are different (in interval to
estrus, P < 0.05 and P < 0.01, respectively; in interval to ovulation, P < 0.05; P < 0.07,
respectively).
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Progesterone. Mean (± SEM) plasma progesterone concentrations did not differ among
groups (P = 0.9). Combined for all heifers, progesterone concentrations were 3.0 ± 0.3,
4.3 ± 0.3, and 0.7 ± 0.2 ng/mL, respectively at CIDR-B insertion, CIDR-B removal, and
24 h after CIDR-B removal (Table 5.4).
Estradiol. Plasma estradiol concentrations increased (P < 0.001) within 6 h after
treatment with 1 mg EB, which differed from those in the Control group (P = 0.0002).
Peak concentrations are shown in Table 5.4. Maximal mean estradiol concentrations
were detected at 12 (35.9 ± 3.8 pg/mL), 18 (39.6 ± 3.8 pg/mL) and 12 h (42.8 ± 3.8
pgjmL) after treatment with EB at 12, 24, or 36 h, respectively, and all were higher (P <
0.0001) than in the Control group (peak = 5.0 ± 2.1 pg/mL) at 48 h after CIDR-B
removal (Figure 5.2; Table 5.5).
Luteinizing hormone. Peak concentrations of plasma LH are shown in Table 5.4.
Maximal mean (±SEM) plasma LH concentrations after CIDR-B removal did not differ
(P < 0.14) between the Control group and EB-treated groups (2.8 ± 0.3 ng/mL). There
was a time of treatment effect on the interval from EB to LH peak (P = 0.02); the
interval was shorter (P = 0.007) in the group treated with EB at 36 h (15.0 ± 1.6 h) than
in the group treated with EB at 12 h (25.8 ± 2.7 h), whereas the group treated at 24 h
(20.4 ± 3.2 h) was not different from either. The interval from the estradiol peak to the
LH surge in groups treated with EB at 12,24, and 36 h was less variable (P = 0.02) than
in the Control group (21.6 ± 7.4 h; Figure 5.2 and Table 5.5).
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Table 604 Mean (± SEM) concentrations of progesterone, estradiol and LH in heifers
treated with estradiol benzoate (EB) at 12, 24 or 36 h after CIDR-B removal
in beefheifers.
Estradiol benzoate administered at
End points Control
No. ofheifers 10
Plasma progesterone (nglmL)
CIDR-B insertion 3.6 ± 0.8
CIDR-B removal 3.8 ± 0.8
24 h after CIDR-B removal 0.7 ± 0.1
Peak plasma estradiol (pg/mL) 6.9 ± 1.1a
Peak plasma LH (pglmL) 3.3 ± 0.4
12 h 24 h 36h
333
2.9 ± 0.9 2.7 ± 0.7 2.8 ± 0.9
4.7 ± 0.9 4.4 ±0.9 4.5 ± 1.0
0.9± 0.3 0.6 ± 0.1 0.5 ± 0.1
37.7 ± DAb 45.3 ± 3.9b 43.7±8.9b
4.2 ± 0.5 3.9 ± 0.2 3.8 ± 004
ab Means with different superscripts differ (P < 0.05).
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Table 6.5 Mean (± SEM) intervals from CIDR-B removal and estradiol benzoate (EB)
treatment to estradiol and LH peaks and to estrus and ovulation after
treatment with EB at 12,24 or 36 h after CIDR-B removal in beefheifers.
Estradiol benzoate administered at
End points Control 12 h 24h 36h
Interval (h) from CIDR-B removal to
Estradiol peak 56.4 ± 3.6a 24.0 ± O.Ob 42.0 ± 3.5c 52.0 ± 4.0ac
No. of heifers 10 3 3 3
LHpeak 78.0 ± 7.27a 37.8 ± 2.7b 44.4 ± 3.3 bc 51.0 ± 1.6c
No. ofheifers 10 10 10 10
Estrus 63.6 ± 6.9a 33.3 ± 1.5b 45.0 ± 3.3bc 52.0 ± 2.8ac
No. ofheifers 10 9 10 9
Ovulation 102.0 ± 6.8a 63.6 ± 3.6b 81.6 ± 3.5c 78.0 ± 4.1 c
No. ofheifers 10 10 10 10
Interval (h) from estradiol injection to
Estradiol peak 12.0 ± 0.0 18.0 ± 3.5 16.0 ± 4.0
No. ofheifers 3 3 3
LH peak 25.8 ± 2.7a 20.4 ± 3.3ab 15.0 ± 1.6b
No. ofheifers 10 10 10
Estrus (h) 20.0±2.2 21.0±3.3 16.0 ± 2.8
No. ofheifers 9 10 9
Ovulation 51.6 ± 3.6ab 57.6 ± 3.5b 42.0 ± 4.1 a
No. ofheifers 10 10 10
Interval (h) from LH peak to
Ovulation 24.0 ± 5.4d 25.8 ± 5.Od 37.2± 2.0e 28.5 ± 3.9de
No. ofheifers 10 10 10 10
abc Means with superscripts not in common differ (P < 0.05).
de Means with superscripts not in common differ (P < 0.06).
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Figure 6.2 Plasma concentrations of estradiol (chart A) and LH (chart B) in Control
heifers and heifers given 1.0 mg EB 12, 24 or 36 h after CIDR-B removal
(10 heifers per group). Blood samples were collected every 6 h (starting at
the time of estradiol treatment). In the Control group, samples were collected
for 66 h (starting 24 h after CIDR-B removal).
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6.5 Discussion
Treatment with selected doses of E-l 7~ or EB effectively synchronized the
emergence of ovarian follicular waves and ovulation in beef cattle. In Experiment 1, the
interval from treatment to wave emergence was significantly shorter and more
synchronous in cattle given 5 mg E-17~ than in other three groups (1 mg E-17~, 1 or 5
mg EB). In previous studies, the administration of 5 mg E-17P in progestin-treated
heifers resulted in synchronous emergence of the next follicular wave, on average, 4.3 ±
0.2 days (B6 et aI., 1994, 1995b) or 3.4 ± 0.1 days (Martinez et aI., 2000) after
treatment. In Experiment 2, 1 mg EB consistently induced emergence of a new follicular
wave in 3 to 6 days; neither the mean nor the variance were significantly different
compared to heifers that received 5 mg E-17p. In dairy cows, administration of 1 mg EB
during mid-diestrus was reported to effectively synchronize follicular wave emergence
(4.5 ± 0.2 days after treatment) and development of a new ovulatory follicle; however,
the range was not reported (Burke et aI., 1997a). In contrast, injection of 5 mg EB
(Experiment 1) did not consistently induce synchronous follicular wave emergence
(range, 4 to 8 days after treatment). In addition, two cows in which follicular wave
emergence occurred 2 days before treatment developed a persistent dominant follicle,
which apparently delayed emergence of a new follicular wave. In a previous study in
beef cows (Caccia and B6, 1998), treatment with 2.5 mg EB (at CIDR-B insertion)
resulted in more synchronous follicular wave emergence (3 to 4 days after treatment)
compared to treatment with 5 mg EB (range, 2 to 5 days). It is noteworthy that EB has a
longer circulating life-span than E-17P (approximately 36 and 12 h, respectively,
O'Rourke et aI., 2000; B6 et aI., 1994). Therefore, for synchronization of follicular
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wave emergence, a lower dose of a long-acting estradiol ester (EB) was approximately
as efficacious as a higher dose of E-17p.
In 3/32 (10.3%) and 2/32 (6.2%) of the cattle in Experiments 1 and 2,
respectively, estradiol treatment did not induce emergence of a new follicular wave. B6
et ai. (1995a) reported similar treatment failures in 3/47 (6.3%) of heifers given 5 mg E-
17P and norgestomet implants. It is noteworthy that three of the non-responding cattle in
the present studies appeared to be undergoing spontaneous luteal regression (based on
the ultrasonographic examination) at the time of estradiol treatment. Burke et al. (1997b)
reported that luteolysis within 48 h after treatment with I mg EB prevented
synchronization of follicular wave emergence in dairy cows. Elevated progestin
concentrations may be important for assuring the effectiveness of the estradiol treatment
(B6 et aI., 1995a); in the absence of elevated progestin concentrations, exogenous
estradiol failed to cause regression of the dominant follicle (it resumed growth and
emergence of a new follicular wave was delayed). In the present studies, plasma
progesterone concentrations during spontaneous luteolysis were apparently insufficient
to allow for complete suppression of the growing dominant follicle after estradiol
treatment.
There are many factors that may account for treatment failure, most notably the
stage of development of the dominant follicle at the time of treatment, but also the stage
of development of the CL (and blood progesterone concentrations). For example, when
the CL is regressing at the end of the estrous cycle, plasma concentrations of
progesterone are decreasing and estradiol concentrations are increasing, LH pulsatility is
increasing, and the (preovulatory) dominant follicle has become LH-dependent (Ginther
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et eI., 1996). We speculated that regression of the preovulatory follicle may require
elevated concentrations of progesterone to suppress LH, in addition to estradiol, which
would then synchronize the FSH surge and emergence of the new follicular wave.
Estradiol treatment alone (in the absence of an endogenous or exogenous source of
progestins) resulted in an LH surge; the dominant follicle failed to undergo atresia and
continued to grow (B6 et aI., 1994). Furthermore, in ovariectomized cows, the injection
of progesterone or the presence of a CIDR-B device did not prevent the estradiol-
induced LH surge (section 6.0), and presumably this could stimulate growth of an LH-
dependent dominant follicle in cattle with very low plasma progesterone concentrations.
Concentrations of synthetic progestins nonnally administered apparently are insufficient
to suppress circulating LH concentrations (Kojima et aI., 1992), facilitating the
continuous growth of the dominant follicle (Savio et aI., 1993). If an estradioVprogestin
treatment does not suppress the growth of the selected dominant follicle after the onset
of regression of the CL (approximately Days 16 to 18 of the bovine estrous cycle), the
remaining 2 or 3 days correspond to approximately 10% of the estrous cycle where
treatment failures are likely to occur.
For optimal fertility to fixed-time AI, ovulation must occur synchronously
(within a few hours) in all animals. Therefore, fixed-time AI necessitates the
synchronization of follicular wave emergence, control of follicular growth, and
synchronization of ovulation. Increasing concentrations of estradiol (following the
decline of progesterone) induce the preovulatory LH surge in nonnally cyclic cows
(Stumpf et aI., 1991). In this regard, EB has been used for the synchronization of estrus
and ovulation after PGF; 0.4 mg EB 48 h after PGF resulted in 30% more cows detected
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in· estrus (Dailey et aI., 1986) and a more synchronous LH surge than in non-treated
(Control) cattle (Welch et aI., 1975). In the present study, the interval from CIDR-B
removal to estrus and ovulation was highly sYnchronous in cattle given E-1 7~ or EB
after CIDR-B removal.
In a previo~s study in which the CIDR-B device was left in place for 8 days and
follicular wave emergence was induced by treatment with E-17~ and progesterone at
CIDR-B insertion, ovulation occurred, on average, 82 h (range, 72 to 108 h) after CIDR-
B removal (Martinez et aI., 2000). In that study, heifers ovulated earlier than the cows in
Experiment 1 of this study. To our knowledge, a direct comparison of follicle
development in cows and heifers has not been reported. However, these two different
studies suggest that differences may exist between these two physiological classes of
cattle.
Other factors may affect responses to estradiol treatment after CIDR-B removal.
In Experiment 2, a heifer did not respond to E-17~ and ovulated 120 h after CIDR-B
removal. In Experiment 3, a heifer treated with EB (at 24 h) had a dominant follicle (10
mm in diameter at treatment) that ovulated 108 h after CIDR-B removal, presumably in
response to her own endogenous LH surge at 72 h. Burke et aI., (2001) reported no
effect of the maturity of the follicle on the ovulatory response to EB treatment.
However, more information on the factors affecting the interval from estradiol treatment
to ovulation is needed.
Concentrations of endogenous estradiol probably contributed to the variation in
the interval from CIDR-B removal (or estradiol administration) to ovulation. In
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Experiment 3, circulating estradiol concentrations peaked approximately 15 h after EB
treatment, with a range of approximately 6 h. In cattle given 10 mg EB during diestrus,
plasma estradiol concentrations peaked with a mean (±SEM) concentration of 175.0 ±
29.0 pg/mL at 13 h (Vynckier et aI., 1990); this concentration was 10-fold greater than
that obtained following administration of 1 mg EB in our study. When 1 mg EB was
administered to ovariectomized heifers that received a PRID, plasma estradiol
concentrations peaked by 15 h (O'Rourke et aI., 2000). In another study, 0.75 mg EB
given to intact beef heifers resulted in an increase in plasma estradiol concentrations by
4h, with a peak (average, 50 pg/mL) at 16 h (coinciding with the LH peak). This
demonstrated that lower concentrations of plasma estradiol were needed for the
induction of the LH surge under an environment in which progesterone concentrations
were baseline (Lammoglia et aI., 1998). In experiments involving fixed-time AI in cattle
fed MGA for 7 days, estrus and fertility after a single AI were not different after
treatment with 0.5 or 1 mg EB on Day 8 (24 h after pap treatment; Section 8.0). In
addition, an injection of 1 mg EB 24 h after CIDR-B removal in ovariectomized cows
(Section 5.0) resulted in an average peak concentration of estradiol of 15 pg/mL, which
was sufficient to trigger the LH surge 6 h later.
Plasma LH concentrations in heifers given EB 12 or 24 h after CIDR-B removal,
declined slightly by 6 h and then increased, reaching maximal values between 20 and 25
h after estradiol treatment. Similar hormonal patterns following estradiol treatments
have been reported previously and have been attributed to a biphasic effect of estradiol
on plasma LH concentration which was described in ovariectomized beef heifers (Bolt
et aI., 1990). In that study, plasma LH concentrations were lower at 4, 8 and 12 h after
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treatment with 10 mg E-17~ but were higher at 20, 24 and 28 after estradiol treatment
than that of control animals. In experiments using ovariectomized cows (Section 5.0),
plasma LH concentrations declined transiently (6 h after E-17~ treatment), followed by
an increase 18 to 24 h after treatment. In the present study, low doses of EB were used;
therefore, other factors (e.g. progesterone decline) probably influenced LH release.
In Experiment 3, it appeared that there was an effect of plasma progesterone
concentrations on the timing ofLH release. In heifers given 1 mg EB 12 h after CIDR-B
removal, the interval from EB treatment to LH surge (25 h) was longer than treatment at
36 h (15 h) after CIDR-B removal. The interval to the LH surge also tended to be longer
in heifers treated with EB at 12 h than in heifers that received EB at 24 h (20 h).
Although progesterone concentrations decreased to less than 1 ng/mL at 24 h in all
treatment groups, blood sampling was not frequent enough to determine when
progesterone concentrations reached baseline. The presence of progesterone may have
affected the timing of estradiol-induced LH release. There may be other factors that
affected the interval to· LH release and ovulation, such as stage of dominant follicle
growth and proximity to the selection of the dominant follicle at the time of
progesterone decline.
The interval from CIDR-B removal to ovulation was shorter in heifers treated
with EB 12 h after CIDR-B removal (64 h) than in heifers treated with EB at 24 (82 h)
or 36 h (78 h). These two latter intervals were comparable to those observed in
Experiment 2 for E-17~ (76 h) or EB (77 h) given 24 h after CIDR-B removal. If
ovulation is expected approximately 75 to 80 h after CIDR removal, fixed-time AI
should be done about 28 to 34 h after estradiol treatment (52 to 58 h after CIDR
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removal) in beef cattle. In similar studies, EB was administered 30 h after progesterone
insert removal and resulted in pregnancy rates greater than 50% following fixed-time AI
28 to 30 h later (Bridges et aI., 1999). Once the estradiol-induced endogenous LH surge
occurred, heifers in Experiment 3 ovulated with no significant differences among
groups. Although there was a numerical difference in the mean interval from LH peak to
ovulation between heifers in the Control group vs those in the group treated with
estradiol 24 h after CIDR-B removal (24 and 37 h, respectively), this difference was
attributed to the ultrasonographic examinations which were performed at 12-h intervals.
Both E-17~ and EB effectively synchronized follicular wave emergence and
ovulation. The favored dose for the synchronization of follicular wave emergence was 5
mg E-17~ or 1 mg EB. Time of ovulation following CIDR-B removal was hastened in
all EB-treated groups as compared to Controls, and was significantly earlier in heifers
treated with EB 12 h after CIDR-B removal than in those treated with EB at 24 or 36 h
after CIDR-B removal. However, EB treatment administered at 24 h consistently
synchronized ovulation and, allowed the preovulatory follicle to mature for another 12 h
compared to treatment at 12 h. For fixed-time AI, administration ofEB 24 h after CIDR-
B removal reduced the risk of early ovulations, which would adversely affect fertility
following fixed-time AI. Finally, from a management perspective, 24-h intervals
between treatments would enable treatments to be given during a ~onsistent time, i.e., in
the morning.
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7.0 ESTRUS SYNCHRONIZATION AND PREGNANCY RATES IN BEEF
CATTLE GIVEN CIDR-B, PROSTAGLANDIN AND ESTRADIOL OR
GNRH
7.1 Abstract
Two experiments were conducted to determine estrous response and pregnancy
rate in beef cattle given a controlled internal drug release (CIDR-B) device plus
prostaglandin F2a (PGF) at CIDR-B removal, and estradiol or gonadotropin releasing
hormone (GnRH). In Experiment 1, crossbred beef heifers received a CIDR-B device
and 1 mg estradiol benzoate (EB) plus 100 mg progesterone (E+P group; n = 41), 100
Ilg gonadorelin (GnRH group; n = 42) or no further treatment (Control group; n = 42) on
Day O. On Day 7, CIDR-B devices were removed and heifers were treated with PGF.
Heifers in the E+P group were given 1 mg EB 24 h after PGF and were inseminated 30
h later. Heifers in the GnRH group were given 100 f.1g GnRH 54 h after PGF and
concurrently inseminated. Control heifers were inseminated 12 h after onset of estrus.
The estrus rate was lower (P < 0.01) in the GnRH group (54.7%) than in either the E+P
(100%) or Control (83.3%) groups. The mean interval from CIDR-B removal to estrus
was shorter (P < 0.01) and less variable (P < 0.01) in the E+P group than in the GnRH or
Control groups. Pregnancy rate in the E+P group (75.6%) was higher (P < 0.01) than in
the GnRH (47.6%) or Control (38.1 %) groups.
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In Experiment 2, 84 cows were treated similarly to the E+P group in Experiment
1. Cows received 100 mg progesterone and either 1 mg EB or 5 mg estradiol-17P (E-
17P) on Day 0 and either 1 mg of EB or 1 mg of E-17P on Day 8 (24 h after CIDR-B
removal) in a 2x2 factorial layout and were inseminated 30 h later. There were no
differences among groups for estrus rates or conception rates. The mean interval from
CIDR-B removal to estrus was 44.2 ± 1.2 h. Conception rates were 66.7, 61.9, 52.4, and
71.4% in Groups E-17PIE-17P, E-17P/EB, EBIE-17P and EBIEB, respectively. In cattle
given a CIDR-B device and estradiol plus progesterone, treatment with either EB or E-
17P effectively synchronized estrus and resulted in acceptable conception rates to fixed-
time artificial insemination.
7.2 Introduction
Recent approaches to estrus synchronization and fixed-time artificial
insemination (AI) involve control of the luteal phase (endogenous and/or exogenous
source of progestins), synchronization of follicular wave emergence, and
synchronization of the preovulatory LH surge and ovulation (Adams, 1998). One
protocol employing this approach is the Ovsynch regimen, consisting of two
gonadotropin releasing hormone (GnRH) treatments (8 to 9 d apart), prostaglandin F2a
(PGF) treatment 30 to 48 h before the second GnRH treatment, and timed AI 0 to 24 h
after the second GnRH treatment (Wiltbank, 1997). The first GnRH treatment usually
increases peripheral progesterone concentrations by inducing ovulation of a dominant
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follicle (Martinez et aI., 1999) and thereby synchronizes emergence of a new follicular
wave. The second GnRH treatment synchronizes the preovulatory luteinizing hormone
(LH) surge and ovulation. However, 8.7% and 11.8% of cows have been reported to be
detected in estrus between the first GnRH and PGF injections for 6 and 7 d programs,
respectively (Roy and Twagiramungu, 1999). Exogenous progestin treatment would be
expected to minimize the expression of estrus between the first GnRH and PGF
treatments. In that regard, short-term progestin treatments have been successfully used
to synchronize estrus (Macmillan and Peterson, 1993). Furthermore, estrogens have
been shown to synchronize both follicle wave emergence (B6 et aI., 1995 a, b; Caccia
and B6, 1998) and the preovulatory LH surge (Lammoglia et aI., 1998) and may be used
instead of GnRH for these purposes.
The purpose of the present study was to determine the estrous response and
pregnancy rate in beef cattle given a controlled internal drug release (CIDR-B) device
and PGF at CIDR-B removal and estradiol or GnRH to induce follicle wave emergence
and then to synchronize ovulation for fixed-time AI.
7.3 Materials and Methods
7.3.1 Experiment 1
Postpubertal (ultrasonographic detection of a corpus Iuteum), cross-bred
(SimmentaI-Angus-Gelbvieh) beef heifers (n = 125) were housed outdoors in feedlot
pens at a farm near Saskatoon (Saskatchewan) and fed barley silage, with free access to
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water. Heifers received a CIDR-B device (Vetrephann Canada Inc, Belleville, Ontario,
Canada) at random stages of the estrous cycle (device insertion = Day 0). Heifers were
randomly allocated to receive: 1 mg of estradiol benzoate (EB) and 100 mg of
progesterone (Sigma Chemical Co, St Louis, Missouri, USA) dissolved in 2 mL of
canola oil (E+P group; n = 41); 100 Jlg gonadorelin acetate (Cystorelin, Merial Canada
Inc, Victoriaville, Quebec, Canada; GnRH group; n = 42); or no further treatment
(Control group; n = 42). On Day 7, CIDR-B devices were removed and heifers were
given 500 Jlg cloprostenol (PGF; Estrumate, Schering-Plough Animal Health, Pointe
Claire, Quebec, Canada). Heifers in the E+P group were given 1 mg EB 24 h after PGF
and were inseminated 30 h later (54 h after PGF). Heifers in the GnRH group were
given 100 Jlg gonadorelin 54 h after PGF and concurrently inseminated. Control heifers
were inseminated 12 h after onset of estrus. All hormone solutions were injected i.m.
Estrus detection devices (Kamar Heatmount Detector; Kamar Inc, Steamboats Springs,
Colorado, USA) were glued onto the sacral regions of the heifers at the time ofCIDR-B
removal. Heifers were observed for signs of mounting behaviour and the mount
detectors were examined for evidence of activation (red color) twice daily for 5 dafter
CIDR-B removal. The onset of estrus was defined as the first observation period at
which the detector device had been activated or the heifer was observed in standing
estrus. Pregnancy diagnosis was conducted 30 dafter CIDR-B removal with a real-time,
B-mode scanner (Aloka SSD-500, Instruments for Science and Medicine Inc,
Edmonton, Alberta, Canada) equipped with a 7.5 MHz linear-array transducer.
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Estrus rate was defined as the proportion of heifers detected in estrus.
Conception rate was defined as the percentage of inseminated heifers that became
pregnant and pregnancy rate was defined as the percentage of the total number ofheifers
in the group that became pregnant. Mean and standard error of the mean (SEM) were
used to describe data. For the interval from PGP treatment to estrus, analysis of variance
and Bartlett's test were used to compare means and variances, respectively. If there was
a significant effect of group on means, differences were located with a least significant
difference (LSD) multiple range test. Chi-square analyses were used to detect
differences among treatments for estrus, conception and pregnancy rates. All statistical
analyses were conducted with a commercial program for statistical analysis (Statistix
Student Version, version 2.0, Analytical Software, Tallahassee, Florida, USA).
7.3.2 Experiment 2
Eighty-four, suckled crossbred beef cows that were at least 50 d postpartum and
kept on pasture of native grass at the Animal Disease Research Institute at Lethbridge
(Alberta) were treated similarly to the E+P group in Experiment I. Cows received 100
mg progesterone and either 1 mg EB or 5 mg estradiol-17~ (E-17~; Sigma Chemical Co)
on Day 0 and either 1 mg ofEB or 1 mg ofE-17~ on Day 8 (24 h after CIDR-B removal
and PGF treatment) in a 2x2 factorial design. On Day 7, CIDR-B devices were removed
and cows were given PGF. Estrus detection was done by twice-daily observations.
Cows were artificially inseminated 30 h after the second estradiol injection (54 h after
PGP treatment and CIDR-B removal), whether they showed estrus or not. Pregnancy
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diagnosis was conducted by rectal palpation 45 dafter PGF treatment. Statistical
analyses were conducted as described in Experiment 1.
The protocols for these experiments were approved by University of
Saskatchewan Animal Care Committee.
7.4 Results
7.4.1 Experiment I
Results are summarized in Table 1. The estrus rate was significantly different (P
< 0.01) between the GnRH group (54.7%), and the E+P group (100%) and the Control
group (83.3%). The mean interval from CIDR-B removal to estrus was shorter (P <
0.01) and less variable (P < 0.01) in the E+P group (48.6 ± 0.4 h) than in either the
GnRH (63.7 ± 3.5 h) or Control (65.1 ± 3.0 h) groups. Conception rate in the E+P group
(75.6%) was higher (P < 0.01) than in both the GnRH (47.6%) and Control (38.1%)
groups (35 of 42 heifers in the Control group were observed in estrus and inseminated,
and 16 became pregnant).
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Table 7.1 Estrus, conception and pregnancy rates in Control heifers or those treated
with estradiol benzoate and progesterone (E+P) or GnRH in a CIDR-B-based
estrus synchronization program with PGF at CIDR-B removal.
End points Control E+P GnRH
No. ofheifers 42 41 42
PGF to estrus
Mean (h) 65.1 b 48.6 a 63.7 b
SEM. 3.0 y 0.4 x 3.5 y
Range (h) 48 to 120 48 to 60 48 to 108
Estrus rate (%) 35 (83.3)c 41 (lOO)a 23 (54.7)b
Conception rate (%) 16/35 (45.7)b 31 (75.6)a 20 (47.6)b
Pregnancy rate (%) 16 (38.1)b 31 (75.6)a 20(47.6)b
ab Means or percentages with different superscripts were different (P < 0.01).
xy Variances with different superscripts were different (P < 0.01).
SEM = standard error of the mean.
. 7.4.2 Experiment 2
Although some cows lost their CIDR-B devices (11/84, 13%; no differences
among groups), they were inseminated at a fixed-time along with those that retained
their CIDR-B devices. Results are shown in Table 2. There were no significant
differences among groups for estrus rates or conception rates (P = 0.67 and P = 0.61,
respectively). Estrus rate for all cows combined (69/84; 82.1 %) was not different (P =
0.70) from only those with a retained CIDR-B (60/74; 81.1 %). Similarly, there was no
difference (P = 0.82) in conception rates between all cows combined and cows with a
retained CIDR-B (53/84, 63.1% vs. 46/75, 61.3%).
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Table 7.2 Response of cows treated with a CIDR-B device and given estradiol-17P (E-
17P) or estradiol benzoate (EB) plus 100 mg progesterone at CIDR-B
insertion and either E-17P or EB 24 h after PGF treatment and CIDR-B
removal.
End point
No. of cows
E-17P/E-17P E-17P/EB
21 21
EB/E-17~
21
EB/EB
21
Estrus rate (%)
All cows 76.2 (16/21) 90.4 (19/21) 81.0 (17/21) 81.0 (17/21)
Cows with retained CIDR-B 70.6 (12/17) 88.9 (16/18) 80.0 (16/20) 78.9 (15/19)
PGF to estrus
Mean (h)
SEM
Range
Conception rate (%)a
41
36 to 48
46
1.3
36 to 48
44
1.1
36 to 48
46
1.3
36 to 48
1.0
All cows 66.7 (14/21) 61.9 (13/21) 52.4 (11/21) 71.4 (15/21)
Cows with retained CIDR-B 64.7 (11/17) 61.1 (11/18) 50.0 (10/20) 70.0 (14/20)
a Fixed-time insemination at 54 h after PGF treatment and CIDR-B removal.
SEM = standard error of the mean.
No significant differences were found among groups for estrus (P = 0.67) or pregnancy
rates (P = 0.61).
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7.5 Discussion
In Experiment 1, all heifers in the E+P group were detected in estrus and 75.60/0
became pregnant to a fixed-time AI. In the GnRH group, the conception rate to a fixed-
time AI (47.6%) was acceptable, but the estrus rate (54.7%) was approximately half of
that in the E+P group. In another study, in which GnRH was given 7 d before PGF
treatment, behavioural estrus (after PGF treatment) was detected in 51.3% of cows (Roy
and Twagiramungu, 1999). Treatment with GnRH induces LH release which may cause
premature luteinization of ovarian follicles (thereby decreasing peripheral estrogen
concentrations) or ovulation may be induced before peripheral estrogen concentrations
peak, accounting for the lower rate of estrus detection. The principal purpose of
detecting estrus is to detennine the appropriate time at which to inseminate in
anticipation of ovulation. However, estrus detection, and indeed whether or not estrus is
expressed, is unimportant if ovulation is synchronized in all or most cattle. Conception
rate in the Control group was nearly identical to that in the GnRH group; however, due
to a moderate rate of estrus detection, some heifers were not inseminated and the overall
pregnancy rate was somewhat less than expected. Obviously, when cattle are only
inseminated following detection of estrus, the combination of a moderate estrus rate and
a moderate conception rate results in a relatively low pregnancy rate.
In Experiment 2, EB and E-17~ were equally effective in inducing a high rate of
estrus and pregnancy. Historically, estrogens have been given at the beginning of a
progestin treatment regimen to induce luteolysis (via induction ofPGF release; Wiltbank
and Kasson, 1968). However, the high rates of estrus and pregnancy in cows that lost
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their CIDR-B devices in this experiment suggests that these doses (and/or forms) of
estradiol did not induce luteolysis. More recently, it has been demonstrated that
estrogen treatment causes regression of antral follicles and synchronizes emergence of a
new follicular wave (B6 et aI., 1995a). Further, it has been shown that, in the absence of
elevated progestin concentrations, estrogen treatment induces an LH surge, resulting in
transient or incomplete suppression of the dominant follicle and delayed emergence of
the next follicular wave (B6 et aI., 1994). Therefore, on the possibility of encountering
cows without corpus luteum in a group of randomly cycling cows, we have consistently
included· progesterone with the first estrogen treatment. Estrogen treatment has been
given after POF treatment to increase the proportion ofcattle in estrus and the synchrony
of estrous behaviour and ovulation (Dailey et aI., 1986). In other studies, when 0.5 or
1.0 mg EB was given after CIDR-B removal, the proportion of heifers detected in estrus
was higher than in Control heifers that did not receive estradiol (Hanlon et aI., 1996,
Rasby et aI., 1998). In another study (Lammoglia et aI., 1998), treatment with EB (0.38
and 1.0 mg in heifers and cows, respectively) 24 to 30 h after progesterone removal,
effectively induced estrus (estrus rate, 86% and 100%, respectively). Furthermore,
estrogen treatment in the present study appeared to induce an estrus more characteristic
of a spontaneous estrus (considerable clear mucus discharge and a cervical canal that
was patent) compared with that in the OnRH treatment group.
Two doses of OnRH are given 7 d apart in the Ovsynch regimen and POF is
given just before the second injection (Pursley et aI., 1995). The first injection has been
reported to induce ovulation (18/20 cows and 13/24 heifers responded by ovulating) or
luteinization, followed by the emergence of a new follicular wave in 2.1 ± 0.31 or 1.5 ±
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0.47 days in cows and heifers, respectively. The second injection of GnRH is given to
induce an LH surge and thereby synchronize ovulation. All 20 cows and 18 of 24
heifers ovulated between 24 and 32 h after the second injection ofGnRH, suggesting
that the OvsYnch regimen may not be as efficacious in heifers (Pursley et aI., 1995). It
seems that heifers that failed to ovulate following the second GnRH treatment were in
metestrus or early diestrus and did not undergo luteolysis in response to the PGP
treatment. Therefore, if the first GnRH treatment does not induce ovulation and
emergence of a new follicular wave, ovulation of a dominant follicle following PGP
treatment and a second injection of GnRH may be poorly synchronized. Indeed,
Wiltbank (1997) observed that up to 20% of heifers were detected in estrus before the
PGP treatment in Ovsynch programs. In a recent study (Martinez et aI., 1999), GnRH
treatment induced ovulation in 56% of heifers treated during the growing, static or
regressing phases of the dominant follicle of the first follicular wave; it is noteworthy
that emergence of a new follicular wave occurred only when treatment caused ovulation.
We have also shown that insertion of a CIDR-B device prevents the expression of estrus
between the first injection of GnRH and PGP treatment, and pregnancy rates to a fixed-
time insemination were higher when a CIDR-B device was used in an Ovsynch program
in heifers (Section 10.0).
Estrogens in combination with progesterone administered at the beginning of a
CIDR-B treatment resulted in synchronous emergence of a new follicular wave in both
heifers and cows (B6 et aI., 1996). The estrogens used in the present study (E-17~ and
EB) have a shorter half-life in circulation than either estradiol valerate (commonly
included in norgestomet-based estrus synchronization protocols; B6 et aI., 1993) or
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estradiol cypionate (Thundathil et aI., 1997). Treatment with the latter two fonnulations
of estradiol induced emergence of a new follicular wave at inconsistent and prolonged
intervals. It is noteworthy that E- I 7~ has a shorter circulating half-life than does EB.
Following treatment with 5 mg E-17~, peripheral estradiol concentrations returned to
baseline within 48 h (B6 et aI., 1994), whereas treatment with 5 or 10 mg of EB resulted
in elevated concentrations of serum estradiol for approximately 72 and 96 h,
respectively (Vynckier et aI., 1990). Follicular wave emergence has been reported to
occur 4.3 d after treatment of progestagen-treated cattle with 5 mg of E-17~ (B6 et aI.,
1995b) and 5.4 d after treatment with 5 mg ofEB (B6 et aI., 1996).
Subsequent to the completion of these studies, Bridges et al (1999) reported an
experiment utilizing 139 lactating postpartum beef cows that were given a CIDR-B
device and allocated into three treatment groups to receive 2 mg EB at the time of device
insertion (Groups 1 and 2) or no EB (Group 3) at CIDR-B insertion. The CIDR-B
devices were subsequently removed after 7 d (Group 1) or 5 d (Groups 2 and 3) and all
cows were given 25 mg PGF at that time plus 1 mg EB 30 h after device removal and
were inseminated 28 to 30 h later (58 to 60 h after device removal). Estrus rates were
93, 87 and 81 % and pregnancy rates were 60, 50 and 51 % for cows in Groups 1, 2, and
3, respectively. These results are comparable with those reported in the present study
suggesting that there may be considerable flexibility as to when the CIDR-B device may
be removed without interfering with pregnancy rates to fixed-time insemination.
In the present studies, both E-17~ and EB were highly efficacious In
synchronizing estrus, and presumably ovulation, in a CIDR-B-based, fixed-time AI
program in cattle. Further studies are needed to confinn the necessity of synchronizing
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follicular wave emergence and to precisely document the effects of length of CIDR-B
treatment and intervals to a second estradiol treatment on the time of ovulation in order
to optimize the time of insemination and pregnancy rates.
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8.0 THE USE OF GnRH OR ESTRADIOL TO FACILITATE FIXED-TIME
INSEMINATION IN AN MGA-BASED SYNCHRONIZATION REGIMEN
IN BEEF CATTLE
8.1 Abstract
Two experiments were conducted to compare pregnancy rates when GnRH or estradiol
were given to synchronize ovarian follicular wave emergence and ovulation in an MGA-
based estrus synchronization program. Crossbred beef cattle were fed melengestrol
acetate (MGA, 0.5 mg/day) for 7 days (designated Days 0 to 6, without regard to stage
of the estrous cycle) and given cloprostenol (PGF; 500 flg im) on Day 7. In Experiment
1, lactating beef cows (n = 140) and pubertal heifers (n =40) were randomly allocated to
three groups to receive 100 flg gonadorelin (GnRH), 5 mg estradiol-17f3 and 100 mg
progesterone (EP) in canola canola oil or no treatment (Control) on Day o. All cattle
were observed for estrus every 12 hours from 36 to 96 hours after PGF. Cattle in the
GnRH group that were detected in estrus 36 or 48 hours after PGF were inseminated 12
hours later; the remainder were given 100 flg GnRH i.m. 72 hours after PGF and
concurrently inseminated. Cattle in the EP group were randomly assigned to receive
either 0.5 mg or 1.0 mg estradiol benzoate (EB) in 2 mL canola canola oil i.m. 24 hours
after PGF and were inseminated 30 hours later. Cattle in the Control group were
inseminated 12 hours after the first detection of estrus; if not in estrus by 72 hours after
PGF, they were given 100 flg GnRH i.m. and concurrently inseminated. In the absence
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of significant differences (P>O.l), all data for heifers and for cows were combined and
the 0.5 and 1.0 mg EB groups were combined into a single estradiol group. Estrus rates
were 57.6, 57.4 and 60.0% for the GnRH, EP and Control groups, respectively (P =
0.95). The mean (± SD) interval from PGF treatment to estrus was shorter (P < 0.001)
and less variable (P < 0.001) in the EP group (49.0 ± 6.1 h) than in either the GnRH
(64.2 ± 15.9 h) or Control (66.3 ± 13.3 h) groups. Overall pregnancy rates were higher
(P < 0.005) in the GnRH (57.6°~) and EP (55.7%) groups than in the Control group
(30.0%) as were pregnancy rates to fixed-time AI (47.5, 55.7 and 28.3%, respectively).
In Experiment 2, 122 crossbred beef heifers were treated with melengestrol acetate
(MGA) from Day 0 (beginning of the experiment to Day 6 and given either 100 Jlg
GnRH or 2 mg EB and 50 mg progesterone in canola oil on Day O. Heifers subsequently
received either 100 Jlg GnRH 36 h after PGF (given on Day 7) and inseminated 14 h
later or 1 mg EB i.m. 24 h after PGP and inseminated 28 h later in a 2 x 2 factorial
design. Pregnancy rates were not significantly different among groups (41.9, 32.2, 33.3
and 36.7% in GnRHIGnRH, GnRHIEB, EB/GnRH and EB/EB groups, respectively). In
conclusion, GnRH or estradiol given to synchronize ovarian follicular wave emergence
and ovulation in an MGA-based synchronization regimen resulted in acceptable
pregnancy rates to fixed-time AI.
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8.2 Introduction
Melengestrol acetate (MGA), a synthetic progestin, has been used in various
regimens to synchronize estrus in cattle (Patterson et aI., 1989; Odde, 1990). However,
when MGA is fed in the absence of a functional corpus luteum (CL), a dominant follicle
persists and fertility at the ensuing estrus is reduced (Custer et aI., 1994; Patterson et aI.,
1989). The development of persistent follicles may be prevented by strategically
synchronizing follicular wave emergence; either GnRH or estradiol-17P (E-17P) and
progesterone have been given on the first day of a short-term (7- or 8-day) MGA
regimen to synchronize emergence of a new wave (Kastelic et aI., 1996; Thundathil et
aI., 1999). However, these regimens required detection of estrus because ovulation was
not synchronized. In other programs, treatments to synchronize the preovulatory
gonadotropin surge have resulted in relatively synchronous ovulation, facilitating
artificial insemination (AI) at a fixed time. For example, in the Ovsynch regimen
(Pursley et aI., 1995), two doses of GnRH are given approximately 9 days apart (with
PGP given 7 days after the first dose of GnRH). The first dose of GnRH is intended to
cause ovulation or atresia of large antral follicles, with a new follicular wave emerging
approximately 2 days later (Twagiramungu et aI., 1995). The second dose of GnRH is
given to induce LH release and synchronous ovulation (Pursley et aI., 1995). In cyclic
heifers that had a progesterone-releasing device (CIDR-B) in their .vagina for 7 days and
given PGP at CIDR-B removal, estradiol treatment 24 to 30 hours later effectively
synchronized estrus with an acceptable pregnancy rate (520/0; Lammoglia et aI., 1998).
Similar pregnancy rates (65%) have been achieved after fixed-time AI with exogenous
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progesterone delivered by intravaginal CIDR-B devices In heifers assigned to an
OvsYnch program (Section 10.0).
Two experiments were conducted to examine the utility of a short-term MGA
treatment protocol in a fixed-time AI program in beef cattle when GnRH or estradiol
were given to synchronize ovarian follicular wave emergence and ovulation.
8.3 Materials and Methods
8.3.1 Experiment 1
Crossbred (predominantly Angus and Hereford) lactating beef cows (n = 140)
and pubertal heifers (n = 40) were used. At the start of the experiment, cows were
between 30 and 70 days postpartum and had a body condition score of 1.5 to 3.0 (scale
of 1 to 5). The heifers had a body condition score of 3.0 to 3.5 and a CL was detected
by transrectal ultrasonography. The experimental design is summarized in Figure 1. All
cattle were fed 0.5 mglhead/day MGA (Pharmacia Animal Health, Orangeville, Ontario,
Canada) for 7 days (designated Days 0 to 6), without regard to the stage of the estrous
cycle. On Day 0, cattle were randomly assigned to three groups to receive an
intramuscular (im) injection of 100 Ilg gonadorelin (GnRH group; n = 59; Cystorelin,
Merial Canada Inc., Victoriaville, Quebec, Canada) or 5 mg estradiol-l7~ (E-l7~) plus
100 mg progesterone (both from Sigma Chemical Co., St. Louis, Missouri, USA) in 2
mL canola canola oil (EP group; n = 61) or no treatment (Control group; n = 60). On
Day 7, all cattle were given an i.m. injection of 500 Ilg of cloprostenol (PGF; Estrumate,
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Schering Plough Animal Health, Pointe-Claire, Quebec, Canada). In a randomly
selected sub-sample of cattle (11 cows and 7 heifers in each treatment group), a
transrectal ultrasound examination was done at the time of PGF treatment and the
diameter of the largest follicle was recorded. All cattle were observed for estrus
(defined as standing when mounted by a herdmate) every 12 hours from 36 to 96 hours
after PGF. Cattle in the GnRH group that were detected in estrus 36 or 48 hours after
PGF were inseminated 12 hours later and considered not pregnant to the fixed-time AI;
the remainder were given 100 Jlg GnRH i.m. 72 hours after PGF and concurrently
inseminated. Cattle in the EP group were randomly assigned to receive either 0.5 mg or
1.0 mg estradiol benzoate (EB; Sigma Chemical Co., S1. Louis, Missouri, USA) in 2 mL
canola canola oil i.m. 24 hours after PGF and were inseminated 30 hours later. Cattle in
the Control group were inseminated 12 hours after the first detection of estrus; if not in
estrus by 72 hours after PGF, they were given 100 Jlg GnRH i.m. and concurrently
inseminated. In each group, cattle were defined as having a synchronous estrus if they
were detected in estrus < 24 hours before or after fixed-time AI was planned (i.e., 54 h
after PGF in the EP group and 72 hours after PGF in the other two groups); cattle in
estrus ~24 hours before or after fixed-time insemination was planned were defined as
having asynchronous estrus.
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Days 0 6 7 8 9 10
MGA PGF
1) nRH IG
2) EP EB AI
3) No treatment ED+AI GnRH +AI
Figure 8.1. Schematic diagram of treatments in Experiment 1. All treatment groups
received MGA from Days 0 to 6 and PGF on Day 7. The three treatment
groups are each on a separate row, with arrows indicating when specific
activities occurred.
Note: All groups were estrus detected and cattle in Groups 1 and 3 were
inseminated accordingly if they displayed asynchronous estrus with respect
to the fixed-time AI at 72 hours after PGF treatment; all animals in the EP
group were fixed-time inseminated 54 hours after PGF treatment.
MGA = melengestrol acetate
PGF = prostaglandin F2a
GnRH = 100 Jlg gonadorelin
EP = 5 mg estradiol-l 7P plus 100 mg progesterone
EB = 0.5 or 1 mg estradiol benzoate
ED = estrus detection
AI = artificial insemination
Any animal that had an asynchronous estrus was bred approximately 12 hours
later and was considered nonpregnant to fixed-time insemination. Any animal that
received a fixed-time insemination and subsequently was detected in estrus 2:24 hours
later was rebred and considered asynchronous.
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In all cattle, pregnancy was confirmed by a transrectal ultrasound examination
conducted approximately 30 days after AI. All transrectal ultrasound examinations were
done by a single operator using a real-time, B-mode scanner with a 7.5 MHz linear-array
transducer (Aloka SSD-500, ISM Inc, Edmonton, AB, Canada).
Estrus rate (synchronous and asynchronous) was the proportion of cattle detected
in standing estrus. Conception rate (proportion of inseminated cattle that were pregnant)
was calculated for synchronous estrus, asynchronous estrus, and no estrus. Pregnancy
rate (proportion of all cattle that were pregnant) was calculated for fixed-time AI and
overall (pregnant to fixed-time AI plus AI following asynchronous estrus).
Mean and standard error of the mean (SEM) were used to describe data. Two-
way Analysis of Variance was used to detect the effect of age (cows versus heifers) and
treatment group (and their interaction) on the diameter of the largest follicle at the time
of PGF treatment and on the interval from PGF treatment to estrus; differences among
means were compared by a Least Significant Difference test. A Bartlett's test was used
to compare variation in the interval from PGF treatment to estrus among groups. Chi-
square analyses were used to detect differences between cows and heifers and among
treatments for estrus, conception and pregnancy rates. All statistical analyses were
conducted with the Statistical Analysis System (SAS, 1990).
The protocols for these experiments were approved by University of
Saskatchewan Animal Care Committee.
112
8.3.2 Experiment 2
Crossbred (Hereford and Angus) beef heifers (n = 122; approximately 14 to 16
months of age, body condition score 2.5 to 3.0 and 393.5 ± 2.9 kg) were used. For
several weeks prior to the start of the experiment, these heifers were fed a high-energy
diet (principally grain), however, they were fed a mainly roughage diet, from 2 weeks
before initiating treatments to the end of the experiment. All heifers were given MGA
and PGF as described in Experiment 1 and were randomly allocated to the following
four groups in a 2 x 2 factorial design: GnRH versus EB (and progesterone) on Day 0
and GnRH versus EB after PGF. On Day 0, half of the heifers were given 100 Ilg of
GnRH i.m. and the remainder were given 2 mg EB plus 50 mg progesterone i.m. (in 2
mL of canola oil). On Day 8 (approximately 24 hours after PGF treatment), half of the
heifers in each group were given 1 mg of EB i.m. and were inseminated 28 hours later.
In the evening of Day 8 (36 hours after PGF), the remaining heifers in each group
received 100 Ilg GnRH im; these heifers were inseminated in the morning of Day 9 (14
hours later; 50 hours after PGF). Observations for estrus were not done. Pregnancy was
confirmed by transrectal ultrasonography conducted approximately 30 days after
breeding. Chi-square analysis was used to compare pregnancy rates among treatments.
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8.4 Results
8.4.1 Experiment 1
Combined for all three treatment groups, there was no difference between cows
and heifers for estrus rates (57.1 versus 62.5%, respectively; P < 0.6) or pregnancy rates
(49.3 versus 42.5%, P < 0.5). Furthermore, within each treatment group, there were no
significant differences (P>O.2) between cows and heifers for estrus rates or pregnancy
rates. In the EP group, neither estrus nor pregnancy rates were significantly affected by
the dose. of EB (0.5 versus 1.0 mg). Therefore, all estrus and pregnancy data were
combined without regard for animal age (cows versus heifers) or dose of EB.
Mean (± SEM) diameter of the largest follicle at PGF treatment was not different
between cows and heifers (11.7 ± 0.3 rom versus 12.5 ± 0.2 rom, respectively, P < 0.2)
and the age by treatment interaction was not significant (P < 0.9). However, there was
an effect of treatment (P < 0.0001); follicle diameters were 10.5 ± 0.3 (range, 4 to 13),
12.2 ± 0.2 (range, 10 to 14) and 13.6 ± 0.3 rom (range, 8 to 16) for the EP, GnRH and
Control groups, respectively (each treatment was different from the other, P < 0.05).
Estrus rates were not different (P = 0.95) among treatment groups (overall mean, 58.3%;
Table 8.1). There was an effect of treatment group on the interval from PGF treatment
to estrus (P < 0.0001) but neither the effect of age nor the interaction were significant (P
> 0.25). The interval from PGF treatment to estrus was shorter (P < 0.001) and less
variable (P < 0.001) in the EP group (49.0 ± 0.8 h) than in either the GnRH (64.2 ± 2.0
h) or Control (66.3 ± 1.7 h) groups. Pregnancy rates (to both fixed-time AI and overall)
were higher (P < 0.005) in the GnRH and EP groups than in the Control group (Table
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8.1). Within each treatment group, there was no significant difference in conception rate
between cattle that had a synchronous estrus versus those that were not detected in
estrus.
Table 8.1 Interval from PGF treatment to estrus, and rates of estrus, conception and
pregnancy in beef cattle fed MGA for 7 days (Experiment 1).
End point GnRH EP Control
No. cattle 59 61 60
PGF to estrus (hours)
Mean 64.23 49.0b 66.33
SEM 2.03 0.8b 1.73
Estrus rate (%) 57.6 57.4 60.0
Synchronous estrus
No. 22 35 28
Conception rate (%) 68.2 3 62.5 3 35.7 b
No estrus detected
No. 25 26 24
Conception rate (%) 52.0 46.1 29.2
Asynchronous estrus
No. 12 8
Conception rate (%) 50.0 12.5
Pregnancy rate (%)
Fixed-time AI* 47.5 3 55.7 3 28.3 b
Overall 57.6 3 55.7 3 30.0 b
3b Within a row, values with different superscripts are different (P < 0.05).
SEM = Standard error of the mean.
* Fixed-time AI was performed at 54 h after PGF treatment in the EP group and at 72h
after PGF treatment in the GnRH and Control groups.
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8.4.2 Experiment 2
Pregnancy rates were not significantly different among groups (EB/EB, 36.7% ;
EB/GnRH, 33.3%; GnRH/EB, 32.2%; and GnRH/GnRH, 41.90/0).
8.5 Discussion
The diameter of the largest follicle at the time ofPGF treatment was significantly
larger in the Control group than in the other two groups. Although sequential
examinations were not conducted to monitor follicle development, we infer that the
increased size of dominant follicles at the time of PGF treatment in some of the cattle in
the Control group was associated with the development of persistent follicles. In that
regard, the diameter of the largest follicle was 15 to 16 mm in 7 of 18 cattle in the
Control group, whereas there were no cattle with follicles greater than 13 or 14 mm in
diameter in the EP and GnRH groups, respectively. In previous studies, a dominant
ovarian follicle was shoWn to persist when MGA was fed in the absence of a functional
CL (Custer et aI., 1994; Kojima et aI., 1995).
In Experiment 1, overall pregnancy rates and pregnancy rates to fixed-time AI
were significantly lower in the Control group than in either the GnRH or EP groups.
The significantly lower fertility in the Control group was probably due to the
development of persistent follicles. It has been reported that persistent follicles ovulate
(after MGA is withdrawn), but the oocyte is aged and fertility is reduced (Custer et aI.,
1994; Kojima et aI., 1995). In field trials, when beef cows and heifers (n = 138) were
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given MGA (0.5 mg/day) for 7 days with PGF on the last day, the conception rate was
significantly lower in cattle that were on Day 14 to Day 20 of the estrous cycle at the
time MGA treatment was initiated (36%) compared to those that were on days 0 to 13
(66%; Beal et aI., 1988).
In the present study, including either GnRH or estradiol (and progesterone) at the
start of MGA treatment significantly reduced dominant follicle size at PGF treatment
and was associated with improved fertility, likely due to the reduced incidence of
persistent follicles. In the Ovsynch regimen (Pursley et aI., 1995), the first dose of
GnRH was intended to cause ovulation or atresia of large antral follicles, with a new
wave emerging approximately 2 days later (Twagiramungu et aI., 1995; Pursley et aI.,
1995). In previous studies, treatment with E-17P (and progesterone) caused atresia of
existing antral follicles with emergence of a new follicular wave approximately 4 days
after treatment (B6 et aI., 1995a). Progesterone (typically 50 or 100 mg) was given with
the E-17P to prevent an estrogen-induced LH release in cattle without a functional CL
(B6 et aI., 1994). Although estradiol benzoate has a longer half-life than E-17P (B6 et
aI., 1996; Vynckier et aI., 1990), either can be used for both synchronization of follicular
wave emergence and synchronization of ovulation (Section 7.0). Furthermore, treatment
with progesterone alone (200 mg) in MGA-treated cows induced atresia of persistent
follicles, with relatively synchronous emergence of a new wave approximately 3 days
later and improved fertility (Anderson and Day, 1994). Progesterone treatment has
subsequently been incorporated into the middle of 20-day (Anderson and Day, 1998) or
14-day (McDowell et aI., 1998) MGA-based synchronization regimens to obtain normal
fertility at synchronized estrus.
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Combined for all groups in Experiment 1, estrus rates averaged 59.8%> for cows
and heifers. However, these cattle were only observed twice-daily from 36 to 96 hours
after PGF. Estrus rates can be highly variable, depending on the proportion of the cattle
cycling prior to treatment, the nature of the treatment regimen, and the method of estrus
detection (Odde, 1990). The principal purpose of detecting estrus is to determine the
appropriate time to inseminate. However, treatments to synchronize the preovulatory
gonadotropin surge have resulted in synchronous ovulation, facilitating fixed-time AI.
Estrus detection and indeed whether or not estrus is expressed, is unimportant if
ovulation is synchronized in all or most cattle. In the Ovsynch regimen, the second dose
of GnRH was intended to induce ovulation in a majority of treated cattle (Pursley et aI.,
1995). In estradiol-based regimens, estradiol has been given after PGF treatment to
increase the proportion of cattle in estrus and the synchrony of the estrus behaviour and
ovulation (Dailey et aI., 1983; 1986). When 0.5 mg (Hanlon et aI., 1996) or 1.0 mg
(Rasby et aI., 1998) ofEB was given 24 hours after CIDR-B removal, the proportion of
heifers detected in estrus (96 and 81 %, respectively) was higher than in untreated
Control groups (90 and 37%, respectively). In another study, treatment with EB (0.38 or
1.0 mg in heifers and cows, respectively) 24 to 30 hours after CIDR-B removal in a 7-
day treatment regime effectively induced estrus (estrus rate, 86 and 1000/0 respectively;
Lammoglia et aI., 1998).
Although pregnancy rates to fixed-time AI were not significantly different
between the GnRH and EP groups in both experiments, there are indications that
estradiol may be preferable to GnRH. In Experiment 1, the interval from PGF treatment
to estrus was shortest and least variable in the EP group, suggesting that a single fixed-
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time insemination would be more successful in this group. In a prevIous study
(Thundathil et aI., 1999), beef cows were treated with 5 mg E-17p (and 100 mg
progesterone) or 100 Ilg GnRH on the first day of a 7-day MGA regimen with PGF on
the last day; synchronized conception rates were 47.5 and 57.5%, respectively in the first
experiment (n = 141) but were 64.7 and 33.3 in a second experiment (n = 78). It was
concluded that 5 mg E-17P (and progesterone) more reliably resulted in acceptable
estrus and pregnancy rates than 100 ug GnRH. In a study designed to detennine
synchrony of follicular wave emergence, only 15 of 27 (55.6%) heifers ovulated in
response to GnRH (100 Ilg gonadorelin) treatment administered at various times during
the growth of the dominant follicle of the first follicular wave (Martinez et aI., 1999).
There was no indication that GnRH treatment induced follicle atresia nor did it alter the
interval to wave emergence in the heifers that failed to ovulate. Overall, follicular wave
emergence occurred from 2 days before to 7 days after GnRH treatment.
Although pregnancy rates were not significantly different among treatments in
Experiment 2, they were disappointingly low. In retrospect, the change in diet may have
adversely affected fertility. Unfortunately, an ultrasound examination was not done
prior to the initiation of treatments. It has been reported that decreasing the feed intake
from 1.2 x to 0.4 x maintenance suppressed ovulation in two of eight heifers, and in the
remaining six heifers, the growth rate and maximum diameter of the first dominant
follicle after ovulation were also reduced (Mackey et aI., 2000). In another study, the
number of small follicles on days 1 and 2 of the first follicular wave was 37% higher in
cattle fed twice maintenance diets compared to those fed Control or feed-deprived diets
(Gutierrez et aI., 1997). In that study, a short-tenn increase in the level of nutrition
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increased follicular recruitment. In contrast, serum concentrations of LH, estradiol and
IGF-I decreased before the onset of nutritionally induced anovulation in beef heifers,
reducing the growth rate and diameter of the ovulatory follicle (Bossis et aI., 1999) and
shortening the interval of persistence of the dominant follicle (Murphy et aI., 1991). A
reduction in dominant follicle diameter (e.g. < 9 mm) may decrease the proportion of
follicles that ovulate in response to GnRH treatment (Martinez et aI., 1999). Reduced
LH pulse frequency would also inhibit CL development and function, potentially
increasing the incidence of embryonic loss.
In conclusion, both GnRH and estradiol treatments designed to synchronize
follicular wave emergence and ovulation resulted in acceptable pregnancy rates to fixed-
time AI in an MGA-based synchronization regimen. However, the interval from PGF
treatment to estrus was shortest and least variable in cattle treated with estradiol.
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9.0 THE USE OF A PROGESTERONE-RELEASING DEVICE (CIDR-B) OR
MELENGESTROL ACETATE WITH GnRH, LH OR ESTRADIOL
BENZOATE FOR FIXED-TIME AI IN BEEF HEIFERS
9.1 Abstract
The objective of this experiment was to compare two progestins and three
treatments for synchronizing follicular wave emergence and ovulation in protocols for
fixed-time AI in beef heifers. On Day 0 (beginning of the experiment), Angus and
Angus-Simmental cross beef heifers at random stages of the estrous cycle either
received a CIDR-B device (n = 257) or were started on 0.5 mg/animaVd melengestrol
acetate (MGA; n = 246) and were randomly assigned to receive i.m. injections of: 100
J.lg GnRH; 12.5 mg porcine LH (PLH); or 2 mg estradiol benzoate (EB) and 50 mg
progesterone (P). The last feeding ofMGA was given on Day 6, and on Day 7, CIDR-B
devices were removed and all heifers received 500 J.lg cloprostenol (pGF). Consistent
with their treatment groups on Day 0, heifers were given either 100 J.lg GnRH or 12.5
mg pLH 48 h after PGP (and were concurrently inseminated) or 1 mg EB 24 h after
PGP and were inseminated 28 h later (52 h after PGP). Estrus rate (combined for both
progestins) in heifers receiving EB (92.-0%) was greater (P < 0.05) than for heifers
receiving GnRH and pLH (combined) and a CIDR-B device (62.9%) or MGA (34.3%).
Although the mean interval from PGF treatment to estrus did not differ among groups
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(overall, 47.8 h; P = 0.85), it was less variable (P < 0.01) in MGA-fed heifers (SEM =
0.2 h) than in CIDR-B-treated heifers (SEM = 0.5 h). Pregnancy rates (detennined by
ultrasonography approximately 30 days after AI) did not differ (P = 0.30) among the six
treatment groups (average, 58.0%; range 52.5 to 65.0%). Although fixed-time AI was
done, pregnancy rates were greater in heifers detected in estrus than those not detected
in estrus (62.6 versus 51.9%; P < 0.05). In conclusion, GnRH, pLH, or EB treatment in
combination with a CIDR-B device or MGA effectively synchronized ovulation for
fixed-time AI, resulting in acceptable pregnancy rates in beef heifers.
9.2 Introduction
Current approaches to fixed-time AI in cattle involve a source of progestin, and
synchronization of follicular wave emergence, the preovulatory LH surge, and
ovulation (De Rensis and Peters, 1999). One protocol (Ovsynch) consists of two
injections of GnRH (8 or 9 days apart), PGF 30 to 48 h before the second GnRH, and
timed AI, 0 to 24 h after the second GnRH (Risco et aI., 1998). The first GnRH is to
synchronize follicular wave emergence and the second is to induce the preovulatory LH
surge and ovulation. However, this protocol has not resulted in acceptable pregnancy
rates in heifers (Pursley et aI., 1997; Risco et aI., 1998). Failure of ovulation to the first
GnRH (Martinez et aI., 1999) and asynchronous onset of estrus relative to the second
GnRH may account for the reduced fertility in some heifers (Risco et aI., 1998). The
insertion of a progesterone-releasing intravaginal device (CIDR-B) or feeding
melengestrol acetate (MGA) provides the basis for many fixed-time AI programs. The
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addition of a CIDR-B to an Ovsynch program improved pregnancy rates in heifers
(68.0 versus 39.1 %~ Section 10.0). Porcine LH (pLH) has also been used in lieu of
GnRH in an Ovsynch-type program (Section 10.0). Estrogens have also been shown to
effectively synchronize follicle wave emergence (B6 et aI., 1995a, 1996~ Caccia and
B6, 1998) and a preovulatory LH surge (Lammoglia et aI., 1998) and have been used in
synchronization programs with a CIDR-B (Martinez et aI., 2000) or MGA (Kastelic et
aI., 1997). Estradiol resulted in a greater pregnancy rate than GnRH in a CIDR-B-based
fixed-time AI program (Section 7.0), with no difference when MGA was used (Section
8.0).
The objective of the present study was to compare the two progestins (CIDR-B
and MGA) and three treatments that we have used previously to synchronize follicular
wave emergence and ovulation (GnRH, pLH and estradiol benzoate) in a fixed-time AI
program in beefheifers.
9.3 Materials and Methods
Angus (Black and Red) and Angus-Simmental cross heifers, approximately 15
mo of age and weighing from 275 to 350 kg (body condition score approximately 3.25)
were used in this study. Heifers had been in a feedlot for approximately 7 mo and were
fed approximately 5 kg barley silage and 1 kg of rolled barley/animal/d. Heifers were
housed outdoors in feedlot pens (approximately 50 or 100 heifers per pen, 50
m2/animal).
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Transrectal ultrasound examinations were conducted to determine the presence
of a corpus luteum (CL) in order to confirm cyclicity, and that heifers were
nonpregnant and free of morphologic abnormalities of the reproductive tract. Heifers
were randomly assigned to one of six groups in a 2 x 3 factorial design (Figure 1). On
Days 0, 257 heifers had a CIDR-B device containing 1.9 g ofprogesterone (Vetrepharm
Canada Inc, Belleville, ON, Canada) placed in the vagina. The tails of the CIDR-B
devices were cut even with the vulva to prevent pen mates from pulling them out. The
remaining heifers (n = 246) were given 0.5 mg/animaVd MGA in their feed (Pharmacia
Animal Health, Orangeville, ON, Canada) from Day 0 to Day 6. On Day 0, heifers
were given i.m. injections of: 100 J.lg GnRH (Cystorelin; Merial Canada Inc,
Victoriaville, PQ, Canada), 12.5 mg pLH (Lutropin-V; Vetrepharm Canada Inc), or 2
mg estradiol benzoate (EB; Sigma-Aldrich Can Ltd, Oakville, ON, Canada) and 50 mg
progesterone (Sigma-Aldrich) in 2 mL canola oil. On Day 7, CIDR-B devices were
removed and all heifers received an i.m. injection of 500 J.lg cloprostenoI (PGF;
Estrumate, Schering-Plough Animal Health, Pointe-Claire, PQ, Canada). Consistent
with their treatment groups on Day 0 (GnRH, pLH or estradiol), heifers were given
either 100 J.lg GnRH or 12.5 mg pLH 48 h after PGF and concurrently inseminated or 1
mg EB in 2 mL canola oil i.m. (Sigma-Aldrich) 24 h after PGF and inseminated,
approximately 28 h later 52 h after PGF; the LH peak is expected to occur
approximately 18 h after treatment with estradiol; Bo et aI., 1994)]. Frozen-thawed
semen from a single sire was used and the same operator performed all inseminations.
Although observations for behavioural estrus were conducted at least twice daily from
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24 to 72 h after PGF treatment to determine estrus synchrony, all heifers were fixed-
time inseminated.
Days
o
GnRH (100 /lg)
6 7
t
PGF
8 9
t
GnRH+AI
pLH (12.5 mg)
EB/Progesterone (2 mg/50 mg)
In
all pLH+AI
groups
1-24 h-EB-28h-Al
Figure 9.1 Schematic outline of the experiment (arrows indicate times of administration
of treatments). The CIDR-B devices were removed after 7 days and MGA
was fed once daily from Days 0 to 6. Heifers were treated with GnRH, pLH
or estradiol benzoate (EB) and progesterone on Day 0 and all received PGF
on Day 7. Heifers that received GnRH or pLH received a second injection of
the same hormone 48 h after PGF (Day 9) and were inseminated
concurrently, while those in the EB group received EB 24 h after PGF (Day
8) and were inseminated 28 h later (52 h after PGF; Day 9).
Heifers were retained in the feedlot and exposed to fertile bulls for 17 d, starting
approximately 20 days after AI. Pregnancy was diagnosed by transrectal ultrasound
examination approximately 30 days after AI (Curran et aI., 1986). Following bull
exposure, heifers were sent to pasture. Fall pregnancy rate was determined by rectal
palpation, conducted approximately 150 days after fixed-time AI. A heifer diagnosed as
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pregnant at the first examination but subsequently diagnosed non-pregnant in the fall
was defined as having a pregnancy loss.
Mean and standard error of the mean (SEM) were used to describe data. A two-
way analysis of variance was used to determine the effect of progestin, synchronizing
treatment, and their interaction, on the interval from PGF treatment to estrus. Bartlett's
test was used to compare the variances in the interval from PGF treatment to estrus
among the six treatment groups, between the two progestins, and among the three
synchronizing treatments. Logistic regression analysis was used to compare the effect
of progestin, treatment, and progestin-by-treatment interaction on estrus and pregnancy
rates. Embryonic loss rate was compared among the six treatment groups, between the
two progestins, and among the three synchronizing treatments by Chi-square analysis.
Chi-square was also used to compare the pregnancy rate between heifers that showed
estrus and those that did not. All statistical analyses, except logistic regression (SPSS,
version 10.05, 1999, SPSS Inc., Chicago, IL, USA), were conducted using SAS (SAS
Institute Inc., Cary, NC, USA).
The protocols for these experiments were approved by University of
Saskatchewan Animal Care Committee.
9.4 Results
The distribution of estrus is shown in Table 9.1 and Figure 9.2. Reproductive
performance according to presence or absence of detected estrus is shown in Table 1.
The proportion of heifers detected in estrus was greatest in EB groups (combined for
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both progestins, 92.0%) and least in GnRH or pLH groups fed MGA (35.6 and 33.0%,
respectively). Estrus was detected in a greater (P < 0.0001) proportion of heifers given
a CIDR-B device than in those fed MGA (68.9 versus 45.5%). The mean interval from
POF treatment to estrus was not different among groups (overall, 47.8 h; P = 0.85) and
the modal interval from PGF to estrus was 48 h. However, the interval from PGF
treatment to estrus was less variable (P < 0.01) in heifers fed MGA (SEM = 0.2 h) than
in those treated with a CIDR-B (SEM = 0.5 h). There was an effect of progestin (P <
0.001), but there was no effect of treatment (P = 0.72), or progestin-by-treatment
interaction (P = 0.11) on estrus rate (overall mean, 58.0%). There was no effect of
progestin (P = 0.11), treatment (P = 0.26), or progestin-by-treatment interaction (P =
0.22) on pregnancy rate to fixed-time AI (overall mean, 58.0%). Combined for all
treatments, pregnancy rate was greater (P < 0.05) in heifers detected in estrus (62.6°~)
than in those not detected in estrus (51.9%). Fall pregnancy rate was not different (P =
0.86) among groups (overall mean, 77.1 %). Pregnancy losses were not different among
groups and ranged from 5.3% in CIDR-B-treated heifers that were synchronized with
pLH to 13.0% in MGA-treated heifers synchronized with pLH (overall mean, 9.3%).
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Figure 9.2 Distribution of estrus after PGF administration in heifers that received a
CIDR-B device (A) or were fed MGA (B) and treated with GnRH, pLH or
estradiol benzoate (EB) to synchronize follicular wave emergence and
ovulation for fixed-time AI.
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Table 9.1 Estrus rates, interval from PGF to estrus, and pregnancy rates in beef heifers
receiving a CIDR-B device or fed MGA and given GnRH, pLH or EB for
the synchronization of follicular wave emergence and ovulation for fixed-
time All
CIDR-B MGA
GnRH pLH EB GnRH pLH EB
No. heifers 103 102 52 101 97 48
Estrus % 65.0a 60.8a 92.3b 35.6C 33.0c 91.7b
PGF to estrus h
Mean 47.1 47.8 47.3 48.0 48.8 48.3
SEM2 0.8x l.Ox 0.5Y O.3Y 0.3Y 0.3z
Pregnancy rate to AI %
Overall 65.0 55.9 61.5 52.5 55.7 60.4
Detected in estrus 67.2 61.3 62.5 61.1 62.5 59.1
Not detected in estrus 61.1 47.5 50.0 47.7 52.3 75.0
Fall pregnancy rate % 75.7 77.4 78.8 73.3 72.2 77.1
abc Mean and percentages without a common superscript differ (P < 0.05)
xyz Variances without a common superscript differ (P < 0.05)
1 Please refer to Figure 1 for treatment schedule; PGP was administered to all heifers on
Day 7 at CIDR-B removal (1 day after the end ofMGA feeding)
2 Standard error of the mean was calculated for simple effects to show differences in
variation of the interval from PGF to estrus but statistical comparisons were done with
vanances.
9.5 Discussion
The use of progestins in estrus synchronize programs has become widespread in
the last 10 yr (De Rensis and Peters, 1999). In recent reports (Sections 7.0, 8.0),
pregnancy rates to fixed-time AI were greater in cattle that received a CIDR-B than in
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those fed MGA. As pregnancy rates to fixed-time AI in the present study were not
significantly different among groups (overall mean, 58.00/0), factors other than
pregnancy rate (e.g., costs and management) may determine the program selected. For
example, CIDR-B devices are more expensive than MGA, but they can be used in both
confined cattle and those at pasture.
Although MGA is marketed for the suppression of estrus in feedlot heifers, it
has also been used in estrus sYnchronization programs (Patterson et aI. 1989; Odde
1990). Feeding ofMGA for 14 to 17 days effectively sYnchronizes estrus, but results in
low fertility (Odde, 1990). However, feeding MGA for shorter periods of time (e.g., 7
d) has resulted in improved fertility when feeding was started early in the estrous cycle,
but not when MGA was started late in the cycle (Beal et aI. 1988); this is probably due
to the development of persistent dominant follicles (Custer et aI. 1994; Kojima et aI.
1995) which are associated with reduced fertility (Patterson et aI., 1989; Custer et aI.,
1994; Ahmad et aI., 1995). This problem may be overcome by strategically
synchronizing follicular wave emergence at the start ofMGA treatment.
It has been shown that estradiol synchronizes emergence of a new follicular
wave by suppressing FSH (B6 et aI., 1995a). Estradiol and progesterone given at the
beginning of a CIDR-B protocol in beef heifers was followed by follicle regression and
the sYnchronous emergence of a new follicular wave, 3.4 ± 0.1 days later (Martinez et
aI., 2000). Therefore, in a 7-day protocol (as used in the present study), the dominant
follicle was expected to be on approximately days 3 or 4 of its growing phase (9 to 10
mm) at the time of CIDR-B removal or discontinuation ofMGA.
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There has been continuing development of CIDR-B-based programs in the last
several years. Initially, EB was delivered by a gelatin capsule placed in the vagina
along with the CIDR-B device (Macmillan et aI., 1991). Subsequent work showed that
the i.m. administration of EB resulted in more consistent and synchronous wave
emergence (B6 et aI., 1996). Estradiol-17P and progesterone have been incorporated
into a 7-day MGA feeding program, resulting in acceptable fertility after estrus
detection and AI (Kastelic et aI., 1996). Estrogens and GnRH have been compared in
CIDR-B based programs for synchronization of wave emergence and ovulation
(Section 7.0). In one study, estrus and pregnancy rates to fixed-time AI were 100 and
76%, respectively, in CIDR-B-treated heifers given EB, compared with 55 and 48% in
heifers given GnRH (Section 7.0). In another study, beef cows were given MGA for 7
days (Section 8.0); estradiol or GnRH were given to synchronize follicular wave
emergence and ovulation, resulting in pregnancy rates to fixed-time AI of 55.7 and
47.5%, respectively. The results of the present study suggest that there is likely to be no
difference in pregnancy rates to fixed-time AI between the use ofCIDR-B or MGA and
one of the. three methods of synchronizing follicular wave emergence and ovulation.
We have previously shown that the administration of estradiol when circulating
levels of progesterone are low will induce LH release, incomplete suppression of the
dominant follicle, and a delay in the emergence of the next follicular wave (B6 et aI.,
1994). Therefore, we included progesterone with the first estradiol treatment in the
present study. However, the inclusion of progesterone with EB at the time of CIDR-B
insertion has been reported to have no effect on pregnancy rate (B6 et aI., 2000b).
Plasma progesterone concentrations have been reported to increase by 2 h after CIDR-
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B insertion (Burke et aI., 1999) and may prevent an estrogen-induced LH surge in cattle
without a functional CL. However, progestin levels may increase more slowly and be
less suppressive with an oral preparation such as MGA (Kojimaet aI., 1995). In
addition, progesterone along with estradiol may improve its efficacy in inducing
regression of larger antral follicles (Anderson and Day, 1994, 1998; McDowell et aI.,
1998).
Estrogen treatment has also been given after PGF administration to increase the
proportion of cattle in estrus and the synchrony of estrus behaviour (Dailey et aI., 1983;
1986). B6 et aI. (1994) reported that an LH surge occurred 16 to 18 h after an injection
of estradiol in animals without a functional CL. The administration of EB following
CIDR-B removal has been shown to result in a greater estrus rate than that in Control
heifers (Hanlon et aI., 1996) and an LH surge, and ovulation (Lammoglia et aI., 1998).
In the present study, EB appears to have been very effective in synchronizing both the
emergence of an ovulatory wave and ovulation of the dominant follicle of that wave.
Treatment with GnRH induces ovulation of large antral follicles, with a new
follicular wave emerging approximately 2 days later (Twagiramungu et aI. 1994, 1995).
However, synchronous emergence of a new follicular wave occurs only when treatment
causes ovulation. In an experiment in which GnRH or pLH was administered at various
phases of the first follicular wave, ovulation of the dominant follicle was induced in 56
or 78% of heifers, respectively (Martinez et aI., 1999). Heifers that failed to ovulate
following the second GnRH treatment in an Ovsynch protocol were reported to be in
metestrus or early diestrus at the first GnRH treatment (Pursley et aI., 1995). Therefore,
ovulation following PGF treatment may be poorly synchronized if the first GnRH
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treatment does not induce ovulation of the dominant follicle and thereby fails to
synchronize wave emergence.
The Ovsynch protocol has yielded acceptable pregnancy rates in both dairy
(Pursley et aI., 1997) and beef (Geary et aI., 2001) cows, but pregnancy rates in heifers
have been unacceptably low (Pursley et aI., 1997). The addition of a CIDR-B device to
a GnRH- or pLH-based Ovsynch program resulted in improved pregnancy rates in beef
heifers (68 versus 39% or 65 versus 38%, respectively; Section 10.0). Therefore,
progestins (CIDR-B or MGA) were used in the period between the first GnRH or pLH
treatment and the administration ofPGF in the present study; pregnancy rates to fixed-
time AI were highly acceptable.
In the present study, the use of EB for synchronization of estrus and ovulation
required one additional handling compared with GnRH or pLH treatment groups, but
there was no difference in pregnancy rates. However, insemination 8 to 24 h after
GnRH treatment has been reported to result in numerically the highest pregnancy rates
(Pursley et aI., 1998). Insemination a few hours after GnRH or pLH treatment may have
improved pregnancy rates in the present study, but it would have required an additional
handling. Although stress may affect pregnancy rates, estradiol treatment with an
additional handling resulted in pregnancy rates that were at least as high as that of
groups requiring less handling.
Heifers were fixed-time inseminated in the present study, but they were also
observed for estrus. Although there was no effect of treatment group, estrus rate was
numerically greater in EB-treated heifers (92.0%) than in those given GnRH (50.7%) or
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pLH (47.2%) and was greater in heifers with a CIDR-B device (68.90/0) than in those
fed MGA (45.50/0). High estrus rates have been previously reported for estrogen-treated
cattle (Hanlon et aI., 1996; Ryan et aI., 1996; Day et aI., 2000), but much lower in cattle
given GnRH in an Ovsynch program (Stevenson et aI., 1996). Obviously, many factors
influence the expression and detection of estrus (Loeffler et aI., 1999), and in the
present experiment, the use of a CIDR-B device significantly increased the expression
of estrus. However, synchronization of follicle wave emergence and the preovulatory
LH surge (and ovulation) in fixed-time AI programs preclude the need for estrus
detection. Nevertheless, pregnancy rates were greater in GnRH- or pLH treated heifers
that were detected in estrus, but pregnancy rates were not different in EB-treated
heifers.
Because pregnancy rate is the product of estrus rate and conception rate,
pregnancy rate will be low if either is low, or if both are modest. Fixed-time AI
eliminates variability associated with estrus detection and it may be optimized if
ovulation is synchronous; this can be facilitated by synchronizing wave emergence and
the preovulatory LH surge. The programs used in the present experiment were
successful in achieving this objective.
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Implications
The use of GnRH, porcine LH or estradiol benzoate in combination with an
intravaginal progesterone-impregnated device or feeding melengestrol acetate
apparently synchronized ovulation (and follicular wave emergence), facilitating fixed-
time AI in beefheifers. Pregnancy rates to a single fixed-time insemination were highly
acceptable in all groups (overall average, 58%). Factors including product cost and
availability, animal management, and handling will influence the decision of which
program will be best suited to a particular beefoperation.
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10.0 THE USE OF PROGESTINS IN REGIMENS FOR FIXED-TIME
ARTIFICIAL INSEMINATION IN BEEF CATTLE
10.1 Abstract
Four experiments were conducted to investigate modifications to GnRH-based
fixed-time AI protocols in beef cattle. In Experiment 1, the effect of reducing the
interval from GnRH treatment to PGF was examined. Lactating beef cows (n = 111)
were given 100 Jlg gonadorelin (GnRH) on Day 0 (start of treatment) and either 500 Jlg
cloprostenol (PGF) on Day 6 with AI and 100 Jlg GnRH 60 h later, or PGF on Day 7
with AI and GnRH 48 h later (6- or 7-day CosYnch regimens). Pregnancy rates were
32/61 (52.40/0) versus 26/50 (52.0%), respectively (P = 0.96). In Experiment 2, cattle (n
= 196) were sYnchronized with a 7-day CosYnch regimen and received either no further
treatment or a CIDR-B device (Days 0 to 7). Pregnancy rates were 32/71 (45.1 %) versus
33/77 (42.9%) in cows (P < 0.8), and 9/23 (39.1 %) versus 17/25 (68.0%) in heifers (P <
0.05). In Experiment 3, 49 beef heifers were randomly assigned to receive 12.5 mg pLH
on Day 0, PGF on Day 7 and 12.5 mg of pLH on Day 9 with AI 12 h later (pLH
OvsYnch), or similar treatment plus a CIDR-B device from Days 0 to 7 (pLH
OvsYnch+CIDR-B), or 1 mg estradiol benzoate (EB) and 100 mg.progesterone on Day
0, a CIDR-B device from Days 0 to 7 (EB/P4+CIDR-B), PGF on Day 7 (at the time of
CIDR-B removal) and 1 mg im EB on Day 8 with AI on Day 9 (52 h after PGF).
Pregnancy rate in the EB/P4+CIDR-B group (75.0%) was higher (P < 0.04) than in the
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pLH Ovsynch group (37.5 % ); the pLH Ovsynch+CIDR-B group was intennediate
(64.7%). In Experiment 4, 266 non-lactating cows were allocated to a 7-day Cosynch
protocol (Cosynch), a 7-day Cosynch plus 0.6 mg/head/d melengestrol acetate (MGA)
from Days 0 to 6 inclusive (Cosynch+MGA) or MGA (Days 0 to 6) plus 2 mg EB and
50 mg progesterone on Day 0, 500 Ilg PGF on Day 7, 1 mg EB on Day 8 and fixed-time
AI 28 h later (EBIP+MGA). Pregnancy rates (P < 0.25) were 44.8% (39/87; Cosynch),
47.8% (43/90; Cosynch+MGA), and 60.7% (54/89; EBIP+MGA). In conclusion, a 6- or
7-day interval from GnRH to PGF in a Cosynch regimen resulted in similar pregnancy
rates in cows. The addition of a progestin to a Cosynch or Ovsynch regimen
significantly improved pregnancy rates in heifers but not in cows. Progestin-based
regimens that included EB consistently resulted in high pregnancy rates to fixed-time
AI.
10.2 Introduction
Gonadotropin releasing hormone (GnRH) has been used in many fixed-time AI
programs (Adams, 1998; Pursley et aI., 1995; Twagiramungu et aI., 1995; Wiltbank,
1997). Usually, GnRH is given twice in a 9- to 10-d period. When GnRH is given at the
start of a synchronization regimen, it is expected to induce ov:ulation of the extant
dominant follicle, followed by the emergence of a new follicular wave approximately 2
days later (Pursley et aI., 1995; Twagiramungu et aI., 1995; Martinez et aI., 2000).
Prostaglandin (PGF) treatment is given 6 or 7 days later to induce regression of luteal
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tissue (Pursley et aI., 1995; Twagiramungu et aI., 1995). In the '"Ovsynch" regimen, a
second dose of GnRH is given after PGF treatment to synchronize the LH surge and
ovulation, enabling fixed-time AI 0 to 24 h later (Pursley et aI., 1995). This protocol has
resulted in acceptable pregnancy rates (approximately 50%) in beef cows (Geary et aI.,
2001; Thundathil et aI., 1999). Furthennore, the administration of the second dose of
GnRH, concurrently with fixed-time AI ("Cosynch") in beef cows, resulted in a
pregnancy rate equal to that of a group inseminated 24 h later (Geary et aI., 2001). The
Ovsynch regimen has not been widely used in heifers, since pregnancy rates have been
low (Wiltbank, 1997).
Cattle displaying estrus prior to PGF treatment in an Ovsynch regimen are
unlikely to become pregnant after fixed-time AI. The incidence of early estrus was 6.4
and 8.9% in 6-day regimens in cows (Roy and Twagiramungu et aI., 1996), 12.5 and
11.8% in 7-day regimens in cows (Roy and Twagiramungu et aI., 1999; Seguin, 1997),
and 17.3% in a 6-day regimen in heifers (Roy and Twagiramungu et aI., 1996). The
higher incidence of premature estrus (and poor fertility) in heifers may be the result of
inconsistent response to the first GnRH treatment; ovulation occurred in only 50%
(Martinez et aI., 2000) and 56% (Pursley et aI., 1995) of GnRH-treated heifers. In cows,
however, ovulation rate after the first GnRH ranged from 64% (Vasconcelos et aI.,
1999) to 90% (Pursley et aI., 1995). Induction of ovulation of the dominant follicle is
important as it is followed by the emergence of a new follicular wave; it was concluded
that the timing of follicular wave emergence was not affected when ovulation did not
occur after·GnRH treatment (Martinez et aI., 1999). It has been reported that shortening
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the interval from 7 days to 6 days results in a reduced incidence of premature estrus and
greater precision of estrus (Roy and Twagiramungu, 1996, 1999). We hypothesized that
providing an exogenous source of progestin during the interval from the first GnRH to
PGF treatment would reduce the incidence of premature estrus. Alternatively, estradiol
can be used in lieu of GnRH for synchronization of wave emergence and ovulation in
I
progestin-treated cattle (Martinez et aI., 1999). Estradiol treatment of progestin-treated
cattle results in a new follicular wave 4 or 5 days later, while estradiol treatment of
animals with low levels of progesterone results in a LH surge 18 to 24 h later (B6 et aI.,
1994) and ovulation approximately 30 h after the LH surge (Kojima et aI., 1995).
Four experiments were conducted to evaluate modifications to GnRH-based
fixed-time AI protocols in beef cattle. The objective of Experiment 1 was to detennine
the effect of reducing the interval between the first injection of GnRH and PGF
administration in lactating beef cows. Experiment 2 was designed to determine the
benefit of including a CIDR-B device in a GnRH-based regimen in both cows and
heifers. The objective of Experiment 3 was to compare two synchronization treatments
involving a pLH-based Ovsynch protocol, with or without CIDR-B, and a CIDR-B-
based protocol with estradiol benzoate (EB) in heifers. The objective of Experiment 4
was to compare two synchronization treatments involving a GnRH-based Cosynch
protocol, with or without melengestrol acetate (MGA), and an MGA-based protocol
with EB in cows.
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10.3 Materials and Methods
10.3.1 Experiment 1
Lactating beef cows (n = 111, 45 to 70 days postpartum) were body condition
scored from 1 to 5 (Domecq et aI., 1995), examined with transrectal ultrasonography
(Aloka SSD-500 with a 7.5 MHz linear-array transducer; Instruments for Science and
Medicine, Vancouver, BC, Canada) to determine the presence and size of the corpus
luteum (CL), and randomly assigned to either a 6-day or 7-day Cosynch regimen (Figure
1). For the 6-day regimen, cows were given 100 J.lg im gonadorelin (GnRH,
Cystorelin™, Merial Canada Inc, Victoriaville, PQ, Canada) on Day 0 (start of the
experiment), followed by 500 J.lg cloprostenol (PGF, Estrumate™, Schering-Plough
Animal Health, Pointe-Claire, PQ, Canada) on Day 6. Cows were artificially
inseminated (AI) on Day 8.5 (60 h after PGF) and concurrently given 100 J.lg GnRH. For
the 7-day regimen, cows received GnRH on Day 0, PGF on Day 7, and AI concurrently
with GnRH on Day 9, (approximately 48 h after PGF). All hormone treatments were
administered by im injection. The interval from PGF to GnRH and AI was
approximately 12 h longer in the 6-day versus the 7-day regimen so that the diameter of
the preovulatory follicle at the time of the second GnRH treatment would be
approximately the same in both groups. Cows were observed for signs of estrus at 48
and 60 h after PGF treatment; inseminations using semen from 3 different bulls were
done by a single inseminator. Pregnancy was determined by transrectal ultrasonography
approximately 30 days after AI. Estrus and pregnancy rates were compared by Chi-
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square analysis (Norman and Streiner, 2000; Statistix for Windows™, Analytical
Software, Version 2.0, 1996. Tallahassee, FL, USA).
Days
0 6 7 8.5 9
I I I CD
GnRH 7-day group PGF GnRH+AI
GnRH 6-day group PGF GnRH+AI
Figure 10.1 Treatment schedule for 7-day and 6-day Cosynch treatments. Cows were
treated with GnRH and 6 (6-day) or 7 (7-day) days later with PGF. Cows
in the 7-day group received a second injection of GnRH 48 h after PGF
and were inseminated while those in the 6-day group received a second
injection of GnRH 60 h after PGF and were inseminated.
10.3.2 Experiment 2
Lactating Simmental-cross cows (n = 148; 35 to 60 days postpartum) and heifers
(n = 48) were treated in a 7-day program (as in Experiment 1). Animals were body
condition scored and examined with transrectal ultrasonography to determine the
presence and size of CL. They were randomly assigned to receive either no further
treatment or a once-used CIDR-B device (Vetrepharm) inserted at the time of the first
GnRH treatment (Day 0) and treatment with 500 Jlg im PGF at CIDR-B removal (Day
7; Figure 9.2). Forty-eight hours later, heifers were inseminated by a single inseminator
and received a second injection of GnRH. Transrectal ultrasonography was conducted
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24 days after AI to detennine pregnancy status, and pregnancy rates for CO\\'S and heifers
were compared separately by Chi-square analysis.
Days
--7 0 2
I I I .
GnRH PGF GnRH+AI
GnRH+CIDR-B for 7 days PGF GnRH+AI
Figure 10.2 Treatment schedule for Ovsynch and Ovsynch+CIDR-B treatment
groups. Cattle were treated with GnRH and 7 days later with PGF. Forty-
eight hours later, they were inseminated and received a second injection
of GnRH. Cattle in the first group received no further treatment and those
in the second group also received a CIDR-B device from the time of the
first injection ofGnRH until the injection ofPGF.
10.3.3 Experiment 3
Forty-nine beefheifers were randomly assigned to three treatment groups (Figure
3). Heifers in the first group (pLH Ovsynch) received 12.5 mg pLH (Lutropin-yrM,
Vetrepharm) on Day 0,500 J-lg PGF on Day 7 and 12.5 mg ofpLH on Day 9 with AI 12
h later. Heifers in the second group (pLH Ovsynch+CIDR-B) were treated similarly,
with the addition of a new CIDR-B device from Days 0 to 7. Heifers in the third group
(EB+CIDR-B) were given 1 mg EB (Sigma Chemical Co, St. Louis, MO, USA) and 100
mg progesterone (Sigma) in canola oil im on Day 0, and a new CIDR-B device from
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Days 0 to 7. Heifers were given PGF on Day 7 (at the time of CIDR-B removal) and 1
mg EB im on Day 8 with AI to a single bull done by a single inseminator on Day 9 (52 h
after PGF). Heifers in all 3 groups were observed for estrus every 12 h from 24 to 60 h
after PGF. Transrectal ultrasonography was conducted 30 days after AI to determine
pregnancy status. The interval from PGF treatment to estrus was analyzed by Kruskal-
Wallis nonparametric one-way analysis of variance and variances were compared with a
Bartlett's test. Pregnancy rates were compared by Chi-square analysis (Norman and
Streiner, 2000).
Days
0 7 8 9 9.5
I I I , I
pLH PGF pLH AI
pLH+CIDR-B for 7 days PGF pLH AI
EB/P4+CIDR-B for 7 days PGF EB AI
Figure 10.3 Treatment schedule for pLH-based Ovsynch regimens with or without a
CIDR-B device for 7 days. Heifers in the first 2 groups received an
injection of pLH on Day 0, an injection of PGF on Day 7, a second
injection of pLH on Day 9 and AI 12 h later; heifers in the second group
also received a CIDR-B device between Days 0 and 7. Heifers in the third
group received an injection of estradiol benzoate and progesterone (EB/P4)
along with a CIDR-B device on Day 0, an injection of PGF at the time of
CIDR-B removal on Day 7, a second injection of EB 24 later (Day 8) and
AI approximately 28 h later.
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10.3.4 Experiment 4
Non-lactating, culled crossbred beef cows (n = 266) of unknown reproductive
history were used. The cows were housed in group pens at a feedlot and were fed a diet
of silage and screening pellets. Cows were examined by transrectal ultrasonography and
those that were pregnant or had detectable abnormalities were excluded. Remaining
cows (n = 249) were randomly allocated to three treatment groups (Figure 4). Cows in
the first group (Cosynch) received 100 Ilg im GnRH on Day 0, SOD Ilg ofPGF on Day 7,
and 100 J.lg GnRH im concurrent with AI by a single inseminator using semen from a
single bull 50 h after PGF. To maximize fertility in cows showing premature estrus, all
cows in this group were observed twice-daily from Days 3 to 8 for standing estrus, and
those that were detected in estrus were inseminated approximately 12 h later by the same
operator and were not given the previously scheduled injections. These animals were
considered to be not pregnant to the fixed-time AI. Cows in the second group
(Cosynch+MGA) were treated similarly, except that they were also fed MGA (0.6 mg
head/d; Pharmacia and· Upjohn, Orangeville, ON, Canada) in a grain mix from Days 0 to
6 inclusive and given 100 J.lg im GnRH concurrent with AI approximately 50 h after
PGF. Cows in the third group (EBIP+MGA) were also fed MGA from Days 0 to 6, but
received an im injection of 2 mg EB and 50 mg progesterone on Day 0, 500 Ilg im PGF
on Day 7, 1 mg im EB on Day 8 (approximately 24 h after PGF), and were inseminated
by the same operator approximately 28 h later (52 h after PGF treatment). Semen from a
single sire was used for all inseminations. Transrectal ultrasonography was conducted
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approximately 30 days after AI to determine pregnancy status, and pregnancy rates were
compared by Chi-square analysis.
The protocols for these experiments were approved by University of
Saskatchewan Animal Care Committee.
Days
0 6 7 8 9
I I I I LJ
GnRH PGF GnRH+AI
GnRH+MGA xMGA PGF GnRH+AI
EB/P4+MGA xMGA PGF EB AI
Figure 10.4 Treatment schedule for GnRH-based Cosynch regimens with or without
feeding MGA. Cows in the first 2 groups received an injection of GnRH
on Day 0, an injection of PGF on Day 7, a second injection of GnRH on
Day 9 concurrently with AI; cows in the second group were also fed
MGA between Days 0 and 6. Cows in the third group received an
injection of estradiol benzoate and progesterone (EB/P4) and were fed
MGA from Days 0 to 6, an injection ofPGF on Day 7, a second injection
ofEB 24 h later (Day 8) and AI approximately 28 h after EB.
10.4 Results
10.4.1 Experiment 1
All cows had an ultrasonically detectable CL (range in diameter, 8 to 27 mm) on
Day O. Estrus rates were 24.6 and 26.0% (P = 0.56), and pregnancy rates were 52.4%
145
(32/61) and 52.0% (26/50; P = 0.96) for the 6-day and 7-day Cosynch protocols,
respectively (Table 10.1). There were 22, 72 and 17 cows with BCS of 2.0,2.0 to 3.0,
and 3.0, respectively. For these three categories, pregnancy rates were 31.8, 54.2 and
70.6%, respectively (P < 0.05; 31.8 versus 70.60/0, P < 0.02). There was no bull effect on
pregnancy rates (P = 0.70).
10.4.2 Experiment 2
Results are shown in Table 10.1. Pregnancy rates were 45.1 % (32/71) for
Cosynch cows (without a CIDR-B) and 42.9% (33/77) for Cosynch+CIDR-B cows
(with a CIDR-B; P = 0.79). For the corresponding treatments in heifers, pregnancy rates
were 39.1 % (9/23) and 68.0% (17/25; P < 0.05). Fourteen heifers had a CL at the time of
initiating treatments and, of these, the pregnancy rate was 4/7 and 5/7 for heifers without
and with a CIDR-B, respectively. There were 53, 54 and 41 cows with a BCS 2.0, 2.0 to
3.0, and 3.0, respectively; pregnancy rates were 47.2, 46.3 and 36.6%, respectively, for
these three categories (P = 0.53). It was not possible to rule out a bull effect because of
the high number of bulls used (18 bulls in 148 cows and 20 bulls in 48 heifers) and the
varying numbers of animals inseminated with semen from each bull (cattle producer's
instructions).
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10.4.3 Experiment 3
The mean (± SEM) interval from PGF treatment to estrus tended (P = 0.07) to be
different among groups (54.9 ± 5.1, 57.0 ± 2.6, and 49.6 ± 1.1 h for the pLH, pLH+P4,
and EB+P4 groups, respectively); the variation in this interval was less for the EB+P4
group than for the other two groups (P = 0.002). Estrus rate in the EB+P4 group (15/16,
93.8%) was higher (P < 0.002) than in the pLH Ovsynch group (7/16, 43.8°A.), while the
rate for the pLH Ov-synch+CIDR-B group (12/17, 70.6%) was intermediate and not
different from either. The pregnancy rate in the EB+P4 group (75.0%) was also higher
(P < 0.04) than in the pLH group (37.5%), while the rate for the pLH+P4 group (64.7%)
was intermediate and not different from either (Table 10.1).
10.4.4 Experiment 4
In the Cosynch group, 14 of 17 cows detected in estrus and inseminated between
Days 3 and 8 were diagnosed pregnant. The remaining 70 cows were fixed-time
inseminated and 39 became pregnant with an overall conception/pregnancy rate to fixed-
time AI of 44.8%. In the Cosynch+MGA and EB+MGA groups, pregnancy rates were
47.8% (43/90) and 60.7% (54/89), respectively. The pregnancy rate in the Cosynch and
Cosynch+MGA groups tended (P = 0.08) to be lower than in the EB+MGA group
(Table 10.1).
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Table 10.1 Estrus and pregnancy rates (%) in cattle subjected to different protocols for
synchronization of ovulation in fixed-time AI programs.
Experiment Treatments n Animal class Estrus rate Pregnancy rate
1 6-day Cosynch 61 Cows 24.6 52.4 (32/61)
7-day Cosynch 50 Cows 26.0 52.0 (26/50)
Cosynch 71 Cows 45.1 (32/71)
Cosynch+CIDR-B 77 Cows 42.9 (33/77)
2
Cosynch 23 Heifers 39.1 (9/23)a
Cosynch+CIDR-B 25 Heifers 68.0 (17/25)b
pLH Ovsynch 16 Heifers 43.8c 37.5 (6/16)e
3 pLH Ovsynch+CIDR-B 17 Heifers 70.6cd 64.7 (11/17)ef
EB/P+CIDR-B 16 Heifers 93.8d 75.0 (12/16)f
Cosynch 87 Cows 44.8 (39/87)g
4 Cosynch+MGA 90 Cows 47.8 (43/90)g
EB/P+MGA 89 Cows 60.7 (54/89)h
Within experiments, values with no common superscripts are different.
ab P < 0.05, cd P = 0.002, efp = 0.04, gh P = 0.08
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10.5 Discussion
Pregnancy rates in cows synchronized with Cosynch or Ovsynch regimens in
Experiments 1, 2 and 4 were similar to those reported previously in lactating beef cows
(Geary et aI., 2001, Thundathil et aI., 1999, Downing et aI., 1998, Geary and Whittier,
1997). Furthermore, reducing the interval (from 7 to 6 d) between the first injection of
GnRH and PGF treatment did not affect pregnancy rates in the present study. In a
previous study (Roy and Twagiramungu, 1999), cows (both lactating and non-lactating)
and heifers were given GnRH, followed by PGF 6 or 7 days later, and observed for
estrus. It is noteworthy that although a second dose of GnRH was not given and
pregnancy rates were not reported, there were no significant differences between the 6-
and 7-day regimens for the proportion of cattle in estrus during the interval between
GnRH and PGF (8.9 versus 11.8%), or in estrus within 5 days after PGF (53.2 versus
51.3%; Roy and Twagiramungu, 1999). However, the interval from PGF to estrus
tended (P < 0.1) to be less variable in cattle in the 6-day than in the 7-day regimen (Roy
and Twagiramungu, 1999). Although the estrus rate in Experiment 1 was low
(approximately 25%), the cows were observed only twice, 48 and 60 h after PGF. Low
estrus rates 24 to 72 h after PGF were also reported in nursing cows on 6-day (37.5%)
and 7-day (33.8%) GnRH-based protocols (Roy and Twagiramungu, 1999). Data from
the present study do not suggest any benefit of one regimen over the other in lactating
beef cows.
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Combined for Experiments 2 and 3, pregnancy rates in heifers with Cosynch or
Ovsynch regimens were 38.5% (n = 39), whereas pregnancy rates were 68.0% (n = 42)
for those that also received a CIDR-B device. Low pregnancy rates in heifers have been
reported previously in GnRH-based fixed-time AI regimens that did not include a
progestin. Pregnancy rates in dairy heifers were 26 to 28% following 7-day Ovsynch
protocols (Seguin, 1997, Schmitt et aI., 1996a) and 35% following a 6-day regimen in
beef cows (Geary and Whittier, 1997). Low pregnancy rates in heifers in Ovsynch and
Cosynch regimens may be related to the low incidence of ovulation following the first
GnRH treatment and the high percentage of animals that are in estrus before PGF
treatment (17.3%; Roy and Twagiramungu, 1999). In this regard, the proportion of
heifers ovulating in response to GnRH treatment ranged from 50 to 56% (Pursley et aI.,
1995, Martinez et aI., 2000, Martinez et aI., 1999), while the ovulation rate in cows after
the first GnRH treatment ranged from 64% (Vasconcelos et aI., 1999) to 90% (Pursley et
aI., 1995).
Synchronous emergence of a new follicular wave (approximately 2 days after
GnRH treatment) occurs if the dominant follicle ovulates or if spontaneous wave
emergence occurs by chance (Martinez et aI., 1999). We hypothesized that the addition
of a CIDR-B device to an Ovsynch or Cosynch protocol would improve pregnancy rates
to fixed-time insemination by preventing estrus between the first. GnRH injection and
PGF. In a previous study involving treatment of beef heifers with 100 J.lg GnRH and
insertion of a CIDR-B device at random stages of the estrous cycle (Martinez et aI.,
2000), GnRH-induced ovulation occurred in only 8 of 16 heifers, but follicular wave
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emergence occurred 1.5 ± 0.3 days later (mean ± SEM; range, -1 to 4 days). In that
study, the CIDR-B device was removed (and PGF was given) after 6 days but a second
dose of GnRH to synchronize the LH surge was not given; ovulation occurred 3.5 ± 0.1
days after CIDR-B removal and conception rate to an insemination 12 h after onset of
estrus was 69%. In another study (Section 9.0), heifers treated with a Cosynch+CIDR-B
protocol similar to Experiment 2 had pregnancy rates of 65 and 56% in a GnRH- or
pLH-based regimen, respectively (P < 0.6). Clearly, the inclusion of the CIDR-B device
in a GnRH- or pLH-based fixed-time AI program results in synchronous ovulation and
acceptable pregnancy rates to fixed-time AI in beefheifers.
The addition of progestins (CIDR-B devices or MGA in Experiments 2 and 4,
respectively) to a Cosynch regimen did not significantly improve pregnancy rates in
cows. In a previous study (Thompson et aI., 1999) in which lactating beef cows were
synchronized in an Ovsynch regimen, the pregnancy rate was higher when a
norgestomet implant was inserted at GnRH treatment and removed at the time of PGF
treatment (10/14, 71.4% versus 4/13, 30.8%, P < 0.05). It is noteworthy that cows in that
study were only 34.4 days postpartum at the start of the experiment (range, 7 to 44 days)
and that the increase in pregnancy rate was attributed to a norgestomet-induced
reduction in the incidence of short luteal phases following breeding (Ramirez-Godinez
et aI., 1981). Stevenson (2000) also reported that pregnancy rates.in cows synchronized
with an Ovsynch regimen were higher in those receiving a norgestomet implant (51.1 %,
47/91 versus 30.70/0, 28/91; P < 0.01) or a CIDR-B device (66.3%,63/95 versus 51.1%,
47/92; P < 0.05). In these two studies, pregnancy rates in the GnRH-treated controls
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were unusually low, but the pregnancy rate in the progestin-treated cows was similar to
that in the present study and previous reports (Geary et aI., 2001, Thundathil et aI., 1999,
Downing et aI., 1998, Geary and Whitter, 1997). A similar improvement in pregnancy
rate was expected in the CIDR-B-treated group in Experiment 2. Although pregnancy
rate in the GnRH-treated Control cows was low, the addition of a used CIDR-B device
to the protocol did not result in an increase in pregnancy rate. The body condition of the
cows at the time of breeding suggested that fertility might be reduced (107/158 had a
BCS < 3.0), but there was no significant effect of BCS on pregnancy rate. The semen
used was produced commercially and not examined prior to use; semen quality as a
limiting factor cannot be ruled out. However, the addition of MGA to a GnRH-based
fixed-time AI program in non-lactating beef cows in Experiment 4 also did not result in
an improved pregnancy rate. It was concluded that the addition ofprogestins to a GnRH-
based fixed-time AI regimen was beneficial only in heifers.
The incidence of estrus between Days 3 and 8 in the Cosynch group in
Experiment 4 (19.5%, 17/87) seemed higher than the incidence of 'early' estrus
previously reported for cows (60/0; Roy and Twagiramungu, 1996, 1999; 13%, Seguin,
1997). In another report (Downing et aI., 1998), cows that were between Days 15 and 17
of their estrous cycle when they were given GnRH came into estrus 11 ± 19 h prior to
scheduled PGP treatment (7 days after GnRH). In the present study, the conception rate
to estrus detection and AI (82.4%) indicates that the majority of these cows had a true
and fertile estrus. Ifit were assumed that these cows would not be pregnant to the fixed-
time AI on Day 9, the pregnancy rate for this treatment group would have been 39/87
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(44.80/0), which is not significantly different from the pregnancy rate in the
Cosynch+MGA group (47.80/0). Although cows in the Cosynch+MGA group were not
observed for estrus, we speculate that the MGA may have suppressed the expression of
estrus in a number of cows that may have subsequently developed persistent follicles
(Kojima et aI., 1995; Custer et aI., 1994) resulting in a reduced pregnancy rate.
In Experiments 3 and 4, pregnancy rates to fixed-time AI were highest for EB-
treated cattle. In a previous study utilizing EB in regimens similar to those used in the
present experiments, pregnancy rates were 62 and 60% in heifers given a CIDR-B or
MGA, respectively (Section 9.0). In another study (Section 7.0), overall pregnancy rate
to fixed-time AI was 63% in 84 cows given EB or estradiol-17~ (in a 2 x 2 factorial
design) in a CIDR-B-based regimen very similar to the one used in Experiment 3.
Although the EB+progestin regimens require that the cattle be handled on four
occasions (similar to an Ovsynch program but once more than in a Cosynch program),
estrogen treatment appeared to induce an estrus more characteristic of a spontaneous
estrus (considerable mucus discharge and patent cervical canal) compared to GnRH-
treated cattle.
In conclusion, a 6- or 7-day interval from GnRH to PGF in a Cosynch regimen
resulted in similar pregnancy rates. The addition of a progestin to a Cosynch or Ovsynch
regimen resulted in a significantly improved pregnancy rate in heifers but not in cows.
Progestin-based regimens that included EB consistently resulted in high pregnancy rates
to fixed-time AI in both heifers and cows.
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11.0 THE SYNCHRONIZATION OF FOLLICULAR WAVE EMERGENCE
AND OVULATION WITH ESTRADIOL IN A TWO-DOSE
PROSTAGLANDIN PROTOCOL FOR FIXED-TIME AI IN BEEF
HEIFERS
11.1 Abstract
Prostaglandin has been used in various protocols for estrus synchronization,
resulting in conception rates after estrus detection and artificial insemination (AI) equal
to or greater than those obtained at spontaneous estrus. However, fixed-time AI after
prostaglandin is low. High fertility to fixed-time AI has been achieved in CIDR-B- or
MGA-treated heifers given estradiol to synchronize follicle wave emergence and
ovulation. The objective of this study was to determine the efficacy of two estradiol
formulations for synchronization of follicular wave emergence and ovulation in a two-
dose prostaglandin program for fixed-time AI. In Experiment 1, pubertal (confirmed by
ultrasound) Angus heifers (n = 561; 13 to 15 mo of age and weighing from 275 to 350
kg) received 500 Ilg im of cloprostenol (PGF) twice (Days 0 and 14) and were assigned
to 4 groups in a 2 x 2 factorial design. On Day 7, half were given 2 mg im estradiol
benzoate (EB) and 50 mg progesterone (P) in canola oil (EBP). The other half received
no treatment. Twenty-four hours after the second PGF injection (Day 15), the two
groups were subdivided to receive 1 mg im EB in canola oil or no treatment. All heifers
were observed for estrus twice daily from Days 13 to 17. Heifers treated with EB on
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Day 15 were fixed-time inseminated 52 h after PGF (28 h after EB). Heifers detected in
estrus more than 12 h before the appointed breeding time and those not given EB on
Day 15, were inseminated 4 to 8 h after estrus signs were first detected. All heifers not
inseminated by 72 h after PGF were given 100 Ilg im GnRH and were concurrently
inseminated. Ultrasonographic pregnancy diagnosis was done 30 to 35 d after AI. The
overall pregnancy rate was higher in heifers that received EBP than in those that did not
(61.6 vs 48.2%, respectively). Pregnancy rate was lower in heifers that received EB after
PGF than those that did not, (50.0 vs 59.8%; P = 0.02). However, 52 of 279 (19%)
heifers treated with EBP were detected in estrus early and presumably would not have
conceived to the fixed-time insemination. Although treatment with EBP on Day 7
apparently induced premature luteolysis in these heifers, they were inseminated shortly
after they were detected in estrus (and the conception rate was 44.20/0). Notwithstanding,
treatment with EBP on Day 7 resulted in a conception rate of 58.1 % after GnRH given
72 h after the second PGF treatment with fixed-time AI concurrently. In Experiment 2,
pubertal Angus heifers (n = 401) with a CL (confirmed by ultrasonography) received
500 Ilg im PGF on Day 0 (beginning of the experiment) and Day 14. Heifers were
assigned to 4 groups in a 2 x 2 factorial design. On Day 7, heifers received either no
further treatment (Control) or 1.5 mg estradiol-17~ (E-17~) and 50 mg P in canola oil
im. On Day 15 (24 h after the second PGF), heifers received either no further treatment
or 1 mg E-17~ in canola oil im, with fixed-time AI 28 h later (52 h after PGF). Heifers
that received no treatment after PGF were observed for estrus from Days 14 to 17 and
inseminated accordingly (4 to 8 h later). Heifers, not in estrus by 72 h, were given 100
Ilg GnRH im and concurrently inseminated. Pregnancy was diagnosed by
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ultrasonography 30 d after AI. Estrus rate during the first 72 h after the second PGF
treatment was higher (P < 0.05) in the E-17PP group than in the Control group.
Pregnancy rates to detected estrus were not different (P = 0.5) between the two groups
not receiving E-17P after the second PGF (51 vs 49% for NTINT and E17PINT,
respectively). The group treated only with E-17P on Day 15 tended to have the lowest (P
< 0.06) proportion of heifers pregnant to fixed-time AI (39.0%), while the E-17PP group
treated with E-17P on Day 15 had a pregnancy rate of 48.5% to fixed-time AI. There
was no significant difference among the other treatment groups. In summary,
synchronization of follicular wave emergence and ovulation in a two-dose PGF-based
protocol resulted in acceptable fertility to fixed-time AI. Although EB and E-17P were
not directly compared, both resulted in acceptable pregnancy rates to fixed-time AI after
synchronization of follicular wave emergence and ovulation. In particular, when E-
17f3P was used to synchronize follicular wave emergence, premature estrus was not
induced. Further research is necessary to assess time of ovulation after manipulation of
follicular growth with E-17(3 and progesterone in PGF-based synchronization programs
for fixed-time AI.
11.2 Introduction
Prostaglandin F2a (PGF) has been widely used for estrus synchronization (Odde,
1990; Larson and Ball, 1992). Originally, reports of a single dose, given as an
intrauterine infusion (Rowson et aI., 1972), intravenous, subcutaneous (Lauderdale,
1972) or intramuscular injection (Roche, 1974) effectively induced luteolysis, followed
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by behavioural estrus. When PGF treatment was given between Days 1 and 4 of the
estrous cycle, it did not affect corpus luteum (CL) lifespan (Lauderdale, 1972; Rowson
et aI., 1972; Momont and Seguin, 1984). Although PGF is very effective in inducing
luteolysis from Days 6 to -I6 of the estrous cycle, there is considerable variability in the
interval from treatment to estrus and ovulation (Momont and Seguin, 1984). Early
studies . were designed to ensure the presence of a susceptible CL, either by
administering a single injection PGF after detecting a CL by rectal palpation or giving
two injections ofPGF, 11 or 14 d apart (Larson and Ball, 1992). Although fertility has
been reported to be high, PGF-based protocols did not provide sufficient synchrony for
fixed-time AI (Peters, 1986).
Preliminary studies were designed to investigate follicular wave patterns and the
variation in the interval from PGF administration to estrus (Macmillan and Henderson,
1984). The effect of day of PGF treatment on the selection and development of the
ovulatory follicle was investigated by Kastelic et al. (1990a). When PGF was given on
Days 5 or 8 after ovulation, the dominant follicle of the first follicular wave ovulated in
2 or 3 days, whereas PGF administration on Day 12 after ovulation resulted in ovulation
of the dominant follicle of the second follicular wave 5 days later. Therefore, the length
of the interval from PGF treatment to estrus and ovulation depends on the stage of
development of the dominant follicle at the time of treatment; t4is is the basis of the
variability in the interval from treatment to estrus and ovulation in cattle treated at
random days of the estrous cycle.
Estrogens have been used to increase the synchrony of estrus in PGF-based
estrus synchronization programs. Treatment with 0.4 mg estradiol benzoate (EB) 40 or
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48 h after PGF administration to cyclic beef cows reduced the variation in the interval
from PGF to LH release and onset of estrus (Welch et aI., 1975). In another study, this
protocol tended to increase the proportion of lactating dairy cows in estrus within 5 d
after PGF treatment (Dailey et aI., 1986). However, it did not affect estrus rate in dairy
heifers (Dailey et aI., 1986) or beef cows and heifers (Peters et aI., 1977). In these
studies, synchronization of estrus and ovulation was attempted without synchronization
of follicular development; and thus, there were no effects on pregnancy rates; fixed-time
AI was not investigated.
More recently, treatments to Control the timing of follicular wave emergence,
such as estradiol or estradiol plus progesterone combinations (B6 et aI., 1995a), GnRH
(Twagiramungu et aI., 1995; Pursley et aI., 1995; Thatcher et aI., 1993; Kastelic and
Mapletoft, 1998), pLH (Section 10.0), or hCG (Schmitt et aI., 1996a), have been
incorporated into estrus synchronization programs with the objective of synchronizing
the recruitment of a growing dominant follicle. Approximately 4 to 5 d after emergence
of a new follicular wave, PGF treatment was administered and progesterone was
removed, and the dominant follicle ovulated approximately 3 to 4 d later (Martinez et
aI., 2000). In these protocols, ovulation of the dominant follicle is often synchronized by
a second treatment with estradiol (sections 6.0, 9.0), GnRH (sections 9.0, 10.0), pLH
(sections 9.0, 10.0) or hCG (Schmitt et aI., 1996a), followed by a single, fixed-time
insemination.
High fertility to fixed-time AI has been achieved in CIDR-B- or MGA-treated
heifers given EB (EB) to synchronize follicle wave emergence and ovulation (sections
5.3, 6.0, 7.0). The manipulation of follicular growth and ovulation with estradiol in a
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traditional two-dose PGF protocol has not yet been studied. The objective of this study
was to determine the efficacy of estradiol treatments administered to synchronize
follicular wave emergence and ovulation for fixed-time AI in a two-dose PGF protocol.
11.3 Materials and methods
11.3.1 Experiment 1
Pubertal Angus heifers (n = 561; 13 to 15 mo of age and 275 to 350 kg) with a
CL (confirmed by ultrasonography) that had been in a feedlot for approximately 7 mo
and were fed approximately 5 kg barley silage and 1 kg of rolled barley/animaVd were
used. Heifers received 500 J.1g im of cloprostenol (PGF, Estrumate; Schering-Plough,
Pointe Claire, PQ, Canada) on Day 0 (beginning of the experiment) and Day 14, and
were assigned to 4 groups in a 2 x 2 factorial design. On Day 7, half of the heifers were
assigned to receive no treatment (Control group) and half received 2 mg estradiol
benzoate (EB) and 50 mg progesterone (P; both from Sigma-Aldrich Canada Ltd, ON,
Canada) in canola oil im (EBP group). Half of the heifers in each group received 1 mg
im EB in canola oil 24 h after the second PGF (Day 15). All heifers were observed for
estrus twice daily from Days 13 to 17. Heifers treated with EB on Day 15 were fixed-
time inseminated 28 h later (52 h after PGF). Heifers detected in estrus more than 12 h
before the appointed breeding time and those not given EB on Day 15 were inseminated
4 to 8 h after onset of estrus. All heifers not inseminated by 72 h were given 100 Jlg im
GnRH (Cystorelin; Merial Can. Inc, Victoriaville, PQ, Canada) and concurrently
inseminated. Pregnancy diagnosis was performed by ultrasonography 30 to 35 dafter
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AI. Conception rate was calculated as the number of heifers that became pregnant from
the total of heifers that were inseminated. Pregnancy rate was calculated as the number
of the heifers that became pregnant As the data were considered to be coming from four
different treatment protocols with two of them including GnRH, which modified the
original 2x2 factorial design, a Chi-square test was used to compare proportion of
pregnant animals. Proportional data were compared among groups by Mantel-Haenszel
Chi-square test and the interval from the second PGP treatment to estrus was analyzed
by two-way analysis of variance. Bartlett's test was used to test homogeneity of
variances (Nonnan and Streiner, 2000). All statistical analyses, except Mantel-Haenszel
test, were conducted with a current statistical program (Statistix Student Version,
version 2.0, Analytical Software, Tallahassee, Florida, USA).
11.3.2 Experiment 2
Pubertal Angus. heifers (n = 401; similar age and weight and in the same housing
conditions as in Experiment 1) with a CL (confirmed by ultrasonography) received 500
Jlg im PGP on Day 0 (beginning of the experiment) and Day 14, and were assigned to 4
groups in a 2 x 2 factorial design. On Day 7, half of the heifers were assigned to receive
no treatment (Control group) and the other half received 1.5 mg estradiol-17P (E-17P;
Sigma-Aldrich Canada Ltd) and 50 mg P in canola oil im. Half of the heifers in each
group received 1 mg im E-17P in canola oil 24 h after the second PGP (Day 15). All
heifers were observed for estrus twice daily from Days 14 to 17. Heifers treated with E-
17P on Day 15 were fixed-time inseminated 28 h later (52 h after PGP). Heifers detected
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in estrus more than 12 h before the appointed breeding time were inseminated 4 to 8 h
after first estrus detection. All heifers not inseminated by 72 h received 100 Jlg im
GnRH and were concurrently inseminated. Pregnancy was diagnosed by
ultrasonography 30 to 35 d after AI. Statistical analyses were perfonned the same as in
Experiment 1.
The protocols for these experiments were approved by University of
Saskatchewan Animal Care Committee.
11.4 Results
11.4.1 Experiment 1
Results are shown in Tables 11.1 and 11.2. There were 52 of 279 heifers treated
with EBP (19%) that were detected in estrus more than 12 h before the appointed AI
time (Table 11.1) and they were considered as non-pregnant to fixed-time AI. Estrus
rate differed among groups (P = 0.01); in the heifers treated with EBP, those also treated
with EB were 1.65 times more likely to be in estrus than those that were not. There was
no effect of treatment on the proportion of heifers detected in estrus that became
pregnant (P = 0.16). However, when groups were pooled by treatment, pregnancy rate
was higher in heifers that received EBP, whether or not they received EB after PGF
(61.6 vs 48.20/0, P < 0.001). Pregnancy rate was lower in heifers that received EB after
PGF, regardless ofwhether they received EBP (50.0 vs 59.8%, P = 0.02).
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Table 11.1 Estrus and conception rates in Control (NT/NT) heifers or those treated
with estradiol benzoate (EB) and progesterone (P) to synchronize follicular
wave emergence and/or EB to synchronize of ovulation in a two-injection,
PGF-based program for fixed-time AI.
Treatment
No. ofheifers
No. ofheifers in estrus
(Conception rate (0/0)
NT/NT
142
EBP/NT
139
NTIEB
140
EBP/EB
140
Pre-second PGF (Day 14) 0 11
(27.3)
o 18
(22.2)
Post-second PGF (Day 14)
12-24 h
36-48 h
60-72 h
6
(O.o)a
39
(64.1)a
33*
(72.7)
15
(73.3)b
25
(72.0)a
45*
(84.4)
o
89
(47.2)b
o
8
(62.5)b
73
(58.9)ab
o
ab Within a row, values with different superscripts are different (P < 0.05).
* These heifers were treated with 100 IJ.g GnRH 72 h after the second injection of PGF
and concurrently fixed-time inseminated.
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Table 11.2 Estrus, conception, and conception rates (0/0), and mean (± SEM) interval
from the second PGF treatment to estrus in Control (NT/NT) heifers or
those treated with estradiol benzoate (EB) and progesterone (P) to
synchronize follicular wave emergence and/or EB to synchronize of
ovulation in a two-injection, PGF-based program for fixed-time AI.
NT/NT EBP/NT NT/EB EBPIEB
No. of heifers
Interval PGF to estrus (h)
Estrus rate*
Conception rate
in estrous heifers
No. ofheifers not in estrus
Conception rate
in non-estrous heifers
Conception rate
to fixed-time AI**
Overall pregnancy rate
142 139 140 140
50 ±1.2a x 48 ± 1.4ab x 45 ± O.4be Y 42± 0.8e z
54.9 69.1 63.6 70.7
62.8 72.9 47.2 52.5
64 43 51 41
37.5 58.1 41.2 61.0
37.5a 58.1b 45.0ab 48.6ab
51.4a 68.3b 45.0a 55.0a
ab Means and xyz variances with different superscripts are different (P < 0.05).
* Detection of estrus until 72 h after the second dose ofPGF.
** Pregnant to the fixed-time AI done at the same time as treatment with GnRH at 72 h
after the second PGF in the heifers that received no treatment following the second PGF
injection or to the fixed-time AI at 28 h after 1 mg EB (52 h after the second PGF
treatment) without regard to estrus. Heifers that showed estrus more than 12 h before the
fixed-time for AI in the EBP/EB group were considered as non-pregnant to fixed-time
AI.
NT = no treatment.
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11.4.2 Experiment 2
Results are shown in Table 11.3. Estrus rate during the first 72 h after the second
PGF treatment was higher (P < 0.05) in the E-17~PINT group than in the Control group;
the other two groups were not observed for signs of estrous behaviour. Pregnancy rates
in the two groups in which estrus detection was done were not different (P = 0.5).
Although pregnancy rates to fixed-time AI did not differ (P = 0.28) among groups, the
NTIE-17P group had the least number ofheifers pregnant to fixed-time AI.
Table 11.3 Estrus, conception and conception rates (%) in Control (NTINT) heifers or
those treated with estradiol-17P (E-17P) and progesterone (P) to
synchronize follicular wave emergence and/or E-17P to synchronize
ovulation in a two-injection, PGF-based program for fixed-time AI.
Treatment NTINT E-17PPINT NTIE-17P E-17PPIE-7P
No. ofheifers
Estrus rate
Conception rate
in estrous heifers
Conception rate
to fixed-time AI*
Overall pregnancy rate
100
50.0
51.2
5l.0e
100
60.0
40.0
49.0ed
100
ND
39.0
39.0d
101
ND
48.5
48.5ed
Percentages with different superscripts differed ab (P < 0.05); ed (P = 0.065).
NT = no treatment; ND = not determined.
* Heifers of Control and E-17PPINT groups that were not detected in estrus were fixed-
time inseminated and concurrently given 100 Jlg GnRH 72 h after the second PGF
treatment, whereas heifers treated with E-l 7~ 24 h after the second PGF treatment were
inseminated 28 h later (52 h after PGF).
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11.5 Discussion
To our knowledge, the use of the combination of estradiol and progesterone to
synchronize follicular wave emergence, and estradiol to induce ovulation in a 2-
injection PGF-based synchronization program for fixed-time AI, has not previously
been reported. Pregnancy rates to detected estrus or fixed-time AI with both estradiol
formulations in the two experiments were acceptable, especially when follicular wave
emergence was synchronized.
Estradiol-17~ has been used to synchronize follicular wave emergence in
progestin-treated beef heifers (B6 et aI., 1994, 1995a,b). However, in the absence of
endogenous and exogenous progestins, E-17~ induced an LH surge that was associated
with rescue of the dominant follicle present at the time of treatment (B6 et aI., 1994).
Based on previous studies, the interval from the first PGF treatment at random stages of
the estrous cycle to ovulation varied by at least 3 d (Kastelic et aI., 1990a). Therefore, at
the time of estradiol plus progesterone treatment on Day 7, these heifers would have
been at varying stages of metestrus or early diestrus. As circulating progesterone
concentrations may have not been sufficiently high to prevent an estradiol-induced LH
surge, progesterone was injected along with estradiol. In other studies in our laboratory,
we have successfully used the combination of 100 mg progesterone with 5 mg E-17P or
1 mg EB to synchronize follicular wave emergence at random stages of the estrous cycle
(Section 6.0).
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When 2 mg EB was administered on Day 7 in Experiment 1, the expression of
estrus in heifers prior to the second PGF and the increased variability of the interval
from the second PGF to estrus were attributed to hastening uterine-induced luteolysis.
These heifers were inseminated based on behavioural estrus and were considered not
pregnant to fixed-time AI. The dose of EB used had been derived from reports that
suggested that an intermediate dose of 2.5 mg of EB induced a more synchronous
emergence of the next follicular wave (in CIDR-B-treated cattle) than either 1 mg or 5
mg EB (Caccia and B6, 1998). However, in this study the CIDR-B devices would have
prevented animals from expressing estrus and ovulating, even though the EB may have
induced luteolysis. Cows used had greater body mass and hormone-metabolizing
capacity that may have resulted in EB not inducing luteolysis.
Estrogens have been shown to have luteolytic properties when given alone or in
association with progestins (Wiltbank et aI, 1961; Wiltbank and Kasson, 1968; Munro
and Moore, 1985). Treatment of beef heifers on Days 3, 10 or 17 after estrus with 5 mg
EB decreased blood progesterone concentrations from 2 to 5 d after treatment (Munro
and Moore, 1985). The intravaginal use of the crystalline form of EB (10 mg; slow
release) has also been reported to induce luteal regression in progestin-based estrus
synchronization programs (Macmillan et aI., 1991; Burke et aI., 1999). However, Burke
et aI. (2000) have also shown that a dose of 1 mg EB given im on Day 13 of the estrous
cycle in Holstein cows caused a decline in circulating progesterone concentrations
between 24 and 48 h after treatment and hastened regression of the CL. Therefore, even
a small dose of EB may affect progesterone profiles even though luteolytic effects
increase when the dose ofEB is increased (as in our experiment).
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Based on the assumption that EB treatment would induce premature luteolysis in
some heifers, 1.5 mg E-l7~ was administered (along with progesterone) on Day 7 to
synchronize follicular wave emergence in Experiment 2. Characteristics of plasma
estradiol concentrations 'after E-l7~ treatment are different from those after EB
treatment, as confinned by studies in both ovariectomized (section 5.0) and intact (B6 et
aI., 2000a) cattle. Plasma estradiol concentrations reached a higher peak and declined
more rapidly after an injection of E-l7P as compared to the same dose of EB (section
5.0). When 1 mg E-17~ was given to norgestomet-treated heifers, emergence of the next
follicular 'wave occurred earlier than in Control heifers (B6 et aI., 2000a). Doses less
than 1 mg E-1 7~ were considered to have an inconsistent effect in dominant follicle
suppression (B6 et aI., 2000a). In Experiment 2, luteolysis apparently did not occur after
the administration of E-17~, as there were no heifers detected in behavioural estrus
before the second treatment with PGP on Day 14 (or even before the second E-17P
treatment on Day 15).
The use of estradiol on Day 15 not only resulted in an increased proportion of
cattle expressing estrus, but also reduced the variability in the interval to estrus in both
experiments. It has been reported that EB treatment reduced the variation in the time of
LH release and the onset of estrus, and increased the number of cattle detected in estrus
within a target period of 56 to 86 h after PGP injection (Welch et aI., 1975). However,
conception rates remained similar to those in the animals not receiving EB (Peters et aI.,
1977; Welch et aI., 1975). The administration of estradiol following a two-dose
prostaglandin protocol would appear to only synchronize ovulation when follicular wave
emergence had also been synchronized i.e., a mature dominant follicle was present at the
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time of treatment. If the emergence of follicular waves is not synchronized, the
probability of synchronous ovulation as a result of a large dominant follicle responding
to the estradiol-induced LH surge will be very much reduced resulting in poor
pregnancy rates to fixed-time AI. When follicular waves and ovulation were
synchronized, pregnancy rates to fixed-time AI were comparable to Control groups with
AI after estrus detection.
Previous studies have shown that fixed-time AI 72 and 96 h after the second
PGP injection in a two-dose treatment protocol resulted in calving rates (43%) that were
lower than in untreated Controls inseminated at detected estrus (49.1 %; Roche and
Prendiville, 1979). In another trial, pregnancy rate in cows following a two-injection
PGP treatment protocol with fixed-time AI at 72 and 96 h (31.6%) was poor compared
to that in cows treated with a single dose of PGP and inseminated at estrus (47.8%;
Roche and Prendiville, 1979). More recently, Slenning (1992) reported a low (21 0/0)
pregnancy rate following a single insemination by appointment after PGP treatment and
when GnRH treatment, was administered at 48 h with insemination 16 to 20 h later in a
two-dose PGP regime, pregnancy rate was also low (27%). In the present study, two
doses of PGP 14 d apart, followed by GnRH and AI at 72 h resulted in acceptable
pregnancy rates (37.5 and 51.2%; Experiments 1 and 2, respectively). The interval of72
h after the second PGP provided sufficient time for further growth of dominant follicles
emerging spontaneously in cattle in which follicular wave emergence was not
synchronized. The combination of GnRH and fixed-time AI 72 h after the second PGP
could be an interesting alternative to maintain acceptable fertility in a two-PGP
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synchronization protocol, avoiding additional estrus detection and AI for longer periods
of time.
In summary, fixed-time AI was successful in a PGF-based synchronization
program in which follicular wave emergence and ovulation were synchronized. It is
noteworthy that ~onception rates to fixed-time AI were consistently high when E-17~
was used, whereas EB apparently induced luteolysis in some animals and .effective
synchronization of estrus and ovulation was not achieved. Although EB and E-I 7~ were
not directly compared, both resulted in acceptable pregnancy rates to fixed-time AI after
synchronization of follicular wave emergence and ovulation. Further studies are needed
to detennine the most appropriate dose of EB, which will effectively synchronize
follicular wave emergence in all cattle without causing premature luteolysis. Results
clearly showed that synchronization of follicular wave emergence was necessary if the
objective was the use of an ovulation synchronization program for fixed-time AI in
PGF-treated cattle.
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12.0 GENERAL DISCUSSION
In the last 60 years, AI has relied on visual estrus detection. Using this method,
cattle are observed at different times during the day for signs of estrus and inseminated
within 12 h of standing estrus. The most common schedule of AI in a herd has been the
AM-PM rule, in which cattle detected in estrus in the morning are inseminated the
afternoon of the same day and cattle detected in the afternoon are inseminated the next
morning. The laborious and tedious task of estrus detection has an efficiency, which has
been reported at 50% or less (Stevenson and Britt, 1977; Nebel, 2000). Poor estrus
detection efficiency also results in the insemination of cattle with high circulating
progesterone concentrations (i.e., 19%; Sturman et aI., 2000). In an extensively managed
beef cattle operation, it is necessary to bring the cattle from the pasture, sort cows from
calves, and sort those detected in estrus to be inseminated. Estrus detection and sorting
are performed repeatedly in beef cattle herds throughout the breeding season.
Traditional methods of estrus synchronization (such as two-dose of PGF 11 or
14 days apart) can reduce the number of days that estrus detection must be performed.
However, variation of the interval from the last PGF treatment to estrus remains
substantial (approximately 2 to 7 days). Both the required ·management and the
inaccuracy of visual estrus detection contribute to the lack of interest in the use of AI by
beef cattlemen. The use of AI is very low in beef cattle (5% of Canadian beef herds),
especially when compared to the dairy industry (70% of Canadian dairy herds). The use
of AI will be become increasingly attractive to beef producers with the availability of
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new protocols that involve fewer treatments, less handling and sorting, avoid estrus
detection, facilitate fixed-time AI, and result in high pregnancy rate.
Fixed-time AI has been used since the 1970's. Using a two-dose PGF-based
protocol with double inseminations at 72 and 96 h after the second PGF treatment,
conception rates were similar to those in Control cattle with AI after estrus detection
(Lauderdale, 1975). However, later reports suggested that this protocol did not result in
acceptable pregnancy rates (reviewed by Peters, 1986; Larson and Ball, 1992).
Therefore, the protocol of two PGF injections 11 to 14 days apart followed by two
inseminations was not adopted as a regular synchronization program (Peters, 1986). In
addition, two inseminations considerably increased the cost of the AI program. The
combinations of progestins with PGF or progestins with estradiol as a luteolytic agent
for timed AI have also been used, but again pregnancy rates have been less than
satisfactory (Larson and Ball, 1992).
More recently, ultrasonographic imaging of the ovaries has increased knowledge
of follicular and luteal dynamics in cattle (Pierson and Ginther, 1984). Ultrasound
monitoring of ovaries has enabled the identification of different stages of follicular
development as the cause of variability in estrus and ovulation after PGF treatment
(Kastelic et aI., 1990a). In addition, it was determined that the low fertility reported after
progestin-based synchronization protocols (Odde, 1990) was due to the development of
persistent follicles that ovulated aged oocytes (Smith and Stevenson, 1995; Cooperative
Regional Research Project, 1996). Effects of hormonal (estradiol, progesterone, GnRH,
LH) or mechanical (follicular ablation) treatments on the follicular population have been
also investigated (Macmillan and Thatcher, 1991; B6 et aI., 1995a; Bergfelt et aI. 1994;
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Twagiramungu et aI., 1995; Martinez et aI., 1999). Treatments that resulted in atresia
(estradiol and progesterone) or ovulation (GnRH or LH) of the dominant follicle
(including persistent follicles) induced the emergence of a new follicular wave. These
treatments also reduced, in part, the variation in the interval from PGP treatment to
estrus and to ovulation (reviewed in Section 2.0). Based on these results, a new
generation of protocols has been developed with acceptable fertility to AI at detected
estrus (Twagiramungu et aI., 1992; B6 et aI., 1995a; Martinez et aI., 2000). Although
protocols have been designed to synchronize estrus and ovulation (reviewed in Section
2.0), a' treatment for the synchronization of both follicular wave emergence and
ovulation was not included in the same protocol.
The recently developed GnRH-based Ovsynch (ovulation synchronization)
program involves two GnRH treatments; the first treatment (given 7 days before PGP
injection) is to synchronize follicular emergence, while the second treatment (2 days
after PGP injection) is to induce ovulation of the newly recruited dominant follicle.
Therefore, this protocol allows for the use of fixed-time AI. Results obtained after the
use of this protocol in dairy (Pursley et aI., 1995) and beef (Geary et aI., 1998) cattle
were promising (the need for estrus detection was eliminated and fertility to fixed-time
AI acceptable was acceptable). However, Ovsynch protocols have not been effective in
heifers, which has been attributed to the failure of the first GnRH treatment to induce
ovulation and/or synchronization of follicular wave emergence. The Ovsynch protocol
has resulted in pregnancy rates to fixed-time AI that have varied from 32 to 55% in
lactating dairy cattle (Pursley et aI., 1995, 1997; Jemmeson, 1998) and from 40 to 530/0
in lactating beef cattle (Geary et aI., 2001; Small et aI., 2001), whereas pregnancy rates
172
to the same program in heifers varied from 250/0 (Schmitt et aI., 1996b) to 35%> (Pursley
et aI., 1997). Based on these results, there was still a need for the development of new
protocols that not only included fixed-time AI, but also resulted in pregnancy rates
comparable to AI after estrus detection in cattle in all physiological states. The objective
of an ovulation synchronization program for fixed-time AI is to ensure the presence of a
healthy dominant follicle at the time of treatment for ovulation, which may then be
induced to ovulate within a short interval. Upon ovulation, a healthy oocyte will be
ready for fertilization by a single insemination at a predetermined time. Therefore, a
protocol for ovulation synchronization requires control of both the luteal phase and
follicular growth (synchronization of follicular wave emergence) as well as the
induction of ovulation after progesterone removal.
The overall objective of the work reported in this thesis was the development of
new methods of synchronization of ovulation to facilitate fixed-time AI in cattle. Since
control of follicular growth plays an important role in these methods, different
approaches to the synchronization of follicular wave emergence were investigated. A
detailed description of the effect of the most successfully applied techniques of follicular
wave synchronization have been presented, as well as the effect of estradiol, GnRH, and
LH treatments on fertility after fixed-time AI. In addition, synchronization programs
based on progestins and PGP were examined.
173
12.1 Effects of estradiol and progesterone on follicular development for
synchronization protocols.
Ovarian steroid honnones (estradiol and progesterone) influence the synthesis
and secretion of pituita.ry gonadotrophins (LH and FSH). During the bovine estrous
cycle, gonadal ~teroid production is characterized by high progesterone and low
estradiol concentration in the circulation, while at the end of the estrous cycle, the CL
regresses and the dominant follicle of the last follicular wave becomes preovulatory,
secreting increasing amounts of estradiol. Therefore, the proestrous period is
characterized by declining concentrations of progesterone and increasing concentrations
of estradiol. As a result, LH pulse frequency increases, concluding in an LH surge
concurrently with the onset of estrus. Estrogens (from follicles) and progesterone (from
the CL) influence gonadotrophin secretory patterns during the estrous cycle and also
affect follicle growth and development of the CL.
The use of ovarian steroids to manipulate follicular development has been
reviewed (Section 2.0) and reported in this thesis. Previous studies showed that the
combination of 5 mg E-l 7~ and progestin implants synchronized the emergence of a
new follicular wave (B6 et aI., 1995a). We have also observed that the effect of estradiol
on gonadotrophin~ and follicular wave emergence depended on the dose and form of
estradiol used. Treatment with 1 mg E-17~ resulted in the emergence of a new follicular
wave with more variability (3 to 5 days after treatment) than 5 mg E-17~ (3 to 4 days
after treatment) in CIDR-B treated cows (Section 6.0). In contrast, treatment with 1 mg
EB resulted in the emergence of a new follicular wave with less variability than 5 mg
EB (Section 6.0). In another experiment (Section 6.0), treatment with 5 mg E-17~ or 1
174
mg EB given along with 100 mg progesterone at CIDR-B insertion in beef heifers
resulted in a new follicular wave 3 to 4 and 3 to 5 days later, respectively. Burke et al.
(2001) observed that 1 mg EB 500 Kg-1 body weight (BW) resulted in a mean interval of
3.1 ± 0.1 days from treatment to the emergence of a new follicular wave. These studies
showed that the dose and form of estradiol were important aspects to consider in the
synchronization of follicular wave emergence in CIDR-B treated cattle.
It was hypothesized that the effect of estradiol and progestins on the follicle
development consisted of two principal mechanisms: 1) suppression of follicles, and 2)
induction of emergence of a new follicular wave. The first mechanism would depend on
estradiol suppressing plasma FSH concentrations causing regression of follicles prior to
the time of selection of the dominant follicle, whereas the suppression of plasma
concentrations and pulsatility of LH by progesterone would be associated with the
regression of the selected dominant follicle which has been reported to occur (3 days
after wave emergence, Ginther et aI., 1996b). The second mechanism (induction of
follicular wave emergence) would depend only on the decline of plasma estradiol
concentrations, which would result in resurgence of plasma FSH concentrations in a
surge-like manner and emergence of a new follicular wave.
One of the proposed suppressive mechanisms of estradiol treatment was the
inhibition of follicular growth by suppression of FSH, before selection of the dominant
follicle. Treatment with 5 mg E-17~ in ovariectomized beef cows resulted in
suppression of plasma FSH concentrations within 6 h, with resurgence after 24 h,
reaching concentrations similar to pre-treatment levels at 48 h after the estradiol
injection (Section 5.0). A similar profile in plasma FSH concentrations was achieved
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after an injection of 5 mg E-17~ in progestin-treated intact heifers (B6 et aI., 1994) or
after the injection of 1 mg of EB in ovariectomized cattle (Section 5.0, O'Rourke et aI.,
2000). Since 5 mg E-17~ and I mg EB resulted in similar FSH profiles, these treatments
may result in similar synchrony of follicular wave emergence, similar to that obtained in
intact heifers (Section 6.0). It has also been documented that estradiol treatment in
ovariectomized heifers resulted in decreased plasma FSH concentrations (Price and
Webb, 1988). In intact animals, after treatment with estradiol, follicles do not reach a
diameter greater than 8 mm (size at follicular growth divergence) and go to atresia, as
demonstrated by the reduction in diameter during the subsequent days (B6 et aI., 1994).
There is clear evidence that this suppression is exerted via reduction of plasma FSH
concentrations, which affect FSH-dependent follicles.
The mechanism of progesterone-induced suppressIon of follicular growth is
apparently through inhibition of pituitary secretion of LH that resulted in atresia of a
selected dominant follicle. In intact animals, plasma LH concentrations are influenced
by progesterone secretion by the CL. High concentrations of progesterone during mid-
luteal phase were shown to inhibit LH release; however, plasma progestin
concentrations after treatments at recommended doses for estrus synchronization did not
appear to cause the same suppression on LH release (Kojima et aI., 1995). It has also
been shown that treatment with progesterone-impregnated devices reduced LH pulse
frequency and mean plasma LH concentrations in ovariectomized heifers (Price and
Webb, 1988).
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In our studies in ovariectomized cows, progesterone from the CIDR-B devices
suppressed plasma LH concentrations from 36 to 72 h after insertion, when the
stimulatory effect of estradiol (given at the beginning or one day after the CIDR-B
insertion) on LH disappeared (Section 5.0). Other studies have shown that daily
injections of progesterone in intact heifers caused atresia of the dominant follicle in a
dose-dependent manner (Adams et aI., 1992b). An injection of 100 mg progesterone in
oil or in saline, or a CIDR-B device for 24 h in norgestomet-implanted Zebu heifers also
resulted in suppression of the dominant follicle present at treatment and reduced
variability in the interval to the emergence of the ovulatory wave compared to the
Control group receiving no treatment (Cavalieri et aI., 1998). It is noteworthy that
follicular waves emerged earlier in heifers treated with CIDR-B devices than in those
treated with an injection of progesterone (Cavalieri et aI., 1998). The effect of CIDR-B
on follicular dynamics was probably due to a longer duration of elevated plasma
progesterone concentrations, whereas a progesterone injection would result in a peak
followed by a continuous decline. In addition, 200 mg progesterone resulted in increased
plasma progesterone concentrations more than 1 ng/mL in heifers during the follicular
phase of the estrous cycle and regression of persistent follicles in MGA-treated cattle
(Anderson and Day, 1994). In our studies, a single injection of 100 mg progesterone in
ovariectomized cows increased plasma progesterone concentrations by 2 ng/mL over 24
h, but caused no decrease in plasma LH concentrations (Section 5.0), probably due to a
strong effect of estradiol injected concurrently. Insertion of a CIDR-B device appeared
to have an extended effect on plasma LH concentrations (-72 h after insertion).
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It has been shown that LH receptor mRNA is expressed in granulosa cells of
dominant follicles only after Day 3 following ovulation (Xu et aI., 1995), around the
time selection of a dominant follicle occurs (Ginther et aI., 2000). Therefore, the
dominant follicle becomes LH-dependent and plasma LH concentrations may be critical
to maintain dominance. As an example of dominant follicle regression, the insertion of a
CIDR-B device in beef heifers resulted in the emergence of a new follicular wave 2 to 5
days later in 72% of the heifers (Martinez et a1., 2000). If there were heifers with an LH-
dependent dominant follicle, the steady increase and maintenance of plasma
progesterone concentrations by CIDR-B devices may have affected circulating LH
concentrations at least for the first 3 days after insertion as occurred in ovariectomized
cows, (Section 5.0). This suppression of plasma LH concentrations caused atresia of the
dominant follicle, resulting in an FSH surge and emergence ofa new follicular wave.
Our results in Section 5.0 and previous results reported by Macmillan et al.
(1991) showed that progesterone release from a CIDR-B device over the first 3 days
after insertion was equivalent to that reported between days 11 and 15 of the estrous
cycle (Kesner et aI., 1982). Injection of 100 mg progesterone resulted in a significant
increase in plasma progesterone concentrations in CIDR-B-treated cows or those that
did not receive a CIDR-B device (Section 5.0). However, the increase in plasma
progesterone in both groups of cows was not sufficient to prevent t)le LH surge induced
by the treatment with 5 mg E-17~. It has been also reported that doses ranging from 0.25
to 10 mg E-1 7~ induced LH release in ovariectomized cows that received exogenous
progesterone given in the form of implants 2 to 9 days before the estradiol treatment
(Short et aI., 1973). In the same study, it was shown that the estradiol-induced LH surge
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was prevented in progesterone-treated intact cattle with>1 ng/mL plasma progesterone.
These results in intact cattle were confinned by a study in which an injection of 5 mg E-
17~ did not result in an LH surge in heifers that received a norgestomet implant one day
prior to treatment (B6 et aI., 1994). The differences in the responses obtained in these
experiments may be explained by the status of cattle, i.e., ovariectomized (Section 5.0)
vs intact (B6 et aI., 1994).
The second mechanism that contributes to emergence of the next follicular wave
after treatment with estradiol and progesterone was attributed to the FSH surge, which
depended on the duration of plasma estradiol concentrations. After treatment with 5 mg
E-17~ in CIDR-B treated cattle, at random stages of the estrous cycle, a new follicular
wave emerged 3 to 4 days later (Section 6.0). When 5 mg E-17~ was administered in
CIDR-B-treated ovariectomized cows, plasma estradiol concentrations decreased to
baseline 36 h after treatment; this resulted in resurgence of plasma FSH concentrations
to pretreatment concentrations by 42 to 48 h after treatment (Section 5.0). Similar
profiles of plasma FSH concentrations were also observed after injection of 5 mg E-17~
in intact heifers (B6 et aI., 1994). It has been reported that FSH surges occur one day
before the emergence of a follicular wave in estradiol-treated females (B6 et aI., 1994),
as has been observed in spontaneous follicular waves during the estrous cycle (Adams et
aI., 1992a). Therefore, the interval from treatment with 5 mg E-17~ to the emergence of
the next follicular wave (approximately 4 days in norgestomet-treated heifers reported
by B6 et al. (1995a) and in Section 6.0) was consistent with the time of resurgence of
plasma FSH concentrations observed in ovariectomized cows (Section 5.0) and intact
heifers (B6 et aI., 1994). The interval from estradiol treatment to follicular wave
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emergence was 4.3 days, regardless of day of treatment during the first follicular wave
(Bo et aI., 1995a). This is explainable by resurgence of FSH that followed estradiol-
induced FSH suppression, depending on the circulating life-span of estradiol.
All estradiol formulations tested in this thesis suppressed plasma FSH
concentrations, which remained low for varying periods, depending on the half-life of
the estradiol form used. In Experiment 4 (Section 5.0), the administration of 5 mg E-
17~, EB or estradiol valerate (EV) resulted in similar low circulating FSH
concentrations by 12 to 36 h; however, FSH levels began to increase earlier and by 60 h
were higher in E-17~- than in EB- or EV-treated ovariectomized cows (Section 5.0).
Interestingly, the increase of plasma FSH concentrations in EB or EV groups was
concomitant with relatively high concentrations of plasma estradiol (Section 5.0).
Treatment with 5 mg EB induced a delayed and more variable day of follicular wave
emergence than 5 mg E-17~ or 1 mg EB (Section 6.0), or 2.5 mg EB (Caccia and Bo,
1998). These results supported the notion that high doses of the long-acting estradiol
esters result in a delayed and more variable interval from treatment to follicular wave
emergence in CIDR-B-treated cattle. This may be a consequence of a delay in the
resurgence of FSH surge because of an extended suppression of FSH by EB or EV
treatment.
By reducing the dose of long-acting estradiol esters, the interval from treatment
to emergence of the new follicular wave can be made shorter and less variable. As
mentioned above, a dose of 1 mg EB in ovariectomized cows resulted in a similar
pattern of plasma FSH suppression to 5 mg E-17~ and the interval to the emergence of
the next follicular wave (3 to 5 days) was similar in intact heifers (Section 5.0, 6.0). This
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pattern was also observed in ovariectomized heifers treated with 1 mg EB (O'Rourke et
aI., 2000). It has also been reported that the administration of 1 mg of EB on Day 13 of
the estrous cycle in dairy cows resulted in sYnchronization of follicular growth,
confinned by the emergence of a third follicular wave (Burke et aI., 1999). These
findings were confirmed by our studies in CIDR-B-treated heifers; the injection of 1 mg
EB resulted in sYnchronous emergence of a new follicular wave (Section 6.0). Based on
the results after a reduced dose of EB in our studies, we speculate that the administration
of reduced doses of EV may also result in a more precise interval to follicular wave
emergence. The use of a reduced dose of EV has not been explored in intact animals
Future studies to evaluate the effectiveness of reduced doses of EVon the manipulation
of follicular development are necessary.
It was observed that when estradiol plus progesterone treatment was
administered at the end of the luteal phase, it failed to cause atresia of the dominant
follicle and synchronize follicular wave emergence. In CIDR-B-treated cattle, when
follicular wave emergence occurred prior to treatment and spontaneous regression of the
CL had already commenced, treatment with 5 mg E-17P or 1 mg EB was unsuccessful
to synchronize follicular wave emergence (Section 6.0). In previous studies, E-17P
given on Days 1, 3, or 6 after ovulation in norgestomet-treated intact heifers, suppressed
follicular growth and the emergence of a new follicular wave was. synchronized in 94%
of heifers (B6 et aI., 1995b), whereas in the remaining 6% of heifers, new wave
emergence did not occur. Studies on the effect of estradiol or estradiol and progesterone
given at the end of the estrous cycle are needed.
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In earlier 12-day PGF-based estrus synchronization studies, EB was given 40 to
48 h after the second PGF injection, resulting in increased numbers of cattle in estrus,
but pregnancy rates to AI were not increased (Peters et al.~ 1977). Treatment with EB
also resulted in more heifers in estrus within 48 h after PGF treatment in a CIDR-B-
based protocol (Hanlon et aI., 1996). Treatment with E-17P in intact heifers with low
plasma progesterone concentrations resulted in an LH surge by 18 to 24 h (Bo et aI.,
1994) and in ovariectomized cattle by 20 to 32 h (Hausler and Malven, 1976). Recently,
it has been reported that treatment with EB 24 to 30 h after CIDR-B removal resulted in
a synchronous LH surge at 20 h in cows (1 mg) and 16 h in heifers (0.38 or 0.75 mg;
Lammoglia et aI., 1998). In our studies, the length of the interval from estradiol
treatment to the LH surge depended on when the treatment was given after progesterone
removal. Estradiol benzoate administered at 12, 24 or 36 h after CIDR-B removal,
induced an LH surge in all treated heifers (Section 6.0). When EB was given 12 h after
CIDR-B removal the interval from treatment to the LH surge (-26 h) was longer than
when EB was given at 36 h after CIDR-B removal (15 h; Section 6.0). The interval from
estradiol injection at 24 h after CIDR-B removal to the LH surge was intermediate (20
h; Section 6.0). Although progesterone declined to concentrations less than 1 ng/mL 24
after CIDR-B removal, sampling was not frequent enough to detect when this occurred.
Low concentrations of progesterone may have influenced the LH surge in heifers treated
with EB at 12 h, whereas the effect of progesterone would have been minimal or nil in
heifers treated with EB at 24 or 36 h. The LH surge in heifers treated with EB at 36 h
may have been near the time of the spontaneous LH surge, which occurred 78 h after
CIDR-B removal in Control heifers (Section 6.0). Control ofLH secretion after CIDR-B
182
removal in an ovulation synchronization program involved an interaction between the
exogenous and endogenous estradiol and progesterone. Estradiol benzoate given 24 h
after PGF treatment (CIDR-B removal or 48 h after the last feeding of MGA) was used
in our field experiments. High pregnancy rates to fixed-time AI 28 to 30 h after EB
treatment (Section 7.0, 8.0, 9.0) suggested that this schedule may be appropriate for high
pregnancy rates to fixed-time AI and practical from the point of view of cattle handling
and management. Treatment at 12 or 36 h would compromise a morning/evening
schedule of treatments, which would be more difficult to be carried out in field
conditions by beef cattle producers.
The treatment with estradiol given after progestin removal resulted in almost
100% estrus rate. However, results of our experiments also suggested that treatment did
not always result in ovulation at a predictable time (Section 6.0). In some heifers that
had emergence of a follicular wave near the time of CIDR-B removal, EB treatment
given 24 h after CIDR-B removal did not result in ovulation during the interval from 60
to 84 h after CIDR-B removal (those heifers ovulated between 84 and 108 h after CIDR-
B withdrawal). However, it has been shown that treatment with 0.75 mg EB 500 Kg-1
BW given 24 h after CIDR-B removal induced ovulation of follicles that emerged 2 or 5
days before estradiol treatment; there was also no effect of follicle age on the interval to
ovulation (Burke et aI. 2001). In postpartum cows, follicles that arose one day prior to
CIDR-B removal failed to ovulate in four ofnine cows treated with EB 24 h after CIDR-
B removal (Burke et aI., 2001). The effect of maturity of the ovulatory follicle at the
time of EB treatment remains controversial. Further studies should be conducted to
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detennine the effect of EB on the interval to ovulation in cattle at various intervals after
follicular wave emergence.
The use of estradiol and progesterone to synchronize follicular wave emergence
and estradiol to induce ovulation has been very effective in progestin-based
synchronization protocols for fixed-time AI (Sections 6.0, 7.0, 6.0, 9.0). However,
pregnancy rates to fixed-time AI in field experiments in which estradiol and
progesterone were used to synchronize follicular wave emergence and estradiol was
used to synchronize ovulation in PGF-based programs did not appear to be as high,
especially compared to fertility in CIDR-B based protocols (Sections 7.0, 9.0). In the
two-dose PGF protocol, EB administered 7 days after the first PGF treatment seemed to
induce "early" estrus occurred in some heifers (Section 11.0), which was attributed to a
luteolytic effect of the EB treatment given on Day 7. Estradiol has been previously used
in estrus synchronization protocols to cause luteolysis (Wiltbank et aI., 1961; Wiltbank
and Kasson, 1968). In PRID-treated cattle, the administration of 5 mg EB reduced
plasma progesterone concentrations from days 2 to 5 after treatment (Munro and Moore,
1985). However, small doses of EB (200 Ilg) did not affect the luteal life span (Hixon et
aI., 1983). Results of our studies suggest that 2 mg EB was marginally luteolytic. A
single injection of progesterone given early in the estrous cycle has also been shown to
lead to decreased CL weight, the proportion of functional luteal cells and progesterone
production (Loy et aI., 1960). Daily progesterone treatment starting three days after
estrus has been also shown to shorten the length of the estrous cycle (Ginther, 1971).
Because the first PGF injection in our protocol was given at random stages of the
estrous cycle, great variability in follicular development was expected (Kastelic et aI.,
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1990a). Heifers may have ovulated from 1 to 6 days after treatment while others may
have not ovulated at all. Therefore, when 2 mg EB and 50 mg progesterone were
administered 7 days later, heifers were expected to be at different stages of luteal
development, which may have resulted in a CL highly sensitive to estradiol treatment.
There may not have been a single luteolytic effect of EB, but a synergistic luteolytic
effect ofEB and progesterone in heifers cannot be ruled out.
In a second study in which E-17~ was used in lieu of EB, estrous behaviour was
displayed only after the second PGF treatment, and there were no heifers detected in
estrus before the second estradiol treatment. Since E-17~ did not appear to have
detrimental effects on the CL when given with progesterone, early estrus in some heifers
in Experiment 1 (Section 11.0) was attributed to the luteolytic effect of 2 mg EB given
on Day 7 after PGF treatment. Furthermore, as progesterone was given in both
experiments, estradiol would appear to be the factor that induced luteolysis. Both
estradiol formulations given with progesterone to synchronize follicular wave
emergence followed by a single injection of 1 mg estradiol one day after the second
PGF treatment resulted in acceptable pregnancy rates to AI after estrus detection.
However, E-17~ resulted in acceptable pregnancy rates to fixed-time AI, providing an
alternative to progestin-based protocols for fixed-time AI in beef cattle.
In summary, administration of either E-17~ or EB to synch!onize follicular wave
emergence, and a second treatment to induce ovulation, resulted in increased estrus rates
and improved pregnancy rates in CIDR-B- or MGA-treated cattle (Sections 7.0, 8.0, and
9.0). Furthermore, use of either estradiol ester facilitated fixed-time AI in heifers
assigned to prostaglandin-based programs (Section 11.0). However, use of EB may
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result in uterine-induced luteolysis and, therefore, some estrus detection should be done
when this ester is used in a PGF-based program.
12.2 GnRH or LH to synchronize follicular wave emergence and ovulation in
synchronization protocols
Another method to synchronize follicular wave emergence during follicle
development in cattle is to induce ovulation of the dominant follicle. GnRH and LH are
the hormones of choice for ovulation induction (Macmillan and Thatcher, 1991 ;
Twagiramungu et aI., 1995; Martinez et aI., 1999). Administration of exogenous GnRH
stimulated LH and FSH release (Martinez et aI., 2002) and the interval from treatment
with GnRH or LH to the emergence of a new follicular wave has been reported to be
approximately 2 days (Pursley et aI., 1995; Twagiramungu et aI., 1995; Martinez et aI.,
1999). However, ovulation occurred only when an active dominant follicle was present
at the time of treatment (Kastelic and Mapletoft, 1998; Martinez et aI., 1999). It was
further shown that these honnones effectively synchronized follicular wave emergence
only if ovulation of the dominant follicle occurred (Martinez et aI., 1999). However,
there was an additional number of animals in which a spontaneous emergence of new
follicular wave occurred within 2 to 3 days after treatment (Martinez et aI., 1999). This
makes this approach feasible for estrus synchronization and fixed-time AI.
The use of GnRH for manipulation of follicular growth has been investigated in
cattle (Macmillan and Thatcher, 1991; Drost and Thatcher, 1992; Thatcher et aI., 2001).
Synchronization of follicular wave emergence using GnRH has been also used in estrus
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synchronization programs (Thatcher et aI., 1993; Twagiramungu et aI., 1995). In
previous studies, a single dose of GnRH was incorporated into estrus synchronization
programs to cause ovulation of the dominant follicle and emergence of a new follicular
wave, followed 6 or 7 days later by administration of PGF to cause lysis of the induced
and original CL (Twagiramungu et aI., 1992; Thatcher et aI., 1993). Protocols including
two injections of GnRH given 9 days apart with PGF 2 days before the second treatment
have been developed and named "Ovsynch" protocols (described in Section 1.0). These
protocols have resulted in acceptable fertility to fixed-time AI performed at 0 to 24 h
(optimum 16-18 h) after the second GnRH in dairy cows, but not in dairy heifers
(Pursley et aI., 1995; Wiltbank, 1997). Different modifications to this protocol have
been proposed to increase efficacy such as the reduction of number of handlings
(Cosynch protocol), different intervals between the first GnRH and PGF treatment, and
different times of insemination (De Rensis and Peters, 1999).
In the Ovsynch protocol, a number of heifers have been detected in estrus prior
to the scheduled fixed-time AI, especially during the interval from the first injection of
GnRH to PGF treatment. This may be attributed to a low incidence of ovulation (-50%)
to the first GnRH treatment (Purley et aI., 1995; Martinez et aI., 1999). In a previous
report, there was no difference in estrus response or pregnancy rates to AI after estrus
detection between groups of lactating dairy cows treated with an interval of 7 or 8 days
between the first GnRH and PGF treatment (Thatcher et aI., 1993). A shorter interval (6
days) was used in other studies, based on the notion that the number of females in estrus
before the PGF treatment would also be decreased (Thatcher et aI., 1989;
Twagiramungu et aI., 1992). A direct comparison of intervals showed that the precision
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of estrus tended to be greater in heifers treated with a protocol consisting of an interval
of 6 days over 7 days (Roy and Twagiramungu, 1999). Estrus rates during the intervals
from GnRH to PGF treatment in lactating beef cows were similar (8.9 vs. 11.8 % for 6-
and 7-day intervals, respectively) but fertility to fixed-time AI was not compared (Roy
and Twagiramungu, 1999). When intervals of 6 and 7 days were compared in lactating
beef cows in our studies, no differences in fertility were detected (Section 10.0).
However, we did not compare 6- vs 7-day intervals in heifers in which failure of the first
GnRH treatment and early estrus is more likely to occur. Further research should
evaluate ·fertility after fixed-time AI following 6- and 7-day intervals from the first
GnRH to PGF in heifers, as well as the use of a CIDR-B device in LH- or GnRH-based
Ovsynch or Cosynch protocols with a 6-day interval in beefheifers.
Ovsynch protocols have not resulted in acceptable pregnancy rates in dairy
(Pursley et aI., 1995) or beef (Section 10.0) heifers. Administration of GnRH or LH
treatment at different stages of development of the dominant follicle of the first
follicular wave resulted in ovulation in 560/0 (GnRH) or 780/0 (pLH; Martinez et aI.,
1999) of heifers. Circulating progesterone concentrations at the time of treatment may
have adversely affected the ovulatory response in GnRH-treated heifers; ovulatory
response declined from Day 3 (89%), to Day 6 (56%) and to Day 9 (22%; Martinez et
aI., 1999). However, increasing concentrations of progesterone did not seem to affect
response to the administration of pLH, since ovulatory response after pLH treatment
was not different among days (67, 100 or 67% for heifers treated on Days 3, 6 or 9 after
ovulation). Stage of the dominant follicle also affected the ovulatory response.
Dominant follicles smaller that 8 mm in diameter did not ovulate after treatment, while
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50% of dominant follicles of 8 mm ovulated. It is expected that ovulation following the
second GnRH treatment will be higher if the dominant follicle has been selected and
acquired LH receptors prior to treatment (reviewed in Section 1.0).
It was hypothesized that fertility to fixed-time AI could be improved in an
Ovsynch-type protocol in beef cattle by the incorporation of a progestin treatment
during the interval between the first GnRH injection and PGF treatment. This hypothesis
was supported in heifers since the insertion of a CIDR-B device between the first GnRH
or LH injection and PGF resulted in a two-fold improvement in pregnancy rates.
However, no improvement was observed in lactating beef cows (Section 10.0). The
increased fertility after fixed-time AI in heifers was attributed to suppression of estrus
and ovulation during the GnRH-PGF interval. However, high plasma progesterone
concentrations following the insertion of the CIDR-B devices may have reduced
circulating LH concentrations for a period of 72 h, with the consequent atresia of an LH-
dependent dominant follicle, followed by the emergence of a new follicular wave 2 to 3
days later (Cavalieri et aI., 1998). In other words, the use of a CIDR-B device may have
caused regression of the dominant follicle, resulting in resurgence of FSH and a new
follicular wave.
It was proposed that two mechanisms may have been involved in the elimination
of the dominant follicle and the subsequent emergence of follicular waves in heifers
treated with GnRH at CIDR-B insertion. The first mechanism is the induction of
ovulation of the dominant follicle present at the time of treatment (approximately 50%
of heifers; Martinez et aI., 1999, 2000). The second is the suppression of growth of the
dominant follicle that did not ovulate after the first GnRH or LH treatment, because of
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high levels of progesterone. The CIDR-B devices would contribute to increased plasma
progesterone concentrations for at least 72 h, amplifying the suppressive effect of
endogenous progesterone on circulating LH, and the consequence would be regression
of these ovulatory follicles. Finally, in other cattle that did not ovulate, a new wave may
have emerged within one or two days of treatment and this degree of synchrony may be
adequate for fixed-time AI.
In our studies, low plasma LH concentrations were observed for approximately
72 h after insertion of new or once-used CIDR-B devices in ovariectomized cows
(Section 5.0). The elevated concentrations of progesterone may have resulted in
decreased LH pulsatility (Price and Webb, 1988), which may have led to regression of
LH-dependent dominant follicles (Ginther et aI., 1996b). A study involving monitoring
follicular development and hormonal patterns in heifers and cows treated with CIDR-B
devices and Ovsynch-type protocols would help explain the fertility in these programs
and confinn the mechanisms of action ofa CIDR-B device hypothesized herein.
The inclusion of a CIDR-B device in a Cosynch protocol has not always resulted
in improved fertility in beef cattle. Although overall pregnancy rates in the groups with
or without a CIDR-B device in our studies (-43%) were acceptable for an Ovsynch type
protocol (Pursley et aI., 1995; 260/0, Schmitt et aI., 1996a; 53%, Geary et aI., 2001; 41 to
44%, Small et aI., 2001), the beneficial effect of CIDR-B devices on fertility was only
observed in beef heifers. It has been shown that the use of a CIDR-B device in Cosynch
protocols applied at different herd locations resulted in increased overall pregnancy rates
(58%) in beef cows, compared to Control cows treated only with Cosynch (48%; Lamb
et aI., 2001). However, the results were similar among different farms and there was no
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location in which CIDR-B devices resulted in a significant improvement in pregnancy
rates. It is noteworthy that the use of CIDR-B devices in a CosYllch program resulted in
increased pregnancy rates in anestrus cows (Lamb et aI., 2001). Therefore, reproductive
status could affect results in cattle treated with CIDR-B devices.
Body condition can profoundly affect fertility in cows assigned to OvsYllch-type
protocols. Cows assigned to the Ovsynch protocol, in Experiment 2 of Section 10.0, had
a lower body condition (1.5 to 2.0 in a 5-point body condition-scoring scale) than
desired at the beginning of an AI program (2.5 to 3.5; Section 10.0). CIDR-B devices
may not have a substantial suppressive effect on plasma LH concentrations, as cows
under poor nutrition have with low LH concentrations (Murphy et aI., 1991). In Section
8.0, beef heifers were gaining weight prior to treatment but they were transferred to a
diet of only roughage, and pregnancy rates to fixed-time AI were disappointingly low.
An increase of one unit in a 0 to 9 body condition-scoring scale resulted in an increase
of 16.3% in the proportion of cyclic cows (Lamb et aI., 2001). It appeared that CIDR-B
devices resulted in improved fertility in a Cosynch program when applied to cattle with
an optimum body condition. An important consideration to take into account before
applying these protocols for fixed-time AI in a beef herd is the careful observation of
body condition of females.
Similar results were obtained after the use of either pLH or GnRH in OvsYllch-
type protocols. Ovulation rate after a single LH treatment was higher than after GnRH
treatment in beef heifers (78 vs 56%, respectively; Martinez et aI., 1999). Treatment of
beef heifers with 25 mg pLH on Day 6 of the first follicular wave resulted in 100%
ovulation (Martinez et aI., 1999) and response depended only on the stage of
191
development of the dominant follicle. However, cattle under field conditions are almost
invariably asynchronous and therefore a uniform ovulatory response in the herd to LH
treatment has not been observed (Oswald et aI., 2000). Although not directly compared,
fertility after the administration of 12.5 mg LH in Ovsynch-type protocols (with or
without CIDR-B devices) was almost identical to that in protocols using a dose of 100
Ilg GnRH (Section 10.0). Porcine LH has been used to induce ovulation in pregnant
animals (Lulai et aI., 1994) or to induce ovulation of superstimulated follicles in embryo
transfer programs (D'Occhio et aI., 1999), but there has been no previous research
regarding the use of pLH in ovulation synchronization programs for fixed-time AI. This
gonadotrophin has been shown to be an efficacious alternative to GnRH in Ovsynch-
type synchronization protocols, especially in beef heifers, when a CIDR-B device has
been inserted between the first treatment and PGF. In addition, the dose of LH has been
reduced to less than one-half recommended dose, resulting in an acceptable ovulatory
. response at the beginning and end of an LH-based Ovsynch program (Oswald et aI.,
2000). Nevertheless, experiments designed to critically determine the minimum dose of
LH at different stages of the estrous cycle and dominant follicle development are
necessary before use ofpLH could be recommended as a replacement for GnRH.
12.3 Practical aspects of the use of estradiol/progesterone-estradiol, GnRH or
LH in synchronization protocols.
In the induction of estrus and ovulation, estradiol is the key hormone produced
by the preovulatory follicle that commands all signs associated with estrus, LH release
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and, in tum, ovulation. Estradiol administered at an appropriate dose has resulted in a
high degree of synchrony in emergence of an ovarian follicular wave (Be et aI., 1995a;
Burke et aI., 1997a, 1997b; Section 6.0). The combination of estradiol and progesterone
has been shown to affect different stages of follicular growth at the time of treatment
(i.e., dominant follicle before and after selection), while the emergence of the new
follicular wave depended on the life-span of estradiol in the circulation. On the other
hand, GnRH has been partly effective in inducing ovulation of the dominant follicle
(Pursley et aI., 1995), and the emergence of a new follicular wave has depended on the
elimination of that follicle (Pursley et aI., 1995, Martinez, 1999, 2000). Ovulation is
likely to occur after the acquisition of LH receptors which occurrs at the time of
selection of the dominant follicle (i.e., follicles greater than 8 mm in diameter; Xu et aI.,
1995). However, ovulation of a selected dominant follicle does not always occur
following GnRH treatment; some follicles greater than 8 mm in diameter did not ovulate
in response to GnRH treatment (Martinez et aI., 1999).
The treatment with estradiol resulted in a greater number of heifers detected in
estrus than with GnRH or LH (Sections 7.0, 9.0). Estradiol was more consistent than
GnRH or LH in inducing estrus in either CIDR-B- or MGA-based synchronization
protocols (Section 9.0). Estrus rates by 60 h after PGP injection in estradiol-treated
groups ranged from 92 to 100%, whereas estrus rate in GnRH or LH-based Ovsynch-
type protocols ranged from 20 to 400/0 (Sections 7.0, and 10.0). When the second GnRH
treatment was delayed until 72 h, estrus rates increased to 56.7% (Section 8.0). Low
estrus rates (20%) have reported before the time of the second GnRH injection at 48 h
after PGF treatment in cows and some of those (5%) were even detected in estrus before
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PGF (Dejarnette et aI., 2001). Others have reported a relatively high proportion of cows
detected in estrus before PGF in Ovsynch protocols (11 %~ Mialot et aI., 1999) and
heifers (17%; Roy and Twagiramungu, 1996). These animals would have not conceived
to fixed-time AI after the second GnRH injection and any approach to the improvement
of Ovsynch fixed-time AI programs must address this issue.
From a practical point of view, estradiol treatment ensured a vaginal discharge of
estrous mucus and more fluid in the cervix at 'induced' estrus, which facilitated AI,
especially when a high number of females were inseminated. Even though vaginal
mucus and ease of cervical passage by AI technicians have been reported as not being
predictors of pregnancy (Loeffler et aI., 1999), they are indicative that a female is in
estrus and it will affect the manner that insemination is performed. The more fluid in the
cervix, the easier cervical passage and less roughness associated with the procedure.
Fixed-time AI of heifers detected in estrus resulted in high fertility (Section 9.0) and
those observed in estrus had higher pregnancy rates than those not detected in estrus,
regardless of the treatment group. This also confirmed the high fertility observed after
AI in spontaneous estrus in dairy herds (Sturman et aI., 2000).
Estradiol has been shown to facilitate sperm transport in the female reproductive
tract (Harper, 1994). It has been reported that treatment with 10 mg ofEB increased the
sperm count in oviducts, uterus and cervix after mating (Hawk and Cooper, 1975). In
contrast, GnRH or LH may induce ovulation of follicles that may h,ave not reached
maturity, as evidenced by low estradiol influence at AI with "dry" cervix, reported by
the inseminator (Section 7.0). This could result in impaired sperm transport. Although
estrus rates were low (suggesting low estradiol concentrations), treatment with GnRH
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did not appear to compromise the follicular environment and its capacity to yield a
competent oocyte (Twagiramungu et aI., 1995). In our studies, highly acceptable
pregnancy rates ranging from 50 to 68% were achieved after Cosynch and Ovsynch
protocols in which GnRH 'or LH was used in CIDR-B-treated heifers (Sections 7.0, 9.0,
10.0). It has been reported that follicles of 8 or 9 mm (present at the time of treatment)
will ovulate following a single GnRH treatment (Martinez et aI., 1999). Ovulation of
small follicles may result in decreased plasma estradiol concentrations, small CL size,
low plasma progesterone concentrations, and reduced fertility (Vasconcelos et aI.,
2001). Although the use of estradiol to synchronize estrus and ovulation appeared to be
more physiologic than the use of GnRH or LH, there is no assurance that the follicle that
ovulated was more mature or that the CL formed was more functional. The use of one
type of treatment over the other did not affect pregnancy rates at fixed-time AI (Section
9.0).
Regarding movement of cattle to administer treatments, estradiol-based
protocols require one more cattle handling than GnRH- or LH-based Cosynch programs,
due to the treatment given to induce ovulation. However, estradiol treatments have
resulted in similar pregnancy rates demonstrating that the stress related to one more
handling did not aversely affect results. The use of other estradiol esters such as
estradiol cypionate may be an option for fewer passages of cattle through the chute. In
one study, estradiol cypionate administered at the time of CIDR-B removal and PGF
injection has resulted in acceptable pregnancy rates to fixed-time AI (Colazo et aI.,
2002). However, fertility was not as high as when estradiol cypionate was given at 24 h
after CIDR-B removal and PGF treatment (Colazo et aI., 2002). Numbers of handling
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appeared to have no great influence in pregnancy rates. When estradiol-, GnRH- or
pLH-based protocols (with four or three trips through the chute, respectively) were
directly compared, pregnancy rates following fixed-time AI were similar among groups
(Section 9.0).
12.4 Progestins and endogenous progesterone in synchronization protocols.
Results of several experiments in this thesis suggested that the oral progestin
(MGA) and the intravaginal device (CIDR-B) are equally efficacious; however, CIDR-B
has resulted in a higher number of females in estrus and in numerically higher
pregnancy rates than MGA treatment. Even in the same experiment (Section 9.0), there
was a tendency for higher pregnancy rates in CIDR-B-treated groups than MGA-treated
groups, especially when these progestin treatments were used in combination with
Ovsynch-type programs. It has been reported that exogenous progestins are not given at
a dose sufficient to result in the same effects on gonadotrophins (LH) as with
endogenous progesterone from the CL (Kojima et aI., 1995). Therefore, at the common
used dose, progestational treatments suppress estrus and LH peak, but are not
physiological.
As discussed in Section 1.0, traditional long-term MGA programs have resulted
in low fertility (Odde, 1990). In our studies, a low pregnancy rate (-30%) was obtained
with a short-term MGA program in which follicular wave emergence was not
synchronized (Control group of Experiment 1, Section 6.0), compared with estradiol- or
GnRH-treated groups. The reason for low fertility in regimes without synchronization of
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follicular wave emergence is that either progestin could induce a persistent follicle if
luteal regression was occurring during the time of treatment (Custer et aI., 1994;
Patterson et aI., 1989). Oocytes from persistent follicles apparently undergo in vivo
maturation (Revah and Butler, 1996), which is initiated when a period of dominance
exceeds 8 days before the LH surge (Mihm et aI., 1999). However, if the emergence of
follicular waves was synchronized within the treatment period, the development of a
new dominant follicle capable of ovulating a healthy oocyte would overcome this
drawback in MGA programs (Kastelic et aI., 1996), and this newly recruited dominant
follicle can be induced to ovulate in fixed-time AI programs, with acceptable fertility
(Sections 6.0, 9.0 and 10.0).
The treatment groups for synchronization of follicular wave emergence in
experiments in Sections 7.0 and 10.0 were identical, even though MGA replaced a
CIDR-B device during the period between the first treatment with EB, GnRH or pLH
and PGF. For example, in Section 7.0, pregnancy rates after fixed-time AI in an
estradioVCIDR-B-based program averaged 76 and 630/0 in heifers and cows,
respectively; while pregnancy rates were 55.7% in cows and heifers when the same
protocol was applied using MGA during the first 6 days after the beginning of the
experiment. Another comparison was performed in Section 9.0, in which these protocols
were studied in a single experiment. Although there was no significant difference (most
likely due to number of heifers in each group), overall pregnancy rates in MGA-treated
(56%) heifers were numerically lower than in CIDR-B-treated (61 %) heifers, due to the
pregnancy rates in groups treated with GnRH (52 and 65% in MGA and CIDR-B
groups, respectively). Inconsistent consumption of MGA may have played an important
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role in those groups (Fike et aI., 1999). However, problems with MGA intake would be
more likely to occur in cattle on pasture than in cattle fed in dry lot conditions (Fike et
aI., 1999). It has been also observed that MGA does not mimic endogenous progesterone
regulation (Kojima et aI., ·1992). Mean plasma LH concentrations and frequency of LH
pulses were greater in cows treated with MGA when the CL was not present (Kojima et
aI., 1995)~ A high dose ofMGA (three times the recommended dose) resulted in less LH
suppression than progesterone produced when the CL was present (Kojima et aI., 1995).
In our field studies, it was not possible to collect infonnation on circulating
gonadotrophins. However, there was no evidence of an effect of LH suppression by
MGA, as occurred with CIDR-B devices during the first 48 to 72 h after insertion
(Section 5.0) that would cause regression of the dominant follicle. Studies that monitor
ovarian follicle and luteal dynamics in relation to the use of MGA and treatments to
synchronize follicular wave emergence and ovulation should be designed. In addition,
honnonal and ultrasonographic evaluation of Ovsynch-type programs in MGA-treated
cattle should continue.
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13.0 GENERAL CONCLUSIONS
The hypothesis that the synchronization of ovarian follicular wave emergence
and ovulation will facilitate fixed-time artificial insemination and result in pregnancy
rates comparable to insemination after detected estrus was supported by the results
obtained in this thesis. New synchronization protocols that facilitated fixed-time
artificial insemination were developed and fertility was highly acceptable. In addition,
basic information on the effects of steroid or protein hormones on follicular
development was generated, providing the basis by which treatments could be improved.
The following are the general conclusions based on results of the experiments in this
thesis and the current infonnation that has been discussed:
1 - The synchronization of follicular wave emergence and ovulation in an estrus
synchronization protocol for cattle facilitated fixed-time AI;
2 - The administration of either estradiol-17~ or estradiol benzoate in a 7-day
progestin-based protocol in beef cattle synchronized follicular wave emergence
and ovulation, which facilitated fixed-time AI with high fertility;
3 - The emergence of a follicular wave depended on the resurgence of plasma FSH
concentrations following estradiol-induced FSH suppression or GnRH/pLH
induced ovulation;
4 - The duration of FSH suppression depended on the circulating life-span of the
estradiol and the dose used;
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5 - In a two-dose prostaglandin synchronization protocol, the administration of
either E-17~ or EB for the synchronization of follicular wave emergence and
ovulation facilitated fixed-time AI in beef heifers with acceptable fertility.
However, EB caused uterine-induced luteolysis in some heifers;
6 - Both GnRH and pLH were succesfully used in Ovsynch-type programs in cows;
7 - The duration of the interval from the first GnRH to PGF treatment In an
Ovsynch-type protocol did not affect pregnancy rates in lactating beef cows;
8 - The insertion of a CIDR-B device during the interval from the first GnRH/pLH
to prostaglandin in Ovsynch-type synchronization protocols significantly
improved pregnancy rates to fixed-time AI in beef heifers;
9 - Progesterone from CIDR-B devices suppressed plasma LH release and induced
regression of the dominant follicle;
10 - Progesterone given either intravaginally or intramuscularly was not capable of
blocking the estradiol-induced LH surge in ovariectomized cows.
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14.0 SUGGESTIONS FOR FUTURE RESEARCH
The studies reported in this thesis answered the questions related to our main
hypothesis (Section 3.0). However, these studies also provided for the formulation of
new hypotheses. The experiments that examined dose and forms of estradiol are the
basis for new studies to fine-tune of synchronization of follicular wave emergence,
follicular growth and ovulation. Responses following treatment with estradiol and
progesterone should be carefully investigated to assess the optimum proportion of each
steroid in controlling the development of FSH-dependent or LH-dependent follicles.
Resurgence of FSH following estradiol-induced FSH suppression depended on the
circulating life-span of estradiol. Research on dose and the use of other estradiol esters
could lead to more successful alternatives for the manipulation of the ovarian function.
In that regard, studies to evaluate the effectiveness of reduced doses of EVon follicular
development are needed. Studies of specific doses of EB, with or without progesterone,
in two-dose prostaglandin synchronization protocols should also be initiated. Finally,
synchronous emergence of follicular waves facilitated synchronization of ovulation and
high fertility to fixed-time AI. However, research should focus on the optimal interval
from the emergence of a dominant follicle to ovulation that will result in the highest
fertility.
The simultaneous comparison of treatments that affect gonadotrophins in intact
'.
and ovariectomized cattle would provide insight into hormone dynamics. The same
treatment protocols could influence to each category ofcattle differently. In addition, the
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stage of the estrous cycle may also be important, since it was observed that treatment
with estradiol and progesterone after luteolysis had been spontaneously induced, did not
result in follicle suppression and follicular wave emergence. The study of the effect of
estradiol with or without progesterone given at the end of the estrous cycle would
identify the cause ofpossible failure of such a treatment.
Studies that included a CIDR-B device in an Ovsynch protocol reported herein
provide the basis for more detailed research on ovarian physiology in different
categories of cattle. This would result in a better understanding of the use of CIDR-B in
Ovsynch programs in heifers, and of the potential effect of CIDR-B devices or MGA in
Ovsynch protocols in cows. Although results of induction of ovulation and fertility
indicate that GnRH or pLH have similar effects on cattle, a direct comparison of these
hormones in an Ovsynch program with monitoring of follicular dynamics and fertility to
fixed-time AI would also be valuable. Experiments to determine the minimum dose of
pLH at different stages of the estrous cycle and dominant follicle development should be
initiated before widespread use ofpLH in synchronization programs is recommended.
Ultrasonographic and hormonal monitoring of ovanan follicles and luteal
dynamics during and after MGA feeding (with or without treatments to synchronize
follicular wave emergence and ovulation) would increase the understanding of follicular
dynamics in MGA-based protocols.
Additional studies must address the precision of ovulation required to achieve
optimal timing for high fertility to fixed-time AI. The effect of maturity of the ovulatory
follicle at the time of estradiol-induced LH release remains controversial. Further studies
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should be conducted to clarify the effect of EB on the interval to ovulation in heifers and
cows at various intervals after follicular wave emergence. Furthermore, methods of
synchronization of ovulation that require less cattle handling and management should be
considered to increase producers' confidence in AI programs.
Body condition is also an important factor that strongly affects fertility when
applying synchronization protocols for fixed-time AI in a beef herd. Nutritional
management cannot be replaced by a hormonal treatment. The effect of body condition
and feeding regimens on follicular development and response to hormone treatment
must be investigated. Complementary studies on feeding prior to and during
synchronization protocols will contribute to increase fertility in protocols following
fixed-time AI. In conclusion, the design of a synchronization protocol that requires
minimal cattle handling, low cost and results in high fertilitymust be the ultimate goal of
studies involving fixed-time artificial insemination.
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